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Vitamin A, via its active metabolite retinoic acid (RA), actively participates in many biological 
processes including cardiogenesis. Yet RA was found to be highly teratogenic as both excess and 
deficiency of this critical morphogen result in congenital heart defects. Studies presented here aims to 
gain insight in mechanisms regulating RA metabolism during embryogenesis and enrich our knowledge 
of the critical roles of RA during late heart development. Previously, our lab reported that a short-chain 
dehydrogenase/reductase, i.e. DHRS3, is required for preventing excessive accumulation of RA and thus 
safeguarding mouse embryogenesis during mid-gestation. The current study expanded the investigation 
and studied the physiological importance of DHRS3 in RA metabolism at multiple embryonic stages. 
Consistent with the elevated RA synthesis and signaling at E14.5, genetic ablation of Dhrs3 results in an 
expansion of RA signaling at E10.5 and E12.5 globally; as well as in the fetal hearts at E10.5, 12.5 and 
13.5. Dhrs3-null mutants display a spectrum of congenital defects, including defects in the heart, skeleton 
and cranial nerves, which collectively result in mid-gestational lethality in Dhrs3-/- embryos. Reduction of 
maternal intake of vitamin A successfully rescued the Dhrs3-/- fetuses and allows them to survive into 
full-size adults with normal growth rate. These data jointly demonstrated the indispensability of DHRS3 
in reducing the accumulation of RA in various developmental stages and in the formation of fetal organs.  
With the advancement of knowledge in RA metabolism gained in the first part of this dissertation, the 
critical roles of RA in cardiogenesis was further explored in the current work. During late cardiogenic 
stages, the major source of RA is the epicardium. Epicardium contributes greatly to the formation of 
coronary vessels and the myocardium via 1) giving rise to migratory epicardial cells that differentiate into 
perivascular cells, and 2) secreting cardiogenic factors. This dissertation employed multiple in vivo and in 
vitro models to determine the influence of RA on epicardial behaviors and the subsequent epicardial-
regulated cardiogenic events. In vitro studies demonstrated that inhibition of RA synthesis in epicardial 
cell disrupted cytoskeletal reorganization and preserved epithelial characteristics, which resulted in a 
reduction of migration of epicardial cells. On the contrary, addition of RAR agonist to activate RA 
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signaling strongly induced remodeling of cytoskeleton represented by the formation of stress fibers as 
well as filopodia marked by polymerized F-actin. RA signaling also abolished the membranous 
distribution of epithelial markers and induces expression of numerous metalloproteases to pave the way 
for cell migration. Data from in vivo models showed consistent observation in the regulation of epicardial 
migration by RA: excess RA in Dhrs3-/- embryos enhances the intramyocardial invasion of epicardial 
cells whereas deficiency of RA largely retained epicardial cells in the intact epicardium on the surface of 
the myocardium. To further understand the molecular mechanisms underlying the regulation of epicardial 
EMT by RA, we employed transcriptomic analysis, which in combination with further molecular assays 
clearly demonstrated that RhoA pathway is activated by RA and proves to be critical for RA-induced 
morphological changes in epicardial cells. Furthermore, potentially as a consequence of altered epicardial 
behavior and functions in response to aberrant RA signaling, both deficiency and excess RA led to 
compromised coronary vessel formation and hypoplastic ventricular myocardium in vivo. Vascular 
hierarchy was severely impaired and density of intramyocardial vessels was drastically diminished by 
altered RA signaling. Lack of proper recruitment and differentiation of vascular smooth muscle cells 
further acerbated the malformations in coronary vessels in response to abnormal RA signaling. These 
observations provided novel evidence of the teratogenic nature of RA and collectively demonstrated that 
RA signaling is not only actively involved but also critically important in the late heart development, 
which may shed light on the discovery of methods in preventing congenital heart diseases as well as the 
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Chapter 1 : Introduction 
Vitamin A, is required for multiple biological processes during both embryonic development and 
postnatal life. In adults, vitamin A deficiency (VAD) results in growth arrest, blindness, and impaired 
immunity. Both excess and deficiency of vitamin A during fetal life can result in a variety of congenital 
defects (Dickman & Smith, 1996; Hale, 1937; Lammer et al., 1985; Mason, 1935; Shenefelt, 1972; 
Tickle, Lee, & Eichele, 1985; J. S. Waxman, B. R. Keegan, R. W. Roberts, K. D. Poss, & D. Yelon, 
2008; Wilson, Roth, & Warkany, 1953a). Vitamin A exerts its biological functions primarily through two 
of its metabolites: 11-cis-retinaldehyde and all-trans-retinoic acid (ATRA) (Collins & Mao, 1999; Lohnes 
et al., 1994; Wilson & Warkany, 1948). While 11-cis retinaldehyde is required in visual 
phototransduction, ATRA participates in transcriptional regulation via its cognate retinoic acid receptors 
(RARs) which form heterodimers with the retinoid X receptors (RXRs) (Giguere, Ong, Segui, & Evans, 
1987; Kliewer, Umesono, Mangelsdorf, & Evans, 1992; Petkovich, Brand, Krust, & Chambon, 1987). 
Considering the adverse consequences of altered ATRA-signaling, it becomes clear that the levels of 
ATRA within target cells need to be very tightly controlled. Therefore, it is imperative that we develop a 
better understanding of the metabolic pathways that control ATRA formation, transport and breakdown 
and of the transcriptional pathways controlled via ATRA-signaling within target tissues.  
The heart is the first organ to form during embryogenesis, and the success in establishing 
cardiovascular system lays the foundation of further development of other organs and systems. 
Perturbation of cardiogenesis leads to congenital heart defects (CHDs). CHDs are the most common birth 
defects in humans, affecting nearly 1% of newborns in the United States and resulting in 30% loss of 
embryos prenatally (Bruneau, 2008; Hoffman, 1995; Hoffman & Kaplan, 2002). Previous studies have 
revealed a delicate network of genes that regulate cardiogenesis and multiple signaling molecule have 
been involved, including ATRA (Collop et al., 2006; Heine, Roberts, Munoz, Roche, & Sporn, 1985; 
Niederreither, Subbarayan, Dolle, & Chambon, 1999; Osmond, Butler, Voon, & Bellairs, 1991). In this 
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review, we aim to provide an update of the current understanding of the connection between altered RA 
metabolism and / or signaling and several major aspects of congenital cardiac defects, as well as recent 
efforts in unveiling the underlying mechanisms by which RA regulates the cardiac development. 
1.1. RA metabolism and signaling 
Homeostasis of vitamin A is maintained by proper controlled absorption and transport of vitamin A 
from diet. Dietary sources of vitamin A include both preformed vitamin A such as retinol and retinyl 
esters (REs), as well as provitamin A carotenoids such as β-carotene and β-cryptoxanthin, which have 
unsubstituted β-ionone rings. Both forms of vitamin A are absorbed in the intestine and transported to the 
liver by chylomicrons through lymphatic circulation. Upon arrival at the liver, REs are hydrolyzed and 
taken up by the liver to be esterified and stored in the stellate cells for storage in the form of REs. 
Alternatively, retinol in hepatocytes can be secreted in association with serum retinol binding protein 4 
(RBP4), which forms a complex with transthyretin and retinol for further delivery to other tissues 
(Moasser & Dmitrovsky; Shirakami, Lee, Clugston, & Blaner, 2012). Independent of RBP4, vitamin A 
can also be transported as RE in association with VLDL and chylomicrons for delivery to peripheral 
tissues via the lipoprotein lipase (LPL). Clinical studies showed that total loss of RBP4 function in 
patients was associated with VAD-like symptoms (Cukras et al., 2012). Yet in some clinical cases, such a 
mutation was found to be non-symptomatic or cause only mild symptoms, possibly because the lack of 
transport of vitamin A via RBP4 was compensated by circulating REs and β-carotene in these patients 
(Biesalski et al., 1999). During embryogenesis, VLDL and chylomicrons-associated RE and retinol-
bound RBP4 are also the major pathways for delivery of retinoids to the embryo (Moasser & Dmitrovsky; 
Quadro et al., 2005; Sapin, Bègue, Dastugue, Chambon, & Dollé, 1998). Loss of either maternal or fetal-
derived RBP4 can results in VAD-like symptoms in embryos (Båvik, Ward, & Chambon, 1996; Quadro 
et al., 2005). These defects observed in embryos with Rbp4 null mutation displayed with various severity, 
which could be attributed to different maternal levels of REs and provitamin A carotenoids that can be 
delivered across the placenta in a RBP4-independent manner. Interestingly, maternal transmission of the 
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mutation of Rbp4 was noticed to cause much stronger phenotypes in offspring than the mutation 
transmitted by the father. This is because in addition to defects associated with fetal derived non-
functional RBP4, maternally derived defective RBP4 further disrupts the transport of retinoids cross the 
placenta thus reducing the amount of retinoids the embryos get from the mother via RBP4 (Chou et al., 
2015). Though previous studies have clearly demonstrated the importance of RBP4 in delivery of 
maternal vitamin A to the embryo, the mechanism of how vitamin A is transported in the placenta 
remains mysterious because neither maternal nor fetal RBP4 crosses the placental barrier (Quadro et al., 
2004). In addition, when derived from dams reared on vitamin A sufficient diet, Rbp4-/- embryos display 
normal growth in most organs besides the heart, suggesting that additional transport proteins and 
receptors play a role in retinol transport, and that proper delivery of retinol by RBP4 is required for 
cardiogenesis. Indeed, it was found that the concentration of RE in circulation surged in Rbp4-/- mice 
reared on vitamin A sufficient diet, which is not seen in fasted Rbp4-/- mice, indicating that REs 
transported in the conjunction with lipoproteins may compensate for the loss of Rbp4 in most organs 
(Quadro et al., 2004; Quadro et al., 2005; Wendler et al., 2003). 
At target tissue, retinol is imported into cells and either esterified to RE for storage or metabolized to 
ATRA to exert its biological functions. The retinol-RBP4 complex is recognized by the RBP4 receptors, 
such as Stimulated by Retinoic Acid 6 (STRA6) and Retinol Binding Protein Receptor 2 (RBPR2) 
(Alapatt et al., 2013). STRA6 can bind to RBP4 with high affinity and function as a bidirectional 
transporter of retinol by mediating influx or efflux of retinol, depending on the levels of intracellular 
retinol and the ratio of holo- to apo-RBP4 (Isken et al., 2008). STRA6 has also been found to be 
responsible for transferring retinol across the blood-tissue barrier in adults (M. Kelly, Widjaja-Adhi, 
Palczewski, & von Lintig, 2016). Yet, Stra6 null mutant mice display profound retinoid deficiency and 
impaired development of the visual tissues but otherwise develop normally, possibly due to a 
compensatory effect of other RBP4 receptors such as RBPR2 or other modes of retinol uptake by non-
visual target tissues (Berry et al., 2013). In fact, Rbpr2 has distinct expression domain from Stra6, and has 
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been shown to facilitate retinol import in tissues where Stra6 is absent, such as adult liver and intestine 
(Bouillet et al., 1997).  
 
Figure 1.1 Overview of RA metabolism and signaling 
Intracellular retinol is metabolized to RA through a two-step oxidation (Fig 1.1). Retinol is first 
reversibly oxidized to an intermediate, i.e. retinaldehyde, by either medium-chain alcohol dehydrogenases 
(ADHs), or short-chain dehydrogenase/reductase (SDR) enzymes. Of the latter, retinol dehydrogenase 10 
(RDH10), has been shown to be critical for RA synthesis during embryogenesis. Mouse embryos lacking 
Rdh10 die at E9.5 of a variety of congenital defects similar to those observed in embryonic models 
lacking sufficient RA, such as craniofacial defects and malformed forelimbs (Clagett-Dame & DeLuca, 
2002; Niederreither, Subbarayan, Dollé, & Chambon, 1999; L. L. Sandell et al., 2007). Maternal 
supplementation of either RA or retinaldehyde successfully postponed the embryonic lethality in Rdh10 
null mice. The first oxidation of retinol to retinaldehyde is reversible and the reductive reaction is 
essential for fine-tuning the rate of ATRA formation and to prevent ATRA-induced teratogenic effects. 
Retinol produced as a result of reduction of retinaldehyde can be sequestered as RE for storage internally 
or exported externally to other tissues. Previously, we and others have demonstrated that the reduction of 
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retinaldehyde in embryos is primarily carried out by short-chain dehydrogenase/reductase family member 
3 (DHRS3) (Adams, Belyaeva, Wu, & Kedishvili, 2014; Billings et al., 2013; Feng, Hernandez, Waxman, 
Yelon, & Moens, 2010; R. K. T. Kam et al., 2013). Global deletion of Dhrs3 in mouse embryos results in 
an elevated level of ATRA, which leads to late-gestational lethality as well as congenital defects such as 
cleft palate, heart malformations and skeletal defects (Billings et al., 2013). Interestingly, a recent study 
reported that DHRS3 and RDH10 have overlapped expression patterns in the limb bud where they 
associated and reciprocally activated each other (Adams et al., 2014), which allows for the fine-tuning of 
the production of RA in embryonic tissues. Other enzymes, such as some aldo-keto-reductase, have also 
been shown to participate in the reduction of retinaldehyde in vitro however their importance during 
embryogenesis needs further investigation (Gallego et al., 2007; Ruiz et al., 2009; Ruiz et al., 2011).  
The second oxidation step, converting retinaldehyde to RA, occurs quickly and irreversibly. Though 
multiple enzymes have been found to be able to catalyze this reaction in vitro, genetic evidence identified 
retinaldehyde dehydrogenase (RALDH) 1, 2 and 3 as the major RA-synthesizing enzymes in 
embryogenesis (Kumar, Sandell, Trainor, Koentgen, & Duester, 2012). RALDHs have distinct expression 
patterns and thus are in charge of RA synthesis at different time points and in various tissues. Among 
these enzymes, RALDH2 is the most critical for cardiogenesis, since Raldh2 mutant mouse embryos die 
around E9.0 and display a wide range of severe defects in the heart (Niederreither et al., 2001; Karen 
Niederreither et al., 1999). RALDH3 is found in the embryonic retina, nasal area as well as skeletal 
muscle. Absence of Raldh3 leads to perinatal lethality, primarily because of respiratory distress induced 
by insufficient ATRA signaling reference. On the contrary, a lack of Raldh1, which expresses in the 
brain, retina and cardiac valves, does not cause embryonic death, possibly because of the compensation 
by the other RALDHs (Deltour, Foglio, & Duester, 1999). Besides RALDH1-3, another RALDH-
independent ATRA synthetic enzyme has also been reported, i.e. CYP1B1, whose expression overlaps 
with RALDH2 in the mesoderm and can compensate for the lack of RALDH2. This compensation might 
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be responsible for the ameliorated phenotypes in Raldh2-/- embryos when compared to complete VAD 
quail model. 
Degradation of retinoic acid is catalyzed by cytochrome P450 family member, CYP26 A1, B1 and 
C1, which hydrolyze excess retinoic acid to inactive metabolites. Oxidative products of RA were 
proposed to mediate signaling functions but evidence derived from genetic models demonstrates that 
deficiency in the Cyp26a1 can be rescued by a reduction in the expression of Raldh2. This suggests that 
oxidative metabolites do not carry out essential roles in embryogenesis (Niederreither, Abu-Abed, et al., 
2002). Loss of function studies, highlight the necessity of these enzymes to limit the concentration of RA 
and act to prevent the expansion of RA-signaling domains. Cyp26a1-/- embryos have truncated posterior 
structures and die during mid-gestation (Suzan Abu-Abed et al., 2001); Cyp26b1-/- mice display 
craniofacial and limb defects and die right after birth (Glenn Maclean, Dollé, & Petkovich, 2009; Yashiro 
et al., 2004); while ablation of Cyp26c1 does not result in any embryonic defect (M. Uehara et al., 2007). 
Similar to Raldh1-3, Cyp26a1-c1 has distinct expression domains. Interestingly, their expression patterns 
have been observed to be complementary to ATRA synthesizing enzymes: Raldh2-enriched regions are 
neighbored with Cyp26-expressing regions, for example in the developing anteroposterior axis and 
tailbud (Sakai et al., 2001; Swindell et al., 1999). While Raldhs-expressing domains act as the source of 
producing ATRA, Cyp26-expressing regions function as a sink to constrain the distribution of ATRA and 
thus control its endogenous level at distinct regions and windows of development. These complex 
expression patterns of Raldhs and Cyp26 create a gradient of ATRA in the embryo, which provides 
guidance to the anteroposterior patterning of the body axis and hindbrain (Suzan Abu-Abed et al., 2001; 
Ribes, Fraulob, Petkovich, & Dolle, 2007; Sakai et al., 2001). As mentioned before, the levels of RA are 
further fine-tuned at the level of interconversion of retinol-retinaldehyde (Adams et al., 2014). 
Beside retinol, provitamin A carotenoids can also be converted to retinaldehyde to participate in 
retinoid metabolism. Provitamin A carotenoids, such as β-carotene, serves as the major source of 
retinoids in herbivores. Uptake of carotenoids is mediated by Scavenger receptor class B member 1 
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(SCARB1) in the intestinal epithelial cells. Upon absorption, carotenoids undergo oxidative cleavage by 
β-carotene-15,15-dioxygenase 1 (BCDO1) to produce retinaldehyde, which is either reduced to retinol for 
redistribution into other organs or oxidized to RA for signaling (Hessel et al., 2007; von Lintig & Vogt, 
2000; Wyss et al., 2000). Since the conversion of β-carotene to retinaldehyde and that of retinaldehyde to 
RA are both irreversible and RA levels have to be tightly controlled to prevent toxic effects, enzymes that 
can convert retinaldehyde to retinol and thus prevent the relentless accumulation of RA, for example 
DHRS3, are of critical importance especially in herbivorous animals.  
As a potent teratogen, RA maintains its own homeostasis by regulating metabolic enzymes through 
feedback mechanisms. It was noticed that the levels of absorption of carotenoids are sensitive to the status 
of retinoids. Mice reared on VAD diet have much higher absorption of β-carotene and elevated 
expression levels of Scarb1 and Bcdo1, suggesting a self-adjusting homeostasis of the metabolism of 
retinoids (Lobo et al., 2010). Further analysis identified a RA-responsive transcription factor, namely 
Intestine Specific Homeobox (ISX), to be exclusively expressed in the epithelial cells of the gut where 
carotenoids are absorbed. Activated RAR induces the expression of Isx through binding to a regulatory 
cis-element in the promoter of Isx, while Isx efficiently binds and suppresses the expression of Scarb and 
Bcdo1. Consistently, Isx-null mutant mice absorb higher amount of β-carotene. Thus, RA controls the 
absorption of β-carotene through transcriptionally inducing the expression of Isx, which down-regulates 
the transcription of Scarb and Bcdo1. In addition, RA regulates its metabolism by directly or indirectly 
modulating the transcription of critical enzymes involved in RA metabolism. For example, activation of 
RA signaling strongly up-regulates the transcription of enzymes that either degrade RA or prevent the 
formation of RA, i.e. Cyp26a1 and Dhrs3, respectively; and down-regulates the expression of RA 
synthetic enzymes, such as Rdh10 and Raldh2, was found to be suppressed by excess RA (Abu-Abed et 
al., 1998; Billings et al., 2013; Emoto, Wada, Okamoto, Kudo, & Imai, 2005; Feng et al., 2010). 
The complex regulation of RA in biological processes ensures that RA signaling can transcriptionally 
modulate gene expression in a precise spatial and temporal manner. ATRA regulates the transcription of 
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target genes through binding as a ligand to nuclear receptor RAR and RXR. In the absence of ATRA, 
RAR and RXR form heterodimer which have been found to be associated with a DNA sequence termed 
retinoic acid response element (RARE) in the promoter of RA target gene. The RAR/RXR complex also 
recruits transcriptional co-repressors to suppress gene expression in such a non-ligand silent phase. Once 
ATRA is present, the conformational changes brought by the binding of ligand to the RAR/RXR complex 
lead to dissociation of the co-repressors and the recruitment of co-activators to relax the chromatin and to 
facilitate gene transcription. Though binding of ATRA to the RAR/RXR heterodimer generally results in 
the activation of transcription of target genes, there is evidence that in some cases it can lead to 
suppression of some targets, for example Fibroblast growth factor 8 (Fgf8) (Kumar & Duester, 2014). 
Recent studies have proposed that the mode of regulation of gene transcription by RA (activation versus 
repression) is dictated by the type of RARE and its local environment. Analysis of the occupancy of RAR 
on genome revealed that a typical RARE consists of direct repeats of 5’-PuGGTCA-3’ that are spaced by 
1, 2 or 5 nucleotides, namely DR1, 2 and 5. Novel RAREs are being continuously identified such as DR0 
and DR8 (Emmanuel Moutier et al., 2012). Most DRs were found to be capable of regulating 
transcription independently upon ligand binding to RAR, and DR0-RARE was noticed to Therefore, the 
distribution of RA signaling depends on the expression of both RA metabolic enzymes and the signaling 
elements. RAR and RXR each have 3 isoforms, α, β and γ (Kliewer et al., 1992; Krust, Kastner, 
Petkovich, Zelent, & Chambon, 1989; Petkovich et al., 1987); each has distinct spatiotemporal expression 
patterns and biological functions during embryogenesis (Lohnes et al., 1994; Mollard et al., 2000). Yet 
these receptors also possess some level of redundancy in their physiological roles, since genetic deletion 
of a single RAR has mild phenotype when compared to a double knock-out mutant and does not result in 
a full spectrum of VAD syndrome, most likely due to a compensatory effect by other isoforms of existing 
RARs (Ghyselinck et al., 1997; Hutson & Kirby, 2007; E. Li, Sucov, Lee, Evans, & Jaenisch, 1993; 
Subbarayan et al., 1997). 
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1.2. Cardiogenesis and its dependence on RA signaling 
The formation and maturation of the heart is achieved by contribution from cells derived distinct 
origins including the mesoderm and ectoderm. At E7.5, the myocardial progenitor cells starts to develop 
from the splanchnic lateral plate mesoderm and form the cardiac crescent, which is also known as the 
primary heart field (PHF) (Figure 1.2). Another population of cardiogenic cells derived from the 
pharyngeal mesoderm reside medial to the PHF and form the second heart field (SHF). Progenitor cells 
arising from PHF/cardiac crescent and SHF contribute different to the morphogenesis of the heart. In 
mouse embryos at E8, cardiac crescent folds and fuses medially to form the primitive heart tube, through 
which blood can flow to establish systemic circulation. The heart tube elongates with the addition of cells 
from the SHF and neural crest to the anterior region of the heart. As the heart tube grows, it loops to the 
right at E9 and start to develop septation between chambers at E10. Whereas cells from PHF contribute 
primarily to the myocardium, progenitor cells derived from the SHF facilitates the development of the 
atrium, outflow tract (OFT) and right ventricle (Galli et al., 2008; S. Zaffran, Kelly, Meilhac, 
Buckingham, & Brown, 2004). The neural crest cells that contribute to the formation of the heart are 
termed cardiac neural crest cells and they play an important role in the septation of OFT (Minoux & Rijli, 
2010). During E9.0 to E9.5, cells derived from the proepicardium (PE), a cluster of cardiac progenitor 
cells that originate from mesothelium and reside adjacent to sinus venosus, migrate and cover primitive 
heart tube to form the epicardium, which promotes development and maturation of myocardium and 
coronary vessels (Ingo Stuckmann, Samuel Evans, & Andrew B. Lassar, 2003). With the addition of these 
progenitor cells, the primitive heart tube finally develops to a well-segregated four-chambered organ that 
can pump blood to peripheral tissues to provide nutrients and take away waste, which is fundamentally 
important for embryos when diffusion is not sufficient. This elaborate cardiogenic process requires the 
coordination of multiple signaling molecules, including RA, which can modulate cell proliferation, 





Figure 1.2 Heart morphogenesis in mouse embryos.  
Cardiogenic progenitor cells populate the cardiac crescent (green) and the SHF (red) at embryonic 
day (E) 7. At E8, cardiac crescent fuses to form the primitive heart tube and progenitors derived from 
SHF are added to both poles of heart tube to facilitate the elongation of the heart. Cardiogenic CNCCs 
start to migrate to cardiogenic fields to assist heart formation. Primitive heart tube loops to the right at E9 
and cells from PE (blue) start to migrate to the surface of the looping heart to form epicardium. At E10, 
septation between cardiac chambers begins to form and the heart develops into a four-chambered organ. 
 
The requirement of RA during cardiogenesis has been well established in multiple models. Dietary 
approaches have been historically most common method to study the role of vitamin A in development 
animals. Avian embryo lacking vitamin A displays severe cardiovascular defects, most notably a lack of 
inflow tract due to the closure of posterior heart tube (Heine et al., 1985). Genetic ablation of genes 
involved in RA metabolism and signaling was frequently employed to study the roles of RA in 
cardiogenesis and results derived from those genetically modified models suggest that perturbation of RA 
signaling can lead to various cardiac malformations. Ablation of Raldh2 or Rdh10 in mice leads to early 
embryonic lethality with severe malformations in early heart development, such as dilation and failed 
looping of the heart tube (K. Niederreither et al., 1999; Lisa L. Sandell, Lynn, Inman, McDowell, & 
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Trainor, 2012). Maternal supplementation of RA postpones the lethality induced by deficiency of RA 
signaling in those mutant embryos and the rescued Raldh2 and Rdh10 null mutants display other 
spectrum of cardiac defects, which include double outlet ventricle, common arterial trunk, thin ventricular 
wall and hypoplastic atria; as well as defective coronary vessel formation and misaligned great arteries 
(Azambuja et al., 2010; Hoover, Burton, Brooks, & Kubalak, 2008; Kastner et al., 1997; S.-C. Lin et al., 
2010; M. Rhinn, Schuhbaur, Niederreither, & Dolle, 2011; Muriel Rhinn & Dollé, 2012). Genetic or 
pharmacological approaches have also been employed to test the necessity of RA signaling during 
cardiogenesis and due to the redundancy between different isotypes of RARs and RXRs, two or more 
RARs/RXRs have to be deleted to effectively abolish RA signaling. Loss of function of RAR and/or RXR 
recapitulates cardiac defects observed in VAD models, further supporting the requirement of sufficient 
RA signaling in the formation of the heart (Chazaud, Chambon, & Dolle, 1999; Romeih, Cui, Michaille, 
Jiang, & Zile, 2003) . On the other hand, overexposure of chicken embryos to high levels of RA results in 
a variety of cardiac defects including cardia bifida, abnormal looping of the heart tube and even 
duplicated hearts in severe cases (S. M. Smith, Dickman, Power, & Lancman, 1998; Zile, 1999). 
Hyperactivation of RA signaling achieved by genetic deletion of enzymes that prevent accumulation of 
RA, i.e. CYP26 and/or DHRS3, can also impair cardiogenesis (Billings et al., 2013; Niederreither et al., 
2001; Pennimpede et al., 2010). Mouse embryos lacking Cyp26a1 manifest defective cardiac looping; 
Cyp26a1 and c1 double mutation increases the number of atrial cells; Dhrs3 null mice display several 
defects including double outlet ventricle, septal defects and impaired looping (Suzan Abu-Abed et al., 
2001; Billings et al., 2013; A. B. Rydeen & Waxman, 2014). Interestingly, embryos with excess or 
deficient RA signaling share a largely overlapping spectrum of symptoms (Billings et al., 2013; 
Kolodzinska, Heleniak, & Ratajska, 2013; G. Maclean, Dolle, & Petkovich, 2009; M. Uehara et al., 
2007), the basis of which is worthy of further investigation. 
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1.3. RA and early cardiogenesis 
Early embryonic development of the heart involves the contribution from progenitor cells from two 
distinct cardiogenic fields. Precursors derived from the PHF build up the primitive heart tube and are the 
first to differentiate into cardiomyocytes. These cells contribute primarily to the prospective left ventricle. 
A second wave of splanchnic mesodermal-derived progenitors is the cardiogenic cell population from the 
SHF. During the formation of the cardiac crescent the SHF progenitor cells remain undifferentiated and 
highly proliferative thus facilitating the growth of the heart tube. Strikingly, studies have found that SHF 
cells are pre-patterned before migrating to the initial heart tube. In pharyngeal mesoderm, while LIM 
transcription factor Islet1 being a pan-SHF marker (Cai et al., 2003), the expression of Fgf10 and/or T-
box 1(Tbx1) specifies the anterior SHF and that of Tbx5 marks the posterior portion. Fate-tracing 
experiment using Fgf10 promoter-driven lacZ transgene indicated that the rostral SHF cells contribute to 
the right ventricle and the myocardium of OFT (S. Zaffran et al., 2004). Fluorescent dye based-cell 
tracing in chicken embryos later showed that the posterior SHF progenitor cells give rise to the atria and 
sinus venosus (Galli et al., 2008; R. G. Kelly, 2012). Previous studies have demonstrated that surgical 
ablation of SHF results in defects in OFT such as overriding aorta and pulmonary atresia (Ward, Stadt, 
Hutson, & Kirby, 2005) and the genetic deletion of SHF-specific genes such as Isl1 and Fgf8 leads to 
defective septation and misalignment of the OFT, as well as failure in heart looping and elongation (Cai 
et al., 2003; Ilagan et al., 2006; Xu et al., 2004). These data clearly demonstrated the importance of SHF 
in the heart morphogenesis. 
Sufficient and appropriate RA signaling is critical for the early development of the primitive heart 
tube. Embryos with severe VAD display early mortality; for example, Raldh2-/- mice and quail VAD 
embryos die before E9.5 and E4, respectively (Dersch & Zile, 1993; Kostetskii et al., 1999; Twal, Roze, 
& Zile, 1995). Analysis of the gross morphology of these embryos found that the hearts fail to loop and 
occasionally exhibit situs inversus. The posterior portion of the quail embryonic heart tube is severely 
affected by VAD: the inflow tract is closed and thus not connected to the embryonic or extra-embryonic 
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blood circulation. Detailed examination of cardiac markers demonstrated that shortage of vitamin A 
supply leads to a loss of left-right asymmetry and the disorganization of the A-P axis in the heart tube 
(Karen Niederreither et al., 1999). The early mortality of embryos lacking sufficient RA can be rescued 
by administration of exogenous RA. Maternal replenishment of RA corrected most cardiac abnormalities 
in Raldh2-/- mouse embryos besides the septal defect of OFT (Niederreither et al., 2001). Addition of 
ATRA at the 5-somite stage fully recovered cardiogenic programs in VAD quail embryos, suggesting a 
critical retinoid-sensitive window during early avian development (Kostetskii et al., 1998). From the point 
of view of RA-signaling, the RA receptors RARα, RARγ and RXRα are expressed in the precardiogenic 
mesoderm at 5-somite stage and the major RA synthetic enzyme Raldh2 was found to be expressed 
adjacent to the sino-atrial region of the early heart from E8.25 and on in mouse embryos (Jennifer B Moss 
et al., 1998). In conclusion, all the components of RA signaling are present in early cardiogenesis 
(Kostetskii et al., 1998). Contrary to VAD models, excess RA applied to chicken embryos leads to a 
misshaped and abnormally looped heart tube. Situs inversus and duplication of the heart are also observed 
when teratogenic dose of RA (100µg/ml) is added (Dickman & Smith, 1996; Osmond et al., 1991). 
However, the teratogenic effect of RA in heart looping seems to be position-dependent; ATRA added to 
the right precardiac field disrupts the heart rightward looping while the same dose added to the left has no 
significant effect (S. M. Smith et al., 1997). Therefore precisely controlled amount of RA at the right time 
and place is indispensable for normal early cardiogenesis (Xavier-Neto et al., 2015). 
1.4. The role of RA in specification of cardiac progenitor pool 
Studies from multiple animal models suggest RA limits the size of cardiac progenitor pool especially 
in the SHF. Raldh2-null mutant mouse embryos display an expansion of the cardiac marker Nkx2.5, pan-
SHF markers Isl1 as well as several anterior SHF makers (Lucile Ryckebusch et al., 2008; Sirbu, Zhao, & 
Duester, 2008). Zebrafish embryos with reduced RA synthesis or signaling exhibit an increased Nkx2.5-
positive cardiogenic cell population and while addition of exogenous RA has the opposite effect on the 
size of progenitor pool (Keegan, Feldman, Begemann, Ingham, & Yelon, 2005). Similarly, Xenopus 
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embryos treated with an RA antagonist have transient increase in the size of Nkx2.5-expressing 
cardiogenic domain (Collop et al., 2006). In contrast to RA-deficient models, addition of RA to SHF in 
chicken embryos down-regulates the expression of SHF markers Isl1 and Fgf8 (Narematsu, Kamimura, 
Yamagishi, Fukui, & Nakajima, 2015). As consequences of the changes in early cardiogenesis, the later 
cardiac development shows consistent alteration in heart sizes in response to abnormal RA signaling. 
Blocking either synthesis or signaling of RA leads to enlarged cardiac chambers with significant increase 
in cell number (J. S. Waxman et al., 2008; Waxman & Yelon, 2009). However observation made in 
zebrafish model treated with various doses of RA suggested that RA seemed to have dual roles in the 
formation of heart at different concentrations and that ventricular and atrial cardiomyocytes showed 
different sensitivity to RA signaling. Waxman et al. reported that while addition of teratogenic dose of 
RA (high dose) could dramatically reduce both cardiac chambers in zebrafish embryos, low dose of RA 
paradoxically increased the number of cell in the atrium but did not alter the formation of ventricle (J. S. 
Waxman et al., 2008; Waxman & Yelon, 2009). The authors reasoned that the regulation of the size of 
primitive cardiogenic pool requires higher RA signaling while the A-P patterning of heart tube and 
subsequent determination of chamber sizes are more sensitive to RA signaling and requires only low 
levels of RA. Though this hypothesis might explain the observation, it needs to be considered with 
caution and information about spatiotemporal distribution of RA synthesis and signaling in the 
cardiogenic region, as well as the information of physiological concentrations of RA during early heart 
formation. Despite the paradoxical observation with low dose of RA in zebrafish, previous studies have 
clearly demonstrated a critical role of RA in affecting the size of cardiac progenitor pool during early 
heart formation. 
In zebrafish models, a new mechanism was recently proposed that RA signaling affects the cardiac 
progenitor pool through influencing the fate decision of mesodermal-derived progenitor cells. Embryos 
lacking sufficient RA signaling have expanded cardiac progenitor pool and severely reduced forelimb, 
indicating a converse relationship between the development of the heart and the forelimb (Grandel et al., 
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2002). Zebrafish models have been broadly used in aspect of studying the influence of RA-regulated non-
cardiogenic lineage in cardiogenesis. Unlike mouse and chick embryos where RA synthesizing enzyme 
Raldh2 is expressed in the posterior cardiac field at the cardiac crescent stage (Tatiana Hochgreb et al., 
2003; Sirbu et al., 2008), in zebrafish Raldh2 is expressed in the forelimb field posterior to the 
cardiogenic region. Consistent with this distribution of RA synthesizing enzyme, several RA-responsive 
genes are expressed in the forelimb field but not the heart, for example Homeobox b5b (Hoxb5b) (Joshua 
S. Waxman, Brian R. Keegan, Richard W. Roberts, Kenneth D. Poss, & Deborah Yelon, 2008). These 
observations imply that the functions of RA in regulating cardiac progenitor pool might be indirect and 
acting in non-cell-autonomous fashion. Results from fate mapping technique that marks the multipotential 
blastomeres demonstrated that in response to blocked RA signaling, pluripotent progenitor cells commit 
to cardiac-lineage two times as frequently compared to the control group, suggesting that RA functions to 
limit cardiogenic fate decision and promote non-cardiac lineage commitment (Keegan et al., 2005). Later 
studies from the same lab further reported that the expanding cardiac progenitors in RA-deficient 
zebrafish embryos occupy the domain where normally forelimb progenitor cells would reside, indicating 
a balance between cardiac and forelimb lineages that is RA-responsive. However, even though in the 
transplant study, donor cells contribute more to cardiogenic progenitors and less to fin mesenchyme in 
response to a lack of RA signaling, no fate transformation between these two lineage populations have 
been observed (Joshua S. Waxman et al., 2008). Therefore, RA can influence fate decision of the 
pluripotent progenitor cells independently before their fate decision, but not after.  
Molecular analysis identified Tbx5 to be critical in carrying out the roles of RA in regulating limb 
versus cardiac lineage specification. As discussed above, cell fate decision between limb and cardiogenic 
populations greatly affects the development of the heart and RA signaling may indirectly limit 
cardiogenic pool by promoting forelimb progenitor formation. One of the genes that are RA-responsive 
and regulate forelimb development is Tbx5 (Mercader, Fischer, & Neumann, 2006; Lucile Ryckebusch et 
al., 2008). Similar to Nkx2.5 and Gata4, Tbx5 is one of the earliest expressed genes in cardiogenic 
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mesoderm (Chapman et al., 1996; Liberatore, Searcy-Schrick, & Yutzey, 2000). Embryos lacking 
sufficient RA or RA signaling consistently show a reduced Tbx5 domain and a loss of forelimbs, while 
loss of Tbx5 greatly compromised the limb formation (Agarwal et al., 2003; Grandel et al., 2002; K. 
Niederreither et al., 1999; Niederreither et al., 2001; Lucile Ryckebusch et al., 2008). In zebrafish model, 
activation of RA-signaling was found to promote fin development through activating Wnt, Tbx5 and 
Fgf10 sequentially in the fin bud-forming zone (Mercader et al., 2006), thus potentially inhibiting the 
cardiogenic potential of pluripotent progenitor cells.  
Another candidate downstream of RA signaling in mediating the formation of heart and forelimb is 
Fgf8. Deficiency of RA signaling leads to increased expression of cardiogenic SHF marker Fgf8 
(Mercader et al., 2006; Sirbu et al., 2008) while activation of RA signaling directly suppressed Fgf8 
transcription by modulating the activity of a repressive RARE in the promoter of Fgf8 (Kumar & Duester, 
2014; Sorrell & Waxman, 2011). Previous studies have demonstrated that Fgf8 is capable of increasing 
the number of cardiogenic progenitors but limiting the formation of forelimb (Marques, Lee, Poss, & 
Yelon, 2008; Sorrell & Waxman, 2011). Molecular analysis further suggests that Fgf8 induces the 
expression of key cardiogenic transcription factors such as Isl1 and Nkx2.5 (Marques et al., 2008; 
Reifers, Walsh, Leger, Stainier, & Brand, 2000; Sirbu et al., 2008). Meanwhile, the cardiogenic Fgf 
signaling was noticed to antagonize the expression of Tbx5 that favors limb formation (Marques et al., 
2008). More importantly, reducing Fgf8 level rescued the heart and forelimb defects in those RA 
signaling-deficient embryos (Kumar & Duester, 2014; Sorrell & Waxman, 2011).  Therefore, it was 
plausible that in the forelimb-developing region RA sustains the expression level of Tbx5 through 
suppressing Fgf8, while in the cardiogenic region where RA signaling is reduced, cardiogenic molecule 
Fgf8 is highly expressed to promote the cardiogenesis. 
Besides Tbx5 and Fgf8, Hoxb5b has also been found to be an RA-inducible gene that promotes fin 
development and restrict the formation of atrial cardiomyocytes. Due to the absence of Hoxb5b in the 
heart field, the inhibitory effect Hoxb5b on the number of atrial cardiomyocytes is then believed to be 
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non-autonomous. Strikingly, overexpression of Hoxb5b recapitulate phenotypes seen in zebrafish treated 
with high dose of exogenous RA (0.3µM), such as a reduction in the number of cardiomyocytes in 
ventricles and atria (J. S. Waxman et al., 2008). Thus Hoxb5b has also been considered as a candidate for 
transducing RA signaling from non-cardiac tissue to guide the development of cardiogenic pool. 
Last but not least, the expansion of cardiac progenitor pool in response to reduced RA signaling has 
also been proposed to be attributed to a LIM domain protein, Ajuba. In undifferentiated P9 cells, RA 
induces the expression of Ajuba in a dose-dependent manner (Yu, Levi, Siegel, & Noy, 2012). Hagen et 
al. recently reported Ajuba modulates the number of cardiomyocytes in zebrafish not by affecting their 
proliferation but through limiting the number of the Isl1+ cardiac progenitors. Transcriptional activity 
assay suggested that Ajuba binds Isl1 and represses the transcription of Isl1 in vitro. As consistent with 
previous studies that RA deficiency expands the Isl1 expression domain, addition of RA potentiates the 
interaction between Ajuba and Isl1 and increase the abundance of this complex, thus reducing the 
expression of Isl1. Therefore, RA restricts the size of Isl1+ cardiogenic pool possibly through mediating 
the Ajuba-Isl1 complex. 
1.5. The role of RA in determining the A-P patterning of heart tube 
During early cardiogenesis, anteroposterior (A-P) patterning in fetal heart is tightly correlated with 
RA metabolism and signaling. Immunohistochemistry analysis of RALDH2 in quail embryo 
demonstrated that this critical RA-synthesizing enzyme is highly expressed at the venous pole of the 
avian heart tube and that its expression gradually fades out anteriorly (J. B. Moss et al., 1998; Karen 
Niederreither et al., 1999; Xavier-Neto, Shapiro, Houghton, & Rosenthal, 2000). This expression pattern 
of RALDH2 also overlaps with the marker of the posterior heart tube, atrial-specific myosin heavy chain 
1 (AMHC1), in the cardiogenic region which is destined to develop into atria and sinus venosus (Xavier-
Neto et al., 2000). Moreover, RA signaling revealed by RARE-reporter mouse models was shown to be 
activated in the posterior region of cardiogenic splanchnic mesoderm, which corresponds to the posterior 
SHF and the prospective sinus venosus and atria (Dolle, Fraulob, Gallego-Llamas, Vermot, & 
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Niederreither, 2010; J. B. Moss et al., 1998). The restricted localization of the RA synthetic enzyme and 
RA signaling to the caudal region of the heart tube suggests that RA promotes posterior cardiac identity.  
Multiple approaches have been used to understand the role of RA in the A-P patterning of the heart. 
In Raldh2 deficient mice, the sinoatrial region of the heart tube is severely affected. In Raldh2-/- embryos, 
anterior cardiac markers expand caudally, for instance Fgf8 and the expression of posterior cardiac 
marker Tbx5 is reduced (Niederreither et al., 2001; L. Ryckebusch et al., 2008; Lucile Ryckebusch et al., 
2008). VAD quail embryos exhibit severe truncation of the posterior region of the heart, leading to early 
embryonic lethality (Heine et al., 1985). In contrast, chicken embryos treated with exogenous RA have 
expanded expression domains of Amhc1 (Yutzey, Rhee, & Bader, 1994). As a consequence of altered A-
P patterning of the early heart tube caused by abnormal RA signaling, the morphogenesis of cardiac 
structures which derive from specific anterior or posterior regions of the heart is also affected by changed 
RA signaling. For example, Raldh2-/- mice have compromised atrial development and embryos treated 
with an RAR-antagonist lack atrial chambers (D'Aniello & Waxman, 2014). Similarly, VAD quail 
embryos show a significantly shortened caudal portion of heart tube that cannot link to the extra-
embryonic circulation system, which leads to early embryonic lethality (Dersch & Zile, 1993; Heine et 
al., 1985). On the contrary, with increasing doses of exogenous RA in zebrafish embryos, the anterior 
portion of the embryonic heart tube, corresponding to the nascent ventricle, is truncated progressively 
(Calmont et al., 2009). Administration of exogenous RA to avian hearts during or before the fusion of 
heart primordia evidently expands the atrial domain, even occupying the entire heart tube (Yutzey et al., 
1994). Similar expansion of sino-atrial marker in response to exogenous RA during the fusion of cardiac 
crescent is observed in mouse and zebrafish embryos (Waxman & Yelon, 2009; Xavier-Neto et al., 1999). 
Moreover, an accumulation of RA in Cyp26-deficient zebrafish embryos results in an increase of the 
number of atrial cells (A. B. Rydeen & Waxman, 2014). Altogether, the caudally distributed RA signaling 
is linked to the establishment of the posterior cardiac domain. 
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Molecular analysis has indicated that RA regulates the early cardiogenesis through interacting with 
other developmentally important signaling pathways. VAD quail embryos express significantly low level 
of the key cardiogenic morphogen, Gata-4, and Raldh2-/- mice show a reduction in the expression of 
Bmp2 (Kostetskii et al., 1999) (Lucile Ryckebusch et al., 2008). Interestingly, administration of 
exogenous GATA-4 and BMP2 rescues the cardiac defects in VAD quails, indicating the cross-talk 
between RA signaling and BMP2 as well as GATA-4. In contrast, another cardiogenic factor, Nkx2.5, has 
been found to be involved in RA-mediated early cardiogenesis. Genetic deletion of Raldh2 significantly 
up-regulates Nkx2.5 but down-regulates Tbx5 and Bmp2 (Keegan et al., 2005; Lucile Ryckebusch et al., 
2008). Loss of function of Nkx2.5 in the Raldh2-/- background, however, restores the expression of Tbx5 
and Bmp2, indicating that Nkx2.5 may function downstream of RA signaling but upstream of Tbx5 and 
Bmp2 in early heart formation (Lucile Ryckebusch et al., 2008). Furthermore, RA signaling has been 
found to negatively regulate the expression of transforming growth factor β2 (Tgfβ2), which is critical in 
heart tube formation. The expression levels of Tgfβ2 have been found to be up-regulated in both VAD 
quail embryos and Raldh2-null mice (S. K. Ghatpande et al., 2010; Paschaki et al., 2013). Consistently, 
administration of TGFβ2 to normal quail embryos recapitulates the severe truncation of heart tube 
observed in the VAD quail model (S. K. Ghatpande et al., 2010). In contrary, application of a TGFβ2-
blocking antibody successfully rescues the deleterious cardiac phenotype in posterior heart tube in VAD 
quail embryos (S. K. Ghatpande et al., 2010), suggesting that RA may convey its biological effects 
through suppression of Tgfβ2 signaling during early heart formation. Though multiple potential pathways 
have been proposed to interact with RA signaling, the exact molecular mechanisms by which RA 
regulates the process of heart patterning and early formation have not yet been clearly demonstrated. 
It is now believed that the A-P patterning of the heart tube is generated largely by a well-organized 
SHF through the regulation of RA. As mentioned earlier, cardiac progenitor cells from the SHF migrate 
to the primary heart tube, adding to both arterial and venous poles (R. G. Kelly, 2012). In fate tracing 
analysis, cells derived from anterior SHF contribute mainly to the rostral side of the heart tube, including 
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ventricle and OFT, and those from posterior SHF facilitate the development of atrium and the venous 
pole (Galli et al., 2008; S. Zaffran et al., 2004). Accordingly, a disorganized SHF can result in a defective 
heart tube patterning and development, as demonstrated in fetuses with abnormal RA signaling levels 
(Dersch & Zile, 1993; Niederreither et al., 2001; Park et al., 2006). In Raldh2-/- mice embryos, expression 
of anterior SHF markers, such as Tbx1 and Fgf9, are expanded into caudal region while the expression of 
posterior marker Tbx5 is greatly reduced (Niederreither et al., 2001; L. Ryckebusch et al., 2008; Vincent 
& Buckingham, 2010). Similar expansion of anterior SHF markers has been observed in both VAD quail 
(L. Ryckebusch et al., 2008) and zebrafish treated with RA antagonists (Collop et al., 2006). On the other 
hand, an enlarged region marked by Tbx5 as well as a sino-atrial specific marker smooth myosin heavy 
chain 3 (sMyHC3) was shown in fetal mice and chicken exposed to exogenous RA (Bruneau et al., 1999; 
D'Aniello & Waxman, 2014; Yutzey et al., 1994). Therefore, the proper patterning of SHF modulated by 
RA creates the foundation of the development of a well-organized heart tube. 
Due to such a correspondence between the SHF and the heart tube, the mechanisms by which RA 
influences the SHF patterning may also contribute to the development of the heart tube. One of the well-
known RA target signaling pathway is the Hox family. Hox genes have been well-characterized in 
determination of the patterning of body axis and the hindbrain under the regulation of RA signaling 
(Glover, Renaud, & Rijli, 2006; Koop et al., 2010). In the heart, it is now identified that RA-target genes 
Hoxa1, Hoxb1 and Hoxb3 are expressed in distinct regions in the SHF, potentiating the regulation of RA 
signaling in patterning of the heart tube (Bertrand et al., 2011).  Recent studies also revealed that embryos 
lacking Hox A and Hox B sister cluster genes display multiple embryonic defects that mimic those 
observed in VAD embryos and Raldh2 null mutants, such as dilation of heart tube and failure in cardiac 
looping (Soshnikova, Dewaele, Janvier, Krumlauf, & Duboule, 2013). Taken together, Hox genes 
contribute to the heart tube patterning by regulation of RA signaling.  
Aside from Hox genes, Fgf8 has also been identified to be an RA-responsive modulator of the SHF 
development (Kumar & Duester, 2014). As mentioned above, Fgf8 is transcriptionally repressed by RA 
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and can affect the cell fate determination during early cardiogenesis (Sorrell & Waxman, 2011). Besides, 
FGF8 is also known as an anterior SHF marker that is critical for the development of cardiac structures 
derived from the SHF (Abu-Issa, Smyth, Smoak, Yamamura, & Meyers, 2002; Ilagan et al., 2006). Fgf8 
null mutant exhibits DORV and persistent truncus arteriosus, as a result of perturbation of anterior SHF. 
Similarly, conditional deletion of Fgf8 in Nkx2.5-expressing and/or Isl1-expressing cells results in severe 
truncation of OFT and RV region, primarily due to reduced proliferation of cardiogenic cells and 
increased cell death in the splanchnic mesoderm and pharyngeal endoderm (Ilagan et al., 2006; Park et 
al., 2006). Besides, Fgf8 is also found to promote cell migration through regulating cadherin expression, 
facilitating the migration of SHF progenitors and the elongation of the heart tube (Sun, Meyers, 
Lewandoski, & Martin, 1999). Therefore, the role of RA in promoting posterior identity of the heart tube 
during early heart development may be carried out by suppressing the transcription of anterior marker 
Fgf8, which further affects proliferation and apoptosis of the cardiogenic cells and influence the 
prospective cardiac structures such as the OFT. 
Tbx5 has also been proposed to carry out RA functions in patterning the heart tube. As explained in 
last section, Tbx5 is RA-responsive and can regulate early cardiogenic pool by influencing cell fate 
choices (Agarwal et al., 2003). Expression of Tbx5 is highly dynamic and was found to be exclusively 
confined to the posterior SHF during the heart tube formation (Chapman et al., 1996). Loss of functional 
Tbx5 leads to severe hypoplasia in sinoatrial structures and persistent expression of Tbx5 in the ventricle 
abrogates the expression of ventricular markers, suggesting the requirement of proper Tbx5 signaling in 
promoting the development of posterior heart tube (Liberatore et al., 2000). During the patterning of the 
heart, Tbx5 is highly responsive to the level of RA signaling: maternal administration of RA caused 
anterior expansion of the expression of Tbx5 and an increased expression of an atrial marker AMHC1 
(Bruneau et al., 1999; Liberatore et al., 2000; Niederreither et al., 2001; Karen Niederreither et al., 1999; 
Lucile Ryckebusch et al., 2008; Yutzey et al., 1994). Tbx5 thus may function as a mediator of RA 
functions in SHF patterning, presumably by promoting commitment of a cardiogenic cell to a 
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posterior/atrial fate. Recently reported, the expression of Tbx5 can be directly regulated by Hox genes 
since a Hox response element sequence was identified within the promoter of Tbx5 where Hox4 and 
Hox5 have been found to bind (Kane & Napoli, 2010). Since RA is a well-known regulator of Hox genes 
expression, it is plausible that RA may convey its essential roles in the patterning of the SHF and heart 
tube through Hox genes, which transcriptionally regulate the further downstream target Tbx5. However, 
mutation of hoxb5 results in a partial list of the defects associated with RA-deficiency (Franco, Farooqui, 
Seto, & Wei, 2001), which indicates the involvement of other RA-responsive effectors in heart formation 
(S. Ghatpande, Brand, Zile, & Evans, 2006; Kostetskii et al., 1999).  
Though progress has been made, basic questions about physiological behavior of cardiac progenitor 
cells need to be addressed. One of the key questions to ask is whether the pre-patterned progenitor cells 
move in concert as a sheet to maintain their relative position, or whether they migrate individually and re-
pattern on the heart tube under the guidance of an RA gradient in the new environment. Another 
important question to be answered is if levels of RA signaling function as indicators of current location in 
the migrating path for these cells and if so, how is this map of cell migration regulated. Altogether, 
current studies demonstrated an indispensable role of RA in the patterning of the heart tube. 
1.6. RA and the formation of outflow tract (OFT) 
During normal cardiogenesis, the septum of the OFT is formed by two types of cells under the tight 
regulation of RA signaling: endocardial cells and cardiac neural crest cells (CNCCs). In the OFT, 
endocardial cells undergo epithelial-mesenchymal transition (EMT) and migrate to the middle of 
endocardium and myocardium to form the endocardial cushions (von Gise & Pu, 2012). The cushions 
eventually form the septa and valves that separate the aorta and pulmonary trunk, as well as the chambers 
in heart (Mendez, Kojima, & Goldman, 2010). CNCCs mainly migrate to the anterior heart tube and 
facilitate the formation of endocardial cushions. Ablation of premigratory CNCCS in chicken embryos 
severely impairs the septation of the pulmonary trunk and aorta, which is a congenital defect known as 
common arterial trunk (CAT) (Hutson & Kirby, 2007). Similar to the results of ablating CNCCs, lack of 
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proper RA signaling also leads to congenital heart defects in OFT septation (Jiang et al., 2002; Sakabe, 
Kokubo, Nakajima, & Saga, 2012). Intriguingly, defective formation of OFT septum in response to RA 
deficiency cannot be rescued by repletion of RA which increases the embryonic levels of RA in a global 
manner. This further reflects the specific requirement of a spatially controlled distribution of RA during 
the proper formation of OFT (Niederreither et al., 2001). 
Alterations in RA signaling can cause defects of endocardial EMT, which is a frequent cause of OFT 
defects (Sakabe et al., 2012). Ectopic RA signaling delays endocardial EMT and suppresses Tbx2/ Tgfβ2 
pathway. Consistently, addition of recombinant TGFβ2 in the RA-treated mouse embryos can restore the 
attenuated migration of endocardial cells, suggesting that RA represses endocardial EMT through down-
regulation of Tgfβ2. Further molecular analyses suggest that Tbx2 transcriptionally induces the expression 
of Tgfβ2 and that the expression of Tbx2 is most likely a direct transcriptional target of RA signaling, 
since a repressive RARE was identified in the promoter of Tbx2 (Sakabe et al., 2012). Thus, excess RA 
can directly repress transcription of Tbx2, and further decrease expression of Tgfβ2, which influences the 
endocardial EMT. Moreover, decreased RA signaling due to Rarα1/Rarβ double ablation in mice also 
resulted in CAT (P. Li, Pashmforoush, & Sucov, 2010). Such a reduction in RA signaling increased the 
activity of the Tbx2/ Tgfβ2 pathway and deleting one Tgfβ2 allele ameliorates the septal defect. To sum 
up, these data suggest that lack of septation in the OFT can be at least partially attributed to the disrupted 
Tbx2/Tgfβ2 pathway by altered levels of RA.  
Alteration in CNCC behavior can be a major contributor to the defective OFT in RA-deficient 
models. The migration pattern of CNCCs was impaired in Raldh2-/- mice even when exogenous RA was 
applied maternally (Niederreither et al., 2001). Likewise, the proliferation of CNCCs was decreased after 
the RA administration to zebrafish larvae (Giovannone et al., 2012). However, these observations conflict 
with the results which showed that mutations of Rarα1/Rarβ in fetal mice do not cause changes in the 
distribution and proliferation of CNCCs (Jiang et al., 2002). These conflicting data may be explained by 
the fact that the effects RA deficiency lead to a different repertoire of gene expression changes than the 
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deletion of the RA receptors. To put this simply, RAR is still “active” even in the absence of its ligand by 
carrying out repression of target genes. However, the absence of RAR causes repression of target genes 
which become expressed. Another explanation for the discrepancy between the RA and RAR-deficient 
models could be that the proliferation of CNCCs is mainly controlled by other isoforms of RARs than 
RARα1 and RARβ, thus CNCCs might still proliferate and migrate in the absence of these two RAR 
isoforms. Importantly, since the RA synthetic enzyme Raldh2 is not expressed in CNCC (Calmont et al., 
2009; T. Hochgreb et al., 2003), the RA signaling that orchestrates CNCCs function and migration is 
mediated by RA- produced and secreted by RA in the surrounding neighboring cells (Jiang et al., 2002).  
To sum up, the specific distribution of RA regulates the development of the OFT septum. Since 
abnormalities in OFT caused by RA signaling deficiency cannot be rescued by global supplementation of 
RA, it is clear that RA must carry out a strictly positional or gradient-based effect in the development of 
OFT (Niederreither et al., 2001). To demonstrate this putative RA gradient in the OFT, a more sensitive 
and reliable RA signaling reporter will be needed to image RA distribution in the developing heart tube as 
well as along the path of CNCC migration.  
1.7. RA and the myocardial proliferation in the ventricle 
The growth of the myocardium depends on the normal function of the epicardium. Epicardium is 
critical to cardiomyocyte proliferation as a lack of epicardium results in arrested myocardial growth 
(David J. Pennisi, Ballard, & Mikawa, 2003; Ingo Stuckmann et al., 2003). Epicardium is a thin layer of 
epithelial cells that develop from a transient extra-cardiac tissue, namely the proepicardium (PE). PE-
derived mesothelial cells migrate and populate the surface of the heart to form the epicardium. Upon 
stimulation, epicardial cells undergo epithelial-to-mesenchymal transition (EMT) to become migratory 
and invade into the myocardium where these epicardial-derived progenitor cells (EPDCs) differentiate 
into multiple cell types to facilitate late heart development. Besides its role as a source of cardiac 
progenitor pool, the epicardium also functions as a signaling center and actively produces multiple 
developmentally important signaling molecules to orchestrate the heart maturation, especially the 
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myocardial growth (von Gise & Pu, 2012). One of these epicardial-derived morphogens is RA. RA 
synthesis, as demonstrated by the expression of Raldh2, and RA signaling, visualized by the expression of 
RARE-lacZ transgene (Rossant, Zirngibl, Cado, Shago, & Giguere, 1991), are both localized in cells in 
the epicardium and subepicardial space. Though RA is exclusively made in the epicardium, we still have 
very limited knowledge of the biological significance of RA signaling in epicardial-regulated 
morphogenic events, including the myocardial growth and the development of coronary vessels. 
 
Figure 1.3 Contribution of epicardium during late heart development. 
Epicardial cells (EPDCs) undergo epithelial-to-mesenchymal transition (EMT) to gain migratory capacity 
and invade into myocardium. Intramyocardial EPDCs differentiate into fibroblasts and perivascular 
vascular smooth muscle cells to facilitate the development of coronary vessels and assist the contraction 
of the heart. Epicardium secretes essential morphogens, including RA, to promote cardiomyocyte 
proliferation and heart maturation. 
 
Previously, multiple lines of evidence have demonstrated the importance of RA and its signaling in 
the development of myocardium. Short-term repletion of RA from E7.5 to E8.5 to Raldh2 null mouse 
embryos postpones their embryonic lethality, yet, still results in a thin ventricular myocardium at E12.5. 
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Considering RA has short half-life (less than 12 hrs) in vivo (Lee et al., 2012; Satre & Kochhar, 1989) and 
that the Raldh2-/- heart is devoid of RA signaling at E12.5 revealed by the absence of expression of 
RARE-LacZ transgene in the heart, the hypoplastic ventricular myocardium was attributed to a lack of 
RA  in the heart (Niederreither et al., 2001). Similar hypoplastic ventricles have been also observed in 
mouse embryos that have reduced RA signaling, such as embryos with genetic ablation of Rxrα, those 
expressing a dominant-negative RAR or embryos with Rarα/Rarγ compound loss of function mutation 
(Thomas Brade et al., 2011; T. Chen et al., 2002; Kastner et al., 1997). In addition, Cre-guided epicardial-
specific ablation of Rxrα using GATA5 promoter or the expression of the dominant-negative Rarα in the 
epithelial epicardium (Merki et al., 2005) (T. Chen et al., 2002), results in thin ventricular myocardium, 
while deficiency of Rxrα in the cardiomyocytes does not alter heart morphology (J. Chen, Kubalak, & 
Chien, 1998). These observations suggest that RA signaling within the epicardium is required to promote 
myocardial growth. 
Previous ex vivo studies suggested that RA promotes myocardial growth by stimulating epicardium to 
secrete trophic factors. Surgical removal of the epicardium abolishes the pro-proliferative function of RA 
in cardiomyocytes (Ingo Stuckmann et al., 2003). In addition, conditioned media from RA-treated 
epicardial cell cultures was collected and applied to cultured cardiomyocytes (T. Chen et al., 2002). The 
epicardial-conditioned media potently boosted the proliferation of cardiomyocytes and heat abolished the 
effect of the epicardial-conditioned media, indicating that 1) RA promotes the proliferation of 
cardiomyocytes through stimulating the epicardium to produce trophic factor(s) and 2) the epicardial-
derived RA-responsive factor(s) responsible for promoting cardiomyocyte proliferation is peptide-based. 
Though multiple studies have proposed potential candidates, heated discussion on the identity of this 
trophic factor is still ongoing.  
FGF proteins were thought to be possible epicardial derived mitogens yet their trophic effects were 
questioned by in vivo studies. FGF2 and FGF9 has been previously found to be mitogenic in culture and 
were responsive to alteration of epicardial RA signaling (Kardami & Fandrich, 1989; Kory J. Lavine et 
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al., 2005; Merki et al., 2005; David J. Pennisi et al., 2003). However Fgf2 null embryos display normal 
cardiac morphology, which excludes the role of Fgf2 in the development of the heart (M. Zhou et al., 
1998). Fgf9 null mutation on the other hand results in hypoplasia in the ventricular myocardium. Yet the 
spatiotemporal expression pattern of Fgf9 is not compatible with the requirement of being an epicardial-
derived mitogen. The myocardial thickness typically increases from E11.5 to E14.5 in mouse embryos, 
but at E12.5 Fgf9 is not expressed in the epicardium but exclusively in the endocardium, questioning the 
possibility of FGF9 as an epicardial-derived mitogen in promoting thickening of the myocardium (Kory J. 
Lavine et al., 2005). In addition, Peng et al. performed a screening of secretome of an immortalized 
epicardial cell line, MEC1, to identify the presence of possible mitogens. The MEC1 cells were capable 
of producing trophic factors, yet the authors did not detect FGF2 or FGF9 in the MEC1-conditioned 
culture media, which leaves the role of these two proteins as epicardial-derived mitogens uncertain (Peng 
Li et al., 2011). However, though MEC1 cells do not spontaneously secrete FGF2 or FGF9, it is still 
possible that upon stimulation of RA, the production of these two mitogens might be increased. 
Therefore, this lack of FGFs in the secretome of MEC1 cells needs to be re-examined in conditions where 
the key epicardial stimulant, RA, is applied.  
PDGF-A was also once proposed to transduce the RA signaling in myocardial proliferation. PDGF-A 
is the primary mitogen produced in rat atrial epicardial cell line, namely EMC cells, in response to RA 
stimulation (Kang et al., 2008). However mutation of Pdgfrs in the myocardium and epicardium results in 
normal ventricular myocardium (Kang et al., 2008). Additionally, Pdgfa is barely expressed in the 
epicardium in vivo and its expression was not detected in the ventricular epicardial cell line, MEC1 (Kang 
et al., 2008; Peng Li et al., 2011). Therefore, PDGF-A may not carry out the proliferative function of RA 
signaling on ventricular myocardium. 
Recent studies proposed a new model where extra-cardiac (liver) -derived RA promotes myocardial 
growth. In this model liver-generated RA upregulated the expression of liver erythropoietin (EPO), which 
then induces the epicardium to secrete IGF2 and promote myocardial growth. Support for this model 
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comes from evidence that inactivation of Epo or its receptor led to ventricular hypoplasia, resembling the 
cardiac phenotype observed in mouse embryos lacking sufficient RA signaling (Thomas Brade et al., 
2011; T. Chen et al., 2002; Kastner et al., 1997; H. Wu, Lee, Gao, Liu, & Iruela-Arispe, 1999). Epo was 
found to be expressed in the liver but not heart and ChIP assay studies suggest that the Epo gene is a 
potential direct transcriptional target of RA signalEing (Thomas Brade et al., 2011). Next, it was noticed 
that Rxrα-/- embryos have reduced expression of Epo in the liver, and addition of EPO to cultured Raldh2-
/- and Rxrα-/- embryos successfully restored their myocardial proliferation (Thomas Brade et al., 2011). 
The proliferative effects of RA and EPO on the cardiomyocytes are seemingly redundant in an explant 
model: exogenous RA can resume myocardial proliferation when the EPO receptor is blocked, while EPO 
partially restore the proliferative response in cells treated an RAR antagonist (Ingo Stuckmann et al., 
2003). Such a partial restoration also suggests other trophic factors may respond to RA to promote 
myocardial proliferation, independent of EPO. In addition, the thinned myocardium in either Raldh2-/- or 
Rxrα-/- embryonic hearts can be rescued in heart explant culture by the addition of EPO, which further 
strengthens the tie between RA and EPO signaling in regulating myocardial growth (Thomas Brade et al., 
2011). Based on the fact that Epo is expressed primarily by the fetal liver, not the heart, a hypothesis was 
raised that an extra-cardiac source of RA may be involved in the regulation of hepatic EPO secretion 
which is responsible myocardial development (Kambe et al., 2000; Peng Li et al., 2011). Consistent with 
the hypothesis, expression of a dominant negative Rarα in the cardiogenic mesoderm leads to normal 
ventricular myocardium, while blocking RA signaling in liver results in an underdeveloped thin 
ventricular myocardium (Shen et al., 2015). However, to rule out the possible roles of cardiac/epicardial 
RA signaling in the development of myocardium, animal models with combination of mutation in 
multiple RARs need to be employed because redundancy of RAR functions in the heart formation has 
been frequently reported and deletion of a single receptor may not be effective in abolishing RA 
signaling. Due to the closure of diaphragm and subsequent loss of direct transport of hepatic molecule to 
the heart by perfusion, the regulation of ventricular myocardium by hepatic RA and EPO can only exist 
between E10-11 in mouse embryos. Therefore, even though it is clear that hepatic RA signaling through 
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RARα is critical for ventricular myocardial growth, in face with the wealth of evidence from isolated 
epicardial cells inducing myocardial growth in culture, one cannot completely rule out the requirement of 
epicardial RA signaling in mediating cardiomyocyte proliferation.  
A recently rising candidate of epicardial-derived mitogen is IGF2. The pro-proliferative 
characteristics of IGF2 have been previously demonstrated in both in vitro and in vivo models. 
Application of IGF2 to cardiomyocytes potently induces their proliferation (Liu et al., 1996). Igf2 null 
embryos show reduced myocardial proliferation while excess IGF2, due to the lack of degradation in 
Igf2r-/- mutant mice, results in hyperplastic ventricles (Eggenschwiler et al., 1997; Peng Li et al., 2011). 
Not only qualified as a mitogen on cardiomyocytes, IGF2 has been reported to be the most abundantly 
secreted mitogen in MEC1 cells and the epicardium in vivo (Peng Li et al., 2011). However, the induction 
of Igf2 in the epicardium is dependent on EPO but not RA in MEC1 cell line, excluding the possibility of 
IGF2 as a RA responsive mitogen (Thomas Brade et al., 2011). It is even more confusing that though 
IGF2 is not RA-responsive, knocking down of Igf2 or blocking IGF signaling greatly reduced the 
proliferative response of cardiomyocytes to the conditioned media from MEC1 cells pretreated with RA. 
Nevertheless, inhibition of IGF signaling did not completely abolish the proliferation of cardiomyocyte 
treated with MEC1-conditioned media, suggesting the existence of non-IGF mitogen produced by 
epicardial cells in response to RA treatment (Peng Li et al., 2011).  
Despite all the findings these years by multiple models, the identity of RA-stimulated epicardial-
derived mitogen(s) remains mysterious and we still have poor understanding of the roles of RA signaling 
in the heart during late cardiogenesis. 
1.8. RA and the development of coronary vessels 
Great efforts have been recently made to elucidate the complex program of the formation coronary 
vessels, which has been discussed in several excellent reviews (Lamalice, Le Boeuf, & Huot, 2007; Lie-
Venema et al., 2007; Schmidt, Brixius, & Bloch, 2007). Briefly, the development of coronary circulation 
involves the establishment of a primary endothelial plexus network which is then followed by remodeling 
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and the addition of perivascular cells. Endothelial precursors, i.e. angioblasts, transform to become 
migratory and migrate to form a primitive vascular network at E11.5, which functions as a scaffold for 
further expansion and branching of growing vessels on the surface of the heart and into the myocardium 
(Vrancken Peeters et al., 1997). In the meantime, epicardial cells that derive from the proepicardium 
undergo epithelial-to-mesenchymal transition (EMT) migrate towards the heart and spread to cover the 
myocardium. The epicardium is essential in the development of coronary vessels, shown by failure in the 
establishment of coronary vessels in mouse models lacking proper development of epicardium (Tevosian 
et al., 2000; von Gise et al., 2011; Yang, Rayburn, & Hynes, 1995). As the vascular network forms, the 
coronary vessels connect to the system circulation by ostia that are localized in the sinuses of the aortic 
valves to get oxygenated blood. The shear stress created from the blood flow further refines the existing 
vasculature and facilitate its final maturation. 
Lineage tracing approaches have been used in the past to elucidate the origin of cellular component of 
coronary vessels. Studies using the Wt1-Cre system reported the contribution of EPDCs to 
cardiomyocytes and endothelial cells (Cai et al., 2008; Gittenberger-de Groot, Vrancken Peeters, 
Mentink, Gourdie, & Poelmann, 1998; J.-M. Perez-Pomares et al., 2002; B. Zhou et al., 2008), which is 
however being debated due to the questionable specificity of the “epicardial markers” that were utilized 
in those studies: WT1Cre-EGFP show ectopic signal which is inconsistent with the physiological Wt1 
expression; endothelial cells endogenously express Wt1 and cardiomyocytes naturally express Tbx18, 
which doubted their origin from epicardial cells (Christoffels et al., 2009; Carsten Rudat & Kispert, 2012; 
Bin Zhou & Pu, 2012). In addition the PE contains heterogenous populations of cells and the most 
popular PE/epicardial markers, for example Wt1, Tbx18 and Tcf21, do not mark completely identical 
domains in the PE (Caitlin M. Braitsch, Michelle D. Combs, Susan E. Quaggin, & Katherine E. Yutzey, 
2012). Therefore, the discrepancy in lineage tracing experiment from various studies might be explained 
by different expression patterns of these markers (Acharya et al., 2012; Cano et al., 2016; Grieskamp, 
Rudat, Lüdtke, Norden, & Kispert, 2011; Katz et al., 2012; B. Zhou et al., 2008). Interspecific difference 
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also accounts for the distinct conclusions gained from mouse and avian models (Cai et al., 2008; Juan A 
Guadix, Carmona, Muñoz‐Chápuli, & Pérez‐Pomares, 2006; Mikawa & Fischman, 1992; B. Zhou et 
al., 2008). Besides endothelial cells, epicardial-derived cells (EPDCs) also give rise to perivascular cells 
recruited to the coronary vessels. Multiple lineage tracing studies have clearly demonstrated that in 
response to endothelial and epicardial signals, migrating EPDCs are recruited to the immature vessels 
where they differentiate into vascular smooth muscle cells (VSMCs) and fibroblasts to stabilize the 
immature endothelial tubes (Cai et al., 2008; Lie-Venema et al., 2007). Additionally, EPDCs also 
contribute to fibroblasts in myocardium and anulus fibrosus cordis, which facilitates heart contraction 
(Gittenberger-de Groot et al., 1998; Lie-Venema et al., 2008; Bin Zhou, von Gise, Ma, Hu, & Pu, 2010).  
RA signaling has been implicated in the development of coronary vasculature. RALDH2 and RXRα 
are both detected in endothelial cells in the immature vessels and in EPDCs prior to their differentiation 
into VSMCs and fibroblasts (Juan A. Guadix, Carmona, Muñoz-Chápuli, & Pérez-Pomares, 2006; Pérez-
Pomares et al., 2002).  Consistent with this, insufficient RA synthesis due to the genetic ablation of 
Raldh2, leads to retarded vessel growth and patterning in the coronary system and epicardial mutation of 
Rxrα results in defective branching of coronary artery (S.-C. Lin et al., 2010; Merki et al., 2005). 
Interestingly, once the immature vessels develop, the expression of Raldh2 and Rxrα is gradually lost and 
becomes undetectable in fully developed vessels that are wrapped with mature perivascular cells (Pérez-
Pomares et al., 2002). Similarly, Raldh2 is actively expressed in the EPDCs delaminated from the 
epicardium and is gradually lost as they migrate away from the epicardium and invade deep into the 
myocardium (Lockhart, Phelps, van den Hoff, & Wessels, 2014). Moreover, cardiac expression of Raldh2 
and levels of RA signaling surge at E12.5, which stage correlates with active epicardial EMT, myocardial 
compaction and coronary vessel development (Jennifer B Moss et al., 1998). However, despite the 
information of the dynamic changes and specific localization of RA metabolism and signaling in the 
epicardium and coronary vessels, our knowledge of the exact roles of RA in epicardial behavior and 
coronary vasculature is by far very limited. 
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Previously, genetic mouse models have suggested critical roles of RA and its signaling in epicardial 
EMT. In the epicardial-specific Rxrα null mutant mice, the migratory capacity of EMT in epicardial cells 
was found to be greatly reduced and molecular analysis demonstrated a concomitant down-regulation of 
Wnt9b, a key regulator in Wnt signaling that possibly regulates epicardial EMT through modulating the 
stability of β-catenin (Merki et al., 2005; von Gise et al., 2011). Indirect evidence derived from a Wt1-null 
mutant mouse model suggested that RA was required for proper epicardial migration in vivo. As a classic 
marker of the epicardium, Wt1 is critical to epicardial EMT through up-regulating the expression of Snail 
and down-regulating E-cadherin (Martínez-Estrada et al., 2010). In Wt1-/- mutant mice, the epicardial 
EMT was found attenuated and the subsequent coronary vessel formation was impaired (von Gise et al., 
2011). Coincident with the defective EMT, the expression of RA-synthesizing enzyme Raldh2 is 
drastically suppressed, which was proposed to result in low RA signaling in the Wt1-/- epicardial cells, 
though this remains unconfirmed. Nevertheless, maternal administration of RA partially rescued the 
defective EMT in Wt1-null mutants, strongly suggesting that WT1 conveys its regulatory role in EMT at 
least partially through RA signaling. Further molecular analysis has supported the idea that WT1 
transcriptionally regulates the expression of Raldh2 (J. A. Guadix et al., 2011). The WT1-RA signaling 
interaction is mutual as RA also influences the expression of Wt1, increasing the complexity of this 
regulatory network in epicardial EMT (Caitlin M. Braitsch et al., 2012). Therefore, epicardial EMT could 
be regulated by RA acting downstream of WT1 and reinforcing its signal via positive feedback.  
Currently, whether RA signaling influences epicardial EMT is still at debate and direct evidence of 
the roles of RA in the epicardium is of immediate need to answer this question. Opposing opinions of the 
involvement of RA in epicardial EMT came from a study using the “rescued” Raldh2 mutant mice 
described above. In the “rescued” Raldh2-/- embryos, the expression level of Wnt9b was not altered and 
the collagen gel infiltration capacity of isolated Raldh2-/- epicardial cells was found to be comparable to 
the wildtype (S. C. Lin et al., 2010). However this model of RA deficiency was later proved to be leaky 
because RA signaling was not completely depleted in the heart of the “rescued” Raldh2 null embryos due 
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to the presence of Raldh2-independent RA synthesizing enzymes (Felix A. Mic, Haselbeck, Cuenca, & 
Duester, 2002) (Niederreither, Vermot, Fraulob, Chambon, & Dolle, 2002). Other objectors against the 
necessity of RA signaling in epicardial migration based their opinions on observations derived from 
proepicardial explant culture. Addition of 1mM of RA to proepicardial cells didn’t seem to induce evident 
accumulation of spindle-like mesenchymal cells. Inhibition of RA synthesis, on the other hand, does not 
obviously inhibit the proepicardial EMT induced by 5% FBS (Azambuja et al., 2010). Though 
morphological change is a critical step in EMT, the observation based solely on cell shape was subjective 
and conclusion is not solid unless molecular markers of epithelial/mesenchymal cells are examined. In 
addition, even if the involvement of RA signaling in the proepicardium is minimal, one cannot bluntly 
rule out the possible effects of RA in epicardial EMT suggested by several in vivo models discussed 
above. Last but not the least, as noticed by Shen et al., at E10.5-E11.5, when the epicardial EMT is highly 
active, the embryonic heart forms under hypoxia (Shen et al., 2015), hence the regulation of EMT under 
hypoxia should also be evaluated and is worth investigation. Therefore, the roles of RA in epicardial 
EMT need to be analyzed systematically in more appropriate models. 
Aside from epicardial EMT, RA has also been reported to control the differentiation of EPDCs into 
perivascular cells. Several previous studies suggested RA seemed to inhibit the development of VSMCs. 
In cultures of human coronary VSMCs, RA has been found to inhibit cell proliferation through regulating 
the cell cycle (Wakino et al., 2001). In embryonic proepicardial explants, RA eliminated the expression of 
several markers of VSMCs while inhibition of RA synthesis induced the VSMC differentiation of quail 
proepicardial cells (Azambuja et al., 2010). In contrast, over-expressing the RA-synthesizing enzyme 
Raldh2 in proepicardial cultures led inhibition of the differentiation of EPDCs into VSMCs (Azambuja et 
al., 2010).  Later studies by Braitsch et al. reported that RA induces the expression of epicardial-specific 
transcription factor TCF21, which favors the differentiation of fibroblasts at the expense of VSMCs 
(Acharya et al., 2012; Caitlin M. Braitsch et al., 2012; Kazu Kikuchi et al., 2011; Quaggin, Vanden 
Heuvel, & Igarashi, 1998). Genetic ablation of Tcf21 globally in mouse embryos results in premature of 
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VSMCs, which further supports the potential regulatory pathway in which RA delays VSMCs through 
up-regulating Tcf21 (Acharya et al., 2012; Caitlin M. Braitsch et al., 2012; Felicia Chen et al., 2014; 
Hector, Felicia, Yuxia, & Wellington, 2013). However, another Tcf21-null mouse model raised by 
Archarya et al. showed that ablation of Tcf21 does not affect the formation of VSMCs in the heart 
(Acharya et al., 2012; Caitlin M. Braitsch et al., 2012; Kazu Kikuchi et al., 2011; Quaggin et al., 1998). 
Thus, the exact roles of RA and Tcf21 in VSMC differentiation need further investigation. In addition to 
VSMCs, EPDCs also contribute to the formation of fibroblasts. Loss of Tcf21 in mouse embryos also 
leaded to a significant reduction in the number of Col1a1-expressing fibroblasts (Acharya et al., 2012; 
Caitlin M. Braitsch et al., 2012; Kazu Kikuchi et al., 2011; Quaggin et al., 1998). Collectively, RA has 
clear involvement in the EPDC differentiation and the interaction between RA signaling and Tcf21 is 
worth of in-depth investigation. 
1.9. RA and the heart regeneration 
The regenerative capacity of heart after injury varies between species. In mammals, the heart is one 
of the least regenerative organs. Cardiac injury such as myocardial infarction (MI) leads to ventricular 
remodeling, including ventricular hypertrophy and deposition of collagen in the wound region, which 
results in partial loss of cardiac function due to a lack of contractile cardiomyocytes. In contrast, zebrafish 
and the air-breathing fish Polypterus senegalus can repair the injured heart by up-regulating the 
proliferation of cardiomyocytes near the border zone of wound and establishing new coronary vessels to 
nourish the newly formed muscles. Surprisingly, neonatal mice exhibit full regenerative capacity of the 
heart up to 7 days after birth, which presents the potential of mammalian heart regeneration and provides 
an invaluable model for exploration of potential targets that activate heart regeneration in adult human MI 
patients (Porrello et al., 2011). The cardiac repair program is tightly linked with the epicardium since the 
activation of expression of the epicardial-specific genes serves as the first response to heart wounding. In 
normal animal hearts, the adult epicardium remains quiescent and does not produce migratory EPDCs 
(Duim, Kurakula, Goumans, & Kruithof, 2015; van Wijk, Gunst, Moorman, & van den Hoff, 2012; Bin 
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Zhou et al., 2011). Upon cardiac injury, as observed in both mouse and zebrafish models, the embryonic 
program is once again activated in the epicardium and mesenchymal EPDCs are generated through EMT 
to migrate to the wound (Chablais & Jazwinska, 2012; Lepilina et al., 2006; van Wijk et al., 2012; Bin 
Zhou et al., 2011). The newly formed cardiomyocytes primarily come from undifferentiated progenitor 
cells in zebrafish (Lepilina et al., 2006), or potentially via reprogramming of cardiofibroblasts (Qian et 
al., 2012). Similar to their role in embryonic development, EPDCs also contribute to the re-establishment 
of postnatal coronary vessels by providing progenitors of perivascular cells (Kazu Kikuchi et al., 2011). 
RA has been proposed to play a role in heart repair and regeneration. In the zebrafish heart 
regeneration model, after ventricular apex removal, the epicardium induces the expression of 
developmental epicardial markers, such as Wt1, Tbx18 as well as Raldh2, suggesting the activation of 
epicardium and the need for RA synthesis during heart repair (K. Kikuchi et al., 2011; Nicola Smart et al., 
2011). Additionally, epicardial cells proliferate to cover the wound area and Raldh2-expressing EPDCs 
has been observed to invade into the injury zone and surround the myocardium to facilitate the repair of 
damaged myocardium. In mice subjected to ligation of the left anterior descending artery (LAD) - injury, 
both cardiac retinol levels as well as cardiac RA signaling were seen to increase (Dusan Bilbija et al., 
2012). Concomitantly, the expression of RA-synthesizing enzyme Raldh2 was found to be induced and 
that of the RA-catabolic enzyme Cyp26a1 was noticed to be suppressed in hearts subjected to LAD 
ligation. Direct evidence of the necessity of RA signaling in heart repair comes from a zebrafish heart 
regeneration model, in which genetic disruption of RA signaling or increasing RA degradation 
dramatically reduced the proliferation of cardiomyocytes in the wounded heart (K. Kikuchi et al., 2011). 
Interestingly, in zebrafish, RA signaling is rapidly initiated in both endocardium and epicardium while in 
mouse adult heart RA signaling is only detected in the epicardium, but not the endocardium. The 
difference in the expression patterns of Raldh2 between zebrafish and mice may account for the 
differences in their regenerative capacity. Factors that can augment cardiac RA signaling may constitute 
novel targets in an attempt to promote mammalian heart regeneration after MI. Altogether, these results 
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support a potential role of RA signaling in the repair and potentially in the treatment of cardiac injury. In 
contrast, other studies reported that RA restricts the proliferation of cardiofibroblasts, potentially reducing 
the formation of fibrotic scars that disrupt the signaling transduction in the cardiac conductive system 
(Dusan Bilbija et al., 2012). 
Support for a role of RA in ventricular remodeling and heart repair also comes from other models. In 
rats, RA treatment was reported to lead to ventricular remodeling and enhanced myocardial function, 
while vitamin A-deficiency led to adverse ventricular remodeling after myocardial infarction (de Paiva et 
al., 2003; Minicucci et al., 2010; Paiva et al., 2005). In vitro, RA antagonized the cardiomyocyte 
hypertrophy induced by angiotensin II which is also a contributor to hypertrophy in post-MI hearts 
(Rosenkranz, 2004; Wang, Zhu, & Yao, 2002).  Interestingly, the re-activated epicardium in injured adult 
mice seems to largely recapitulate its embryonic effects in secreting paracrine factors to promote the 
formation of new vessels and cardiomyocytes (Bin Zhou et al., 2011). Similar to what happens during 
embryogenesis, the expression of IGF2 is up-regulated in the injured area in zebrafish, and IGF-signaling 
is indispensable for cardiomyocyte proliferation and heart repair in zebrafish (Y. Huang et al., 2013). 
Whether RA signaling is involved in the secretion of IGF2 by the injured epicardium remains to be 
explored, as does many of the facets of the complex role of RA in heart regeneration. 
1.10. Conclusion  
The teratogenic effects of altered RA signaling on cardiogenesis have been frequently reported and 
the underlying mechanisms are under intensive investigation. As discussed above, RA signaling actively 
participates in the early cardiogenic events including the determination of cell fate between cardiogenic 
versus non-cardiac lineages; regulation of sizes of cardiogenic progenitor pool; as well as the 
anteroposterior patterning of the primitive heart tube. Despite numerous studies aiming at unveiling roles 
of RA in early cardiogenesis, defects associated with altered RA signaling during mid- to late-gestational 
cardiogenesis have been reported, however the underlying mechanisms have been rarely studied due to a 
lack of appropriate models. The temporal requirement of RA and the exact effect of RA signaling in late 
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heart morphogenesis remain ambiguous. Because of the critical roles of RA in early cardiogenesis, it is 
indeed difficult to separate the phenotypes that are truly attributed to mid-gestational RA deficiency or 
excess from those that are secondary to early cardiogenic defects. In addition, there is a critical need for a 
better understanding of the maturation of the embryonic heart under the regulation of RA signaling, 
which would be beneficial to the study of heart regeneration in mammalian systems. In this thesis, I 
sought to establish novel models for the study of RA-mediated heart maturation using mammalian models 
and investigate the teratogenic effects of excess RA in the development of coronary vessels. With the 
help of multiple in vivo and in vitro models, I investigated the roles of RA in late heart formation to better 
understand heart development and to shed light on the potential role of RA signaling during heart 





Chapter 2 : Roles of DHRS3 in Retinoic Acid Metabolism in Early 
Embryogenesis 
Abstract 
Vitamin A embryopathy has been frequently reported in the development of multiple organs. Thus the 
precise amount of the active metabolite of vitamin A, namely RA, needs to be exquisitely controlled 
throughout embryogenesis. Homeostasis of RA is maintained by well-balanced network of RA 
metabolism comprising catabolic enzymes either synthesizing or breaking down RA. Previously our lab 
has demonstrated the physiological role of a short-chain dehydrogenase/reductase, DHRS3, in preventing 
excessive accumulation of RA during mid-gestation. Genetic ablation of Dhrs3 in mouse embryos 
resulted in significant elevation in the amount of endogenous RA and increase in both domain sizes and 
levels of RA signaling in the Dhrs3-/- mice at E14.5. As a result, Dhrs3-/- embryos display mid-gestational 
lethality accompanied with multiple cardiac and skeletal defects. Here, we explored the importance of 
DHRS3 during early embryogenesis and its roles in neuronal development. Our results indicated that 
DHRS3 protected the developing mouse embryos from excessive RA signaling as early as E10 and that 
deletion of Dhrs3 caused neuronal defects associated with malformations of cranial nerves during early 
embryogenesis. Moreover, by rearing the Dhrs3+/- dam on a vitamin A deficient (VAD) diet, we were 
able to improve the skeletal defects observed in Dhrs3-/- embryos receiving normal levels of maternal 
vitamin A. Not only correcting the phenotype, prolonged VAD dietary treatment was found to 
successfully rescue the embryonically lethal Dhrs3-/- mice to fully grown adults with normal body weight 
and life span. Altogether, data presented here further strengthened the indispensability of Dhrs3 in 




RA as an essential signaling molecule has been proved to be critical in many life processes, such as 
reproduction, vision, immune response and embryogenesis (Collins & Mao, 1999; Wilson, Roth, & 
Warkany, 1953b; Wilson & Warkany, 1948). Thus the proper distribution of RA needs to be maintained 
for normal fetal development. The requirement of vitamin A is illustrated by defects shown in animal 
models without sufficient retinol: fetal mice with inadequate vitamin A from maternal sources are not 
viable(Lucile Ryckebusch et al., 2008); even adult rats reared on a vitamin A deficient (VAD) diet are 
growth-arrested but resume growing upon subsequent provision of vitamin A (McCollum & Davis, 
1913). On the other hand, excess intake of retinol or retinoic acid (RA) can be toxic: high dose RA 
treatment impairs fetal organogenesis, leading to various congenital defects (Dickman & Smith, 1996; 
Lammer et al., 1985; Rothman et al., 1995; Shenefelt, 1972). The adverse consequences of both 
deficiency and excess allude to the duality of vitamin A being both teratogenic yet essential for life. Thus, 
the proper distribution of RA needs to be maintained for normal fetal development.  
Homeostasis of RA is precisely controlled by a well-orchestrated network of metabolic enzymes 
safeguarding the formation and degradation of such an essential, yet, teratogenic molecule. Synthesis of 
RA in embryonic tissues starts with the reversible oxidation of retinol to retinaldehyde by retinol 
dehydrogenase 10 (RDH10) (M. Rhinn et al., 2011; Lisa L. Sandell et al., 2012), which can be reversed 
by short-chain dehydrogenase/reductases (SDR) or aldo-keto-reductases (AKR) (Kedishvili, 2013; Porté 
et al., 2013). These two reactions constitute an important point of metabolic regulation to control the level 
of retinaldehyde, since the oxidation of retinaldehyde to RA by retinaldehyde dehydrogenases (RALDHs) 
1, 2 and 3 is irreversible (Deltour et al., 1999; F. A. Mic, Molotkov, Fan, Cuenca, & Duester, 2000; Zhao 
et al., 1996). Excess RA is degraded by CYP26A1, B1 and C1, which are expressed in different tissues 
and time points (Pennimpede et al., 2010; Romand et al., 2006; Masayuki Uehara, Yashiro, Takaoka, 
Yamamoto, & Hamada, 2009). These specifically expressed enzymes function as “sinks” to prevent 
accumulation of RA and thus control its endogenous levels in distinct regions and windows of 
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development. Previous in vitro assays identified a short chain dehydrogenase-reductase, Dhrs3, to be 
capable of catalyzing the reduction of retinaldehyde to retinol (Haeseleer, Huang, Lebioda, Saari, & 
Palczewski, 1998). Further studies based on in vivo models from multiple labs, including our own, 
validated the physiological function of Dhrs3 preventing teratogenic accumulation of RA and its 
indispensability in organogenesis and body patterning (Adams et al., 2014; Billings et al., 2013; Feng et 
al., 2010; Kam et al., 2010; R. K. T. Kam et al., 2013). 
Here we explore and investigate the necessity of Dhrs3 in the metabolism of RA during early 
embryogenesis and its roles in neuronal and skeletal development by utilizing Dhrs3-deficient mice. Our 
results indicated that, deficiency in DHRS3 led to an evident expansion of RA signaling domains in the 
developing Dhrs3-/- embryos at E10.5, which was consistent with the increased RA signaling observed at 
E14.5 (Billings et al., 2013). As a consequence, Dhrs3-/- mutants displayed partially penetrant defects in 
the morphology and outgrowth of cranial nerves. A lack of DHRS3 also resulted in fusion of C1-C2 
cervical vertebrae and delayed ossification of cartilages in the rib cage, both of which phenotypes can be 
reversed by reducing the maternal intake of vitamin A in Dhrs3-/- embryos. Rearing the Dhrs3+/- dam on 
vitamin A deficient diet for three generations successfully rescued the embryonically lethality of Dhrs3 
deficient embryos to survive postnatally. The rescued Dhrs3-/- mice were observed to possess similar 
growth rate as their wild type littermates but were found to have behavioral defects and difficulty in 
breeding. Taken together, our data suggest that DHRS3 plays critical roles in preventing the excessive 
accumulation of RA during early embryogenesis and that well-controlled synthesis of RA is required for 
proper development of cranial nerves and skeleton. 
2.2. Materials and Methods 
Mice 
Generation of Dhrs3+/- mice was previously described (Billings et al., 2013). Female Dhrs3+/- mice 
were maintained on vitamin A sufficient diet, containing 4 IU preformed vitamin A (D13112B, Research 
Diets) per gram of diet, while male Dhrs3+/- were on 2018 chow diet that contains 15 IU vitamin A/gram 
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of diet (Envigo). The RARE-LacZ carry a LacZ gene under the control of an RA-inducible promoter 
(Rossant et al., 1991) and are available at the Jackson Laboratories identified as strain RARE-hsp68LacZ, 
stock 008477.  Timed matings were set up using female mice at proestrus stage and vaginal plugs were 
check on the following morning. Caesarean sections were performed at designated embryonic stages to 
collect embryonic tissues. All animal protocols were approved by the Institutional Animal Care and Use 
Committee at the University of Kansas. 
Rescue study 
Dhrs3+/- parent mice were kept on vitamin A sufficient diet (VAS) and their female Dhrs3+/- 
offsprings were reared on vitamin A deficient diet (VAD) from weaning. VAD-fed female Dhrs3+/- mice 
were bred overnight with male Dhrs3+/- mice fed on 2018 chow diet (Envigo) to generate VAD Dhrs3-/- 
embryos. Caesarean sections were performed at designated embryonic stages to harvest pups. Both VAS 
and VAD diets are derived from AIN-93G growing rodent diet (Reeves, 1997). VAS diet contains 4 IU 
preformed vitamin A (D13112B, Research Diets) per gram of diet whereas VAD diet is depleted with 
vitamin A (D13110GC, Research Diets). 
X-Gal staining 
Detection of LacZ reporter gene was carried out using previously established protocol (Billings et al., 
2013). Embryos were stained under identical conditions to facilitate fair comparison. Stained tissues were 
post-fixed in 4% paraformaldehyde at 4°C overnight and embedded in paraffin blocks for sectioning. 
Samples were cut sagittally at 7μm, counterstained with eosin and mounted in Vectamount Permanent 
Mounting Medium (Vector Laboratories, Cat # H-5000). 
Immunostaining 
E10.5 mouse embryos were harvested and rinsed in ice-cold PBS and fixed in 4% paraformaldehyde 
at 4°C overnight. Endogenous HRP activity was quenched by incubating embryos in Dent’s bleach 
(methanol: DMSO: 30%H2O2=4:1:1) for 4 hours at room temperature. Samples were then rehydrated 
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through a series of methanol solution with decreasing concentrations and blocked by 3% non-fat milk/ 
0.1% Trion X-100/ PBS for two hours at room temperature. Subsequently primary antibody was diluted 
in blocking buffer (2H3 1:200; anti-Tuj1 1:1000) and applied to embryos at 4oC overnight. On the 
following day embryos were washed with PBS for 3 times, one hour each at room temperature and HRP-
conjugated secondary antibody recognizing the species of primary antibody was applied to embryos at 
4oC overnight. After being washed in PBS, DAB kit was used to detect HRP. Chromogenic reactions 
were allowed for 7 minutes for each sample and embryos were washed in PBS to stop the color reaction. 
Stained embryos were dehydrated through methanol, cleared by BABB reagent (benzyl alcohol: benzyl 
benzoate=1:1) and documented using a Leica DMS300 Dissection Microscope equipped with a digital 
camera. 
Skeletal staining 
Cartilages and ossified bones in E14.5 embryos were stained by Alcian blue and Alizarin red reagents 
according to previously described procedure (Billings et al., 2013). In brief, embryos were fixed in 95% 
ethanol overnight at 4oC and subsequently incubated in washing solution containing 70% ethanol/5% 
acetic acid for 30min at room temperature. Staining was performed using 0.4% Alcian blue/1% Alizarin 
red solution at room temperature overnight. After staining, samples were rinsed in washing solution for 
30 min and incubated in series of clearing reagent containing increasing concentrations of glycerol. The 
samples in both experimental and control groups were processed simultaneously using identical protocols 
to avoid artifacts due to staining and the images were documented using a Leica DMS300 Dissection 
Microscope equipped with a digital camera. 
Microarray 
Dhrs3+/+ and Dhrs3-/- embryos were isolated at E14.5 on ice and snap-frozen in liquid nitrogen and 
stored at -80⁰C for RNA isolation later. Extraction of tissue RNA was performed using TRIZOL reagent 
(Invitrogen) according to manufacturer’s protocol. Before submission for microarray, RNA samples were 
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treated with DNase I (New England Biolabs, Cat # M0303S). Two embryos per genotype were utilized 
for the analysis. 
2.3. Results 
Deletion of Dhrs3 leads to altered retinoid metabolism and RA signaling during early embryonic 
stages. 
In order to visualize RA signaling, we employed a reporter mouse model carrying a transgene, LacZ, 
whose expression is under the control of a canonical RA-responsive element (RARE) in the promoter and 
can be detected by β-galactosidase staining (Jennifer B Moss et al., 1998). RARE-LacZ mice were crossed 
with Dhrs3+/- mice and used to generate Dhrs3-/-; RARE-LacZ and Dhrs3+/+; RARE-LacZ embryos as 
previously described (Billings et al., 2013). Mouse estrus cycle was determined by vaginal cytology using 
0.1% crystal violet and female mice at proestrus stage were assigned to mate with Dhrs3+/-; RARE-LacZ 
male for timed mating (Fig 2.1). Mouse embryos were isolated at E10.5 by caesarean section and 
processed for β-galactosidase staining. The results demonstrated that Dhrs3 deficient embryos had 
expanded expression domains of the RARE-reporter, LacZ, in the frontonasal region, in the body trunk, in 
the limbs as well as in the tail (Fig 2.2 A, B vs. D, E). The expression of RARE-driven LacZ was found to 
be mild in the heart and limb buds in the wildtype embryos, but was much higher in the same tissues in 
Dhrs3-/- embryos. Sagittal sections of Dhrs3-/- embryos consistently exhibited a broader expression 
pattern of RARE-reporter in the spinal cord and within the heart (Fig 2.2 C vs. F). Therefore, ablation of 
Dhrs3 causes expansion of RA signaling domains in mouse embryos as early as E10.5. 
We also measured the abundance of retinoid metabolites in wild type, Dhrs3+/- and Dhrs3-/- embryos 
at E12.5 by LC-MS/MS. As expected, global levels of all-trans-RA (ATRA) were found to be higher in 
the Dhrs3-null embryos when compared to either wildtype or heterozygote controls (Fig 2.3 A). These 
results agree with the increased levels of RA observed in E14.5 Dhrs3-/- embryos versus controls (Fig 2.3 
D) (Billings et al., 2013). The neutral retinoids (RE and retinol) were not altered in E12.5 Dhrs3-/- 
embryos versus wild type controls. This is in contrast to the observations that at E14.5, Dhrs3-/- embryos 
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have significantly lower levels of neutral retinoids compared to controls (Billings et al., 2013). The 
decrease in neutral retinoids in E14.5 Dhrs3-/- embryos cannot be accounted simply by their increase in 
their levels of RA. The 50% decreases in neutral forms of retinoids in E14.5 Dhrs3-/- embryos versus 
controls vastly exceeds their modest, 15%, increase in RA levels at the same stage. We propose that the 
dramatic increase in RE levels from E12.5-E14.5 seen in wildtype and heterozygous embryos coincides 
with the acquisition of hepatic functions by the wildtype embryonic liver which among other functions 
also includes storage of RE. However, in the case of Dhrs3-/- there is no apparent increase in RE between 
E12.5 and E14.5 suggesting a delay or an alteration in liver specification, however, such a possibility will 
require further studies. 
Dhrs3 deficiency leads to defects in the development of cranial nerves. 
Excess of RA has been frequently reported to induce craniofacial defect in embryos (Morriss-Kay, 
1993; Maxence Vieux-Rochas et al., 2007) including defects in the development of cranial neural crest 
cells, neurocristopathies which contribute to craniofacial structure and cranial nerves (Cordero et al., 
2011; Rothman et al., 1995).  In addition to CNCC, RA was found to play important roles in the 
patterning of the neural system in multiple models (Chawla, Schley, Williams, & Bohnsack, 2016). 
Altered levels of RA affect hindbrain patterning as well as the neurite outgrowth from spinal cord and 
DRG (Maden, Gale, Kostetskii, & Zile, 1996; Niederreither et al., 2003; Jeffrey C. White, Highland, 
Kaiser, & Clagett-Dame, 2000). Teratology studies of RA has also revealed that maternal exposure to 
excess RA or deficiency of retinoid can result in defective cranial neural crest cell migration in mouse 
embryo models (Pratt, Goulding, & Abbott, 1987). We have previously reported that Dhrs3-/- embryos 
display severe malformation in palate and craniofacial bone ossification (Billings et al., 2013). Therefore, 
we sought to extend our investigation looking at the development of cranial nerves (CVs) in Dhrs3-/- mice 
at E10.5. 
We examined the structure and morphology of CVs by wholemount immunostaining using an 
antibody (2H3) against neurofilament. We compared 7 CVs between Dhrs3-/- and wildtype: V, trigeminal; 
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VII, facial; VIII, vestibulocochlear; IX, glossopharyngeal; X, vagus; XI, accessory; and XII, hypoglossal. 
89% (8 out of 9) Dhrs3-/- embryos examined showed evident neuronal malformation in CVs when 
compared to stage-matched wildtype embryos (Fig 2.4 A-C). Multiple CV defects were present in the 
mutant mice with various degrees of severity and penetrance (Fig 2.4 D). Within the examined mutant 
mice, 89% (8 in 9) exhibit disarray in the organization of neuronal fibers in anterior CV-XII (hypoglossal 
nerve).  CV-IX and X were found to be fused or randomly distributed in 56% (5 in 9) Dhrs3-/- mice when 
compared to the wildtype. Nerve fiber density was found to be reduced in CV-VII and VIII and smaller 
sized CV-V was observed in 33% (3 in 9) Dhrs3-/- embryos. Some knockout embryos have double or 
more symptoms while some only present with defective structure in CV-XII. No obvious morphological 
alteration was seen in CV-XI between Dhrs3-/- and wildtype embryos. We also performed wholemount 
immunostaining of CVs using neuron-specific Class III β- (Tuj1) antibody. Tuj1 staining revealed 
relatively normal development of CVs in Dhrs3-/- embryos at E10.5 (Fig 2.5 A vs. B), except for 
disorganization of CV-XII and alteration in shape of CV-IX and X (Fig 2.5 C vs. D), similar to what was 
observed by neurofilament immunostaining. To sum up, ablation of Dhrs3 in mouse embryos affects the 
development of specific cranial nerves at E10.5. 
Deletion of Dhrs3 leads to malformation in the cervical vertebrae and rib ossification. 
RA embryopathy can often result in a series of congenital defects including skeletal malformations 
(Collins & Mao, 1999; Lammer et al., 1985). Our lab has previously reported that E14.5 Dhrs3-/- embryos 
consistently exhibit a distinguishing fusion of the neural arches of the C1 and C2 cervical vertebrae 
(Billings et al., 2013), which phenocopies another genetic mouse model, Cyp26a1-/-, where RA 
accumulates as a result of a deficiency in its catabolic enzyme CYP26A1 (Suzan Abu-Abed et al., 2001). 
We further investigated the skeletal development in absence of DHRS3 at E14.5 by Alcian blue to stain 
for cartilages and Alizarin red to stain for ossified bones. Our analysis found that the altered levels of RA 
and its signaling in Dhrs3-/- mice did not affect the number of cervical vertebrae (C1-C7) or the formation 
of the first rib at the location of thoracic vertebra T1 (Fig2.6 A vs. B). Yet, whereas the ossification of 
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cartilaginous thoracic rib was initiated normally from the dorsal end (next to the spine) to the ventral end 
in the wildtype embryos, the osteogenesis process was found to be delayed in Dhrs3 null mutant embryos 
at E14.5, indicating a delayed ossification in the developing ribs.  
DHRS3 regulates complement and coagulation cascades at E14.5. 
In order to understand additional biological processes regulated by DHRS3 and RA, we performed 
microarray utilizing E14.5 Dhrs3-/- and Dhrs3+/+ embryos. Specifically, liver functions were noticed to be 
drastically elevated in the Dhrs3-null mutant at E14.5 (Supplementary Figure 2.1). Amongst all the 
altered pathways complement and coagulation cascades represented the largest change. Though 
complement and coagulation are distinct pathways with different physiological functions, they share 
similarity on molecular level and function as critical barrier of the innate immune system against 
exogenous threat. Based on two embryos per phenotype, we generated preliminary results demonstrating 
that genes involved in both extrinsic and intrinsic coagulation pathways were evidently elevated in the 
Dhrs3-/- mutant mice and multiple critical proteins involved in completion pathway, such as complement 
component 2, 3 and 4, are up-regulated by increased RA signaling. Additional investigation of liver 
functions in Dhrs3-/- embryos at various time points is needed in the future to understand the progress of 
hepatic development in response to altered RA metabolism. 
Maternal vitamin A deficient diet successfully rescues Dhrs3 null mutant mice. 
Previous studies from our lab has provided substantial evidence that ablation of Dhrs3 causes 
excessive accumulation of RA and increased RA signaling in the mutant mice (Billings et al., 2013). 
Deficiency of DHRS3 also results in various malformations in cardiac, palatal and skeletal development. 
However, previous studies did not provide evidence that the observed morphological congenital defects 
can be attributed to the biochemical defect of excess RA present in Dhrs3-/- mice. To reach this 
conclusion we performed a “rescue” study, in which we depleted the maternal vitamin A from diet of the 
dam to create a deficiency of RA precursors in the hope that this would then restore normal levels of RA 
and recover normal development in the Dhrs3- null embryos developing in this context. 
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Vitamin A deficient diet (VAD) was provided to Dhrs3+/- dam from weaning and throughout 
gestation. Feeding female Dhrs3+/-mice with VAD diet within one generation did not alter their breeding 
capacity. VAD diet occasionally led to dystocia if the treatment was prolonged beyond two generations. 
Morphological analysis of the axial skeleton of E14.5 VAD-Dhrs3-/- embryos via Alcian blue and 
Alizarin red staining suggested that the reduced maternal intake of vitamin A could partially rescue the 
cervical defect. Though the C1 and C2 cervical vertebrae became discrete and separated in VAD-Dhrs3-/- 
embryos, the neural arches of the C2 and C3 vertebrae were found to be fused laterally on one side. 
Intriguingly, in VAD-Dhrs3-/- embryos, the morphology of the C3 vertebrae was found to be more similar 
to a normal C2 vertebra while the C2 vertebra came to resemble C1. Collectively, reducing maternal 
intake of vitamin A in Dhrs3-/- embryos ameliorated the skeletal defects in cervical vertebrae. 
In contrast to both humans and other experimental models, mice are remarkably resistant to diet-
induced vitamin A deficiency, being able to provide sufficient vitamin A from dam to fetus to last for the 
entire lifetime of the offspring. Mouse vitamin A deficiency requires the depletion of both preforemed 
and provitamin A carotenoids from the diet for several generations. By prolonging the dietary VAD 
treatment through three generation of Dhrs3+/- female mice, we were able to generate a sufficiently 
deficient vitamin A state in the dam to obtain viable Dhrs3-/- mice which survived to adulthood. Unlike 
Dhrs3-/- mice born to dams maintained on vitamin A sufficient diet, Dhrs3-/- mice from vitamin A-
deficient dams were born with their eyelids still fused, did not exhibit clefting and were able to, breath, 
suckle and grow. We were not able to obtain sufficient living Dhrs3-/- mice to perform retinoid analysis to 
verify that the fetal RA levels of the rescued Dhrs3-/- mice was the same as wildtype littermates 
maintained on a normal diet. However, were able to examine the few living Dhrs3-/- mice were put on 
vitamin A sufficient (4 IU/g ) diet and regularly examined for any signs of the potential postnatal effects 
of excess RA. Rescued Dhrs3-/- mice maintained on a vitamin A sufficient diet were able to grow into 
full-sized adult mice with a normal rate of weight gain compared to their wildtype littermates (Fig 2.7). 
Examination of the gross morphology of the surviving adult Dhrs3-/- mice indicated a shortening and 
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reduction in the length of skull when compared normal age-matched mice that have been fed only on 
VAS diet. These rescued mice were found to be easily agitated and displayed stereotypic circling 
behavior upon subtle stimulation, possibly suggesting vestibular dysfunction and/or striatal asymmetry 
(Ishiguro, Inagaki, & Kaga, 2007). Responsiveness to light was also evaluated and the surviving knockout 
mice did not respond to sudden light exposure, possibly due to freezing behavior, defects in neural 
processing or defective visual functions. Taken together, we were able to rescue embryonic lethal Dhrs3-/- 
embryos by removing maternal dietary intake of vitamin A, suggesting that the congenital defects 
observed in Dhrs3 mutant mice were attributed to excessive accumulation of RA. 
In summary, our results demonstrate that genetic ablation of Dhrs3 in developing mouse embryos 
causes alterations in RA signaling, suggesting an indispensable role of Dhrs3 in safeguarding RA 
homeostasis during embryonic development. In addition to altered RA signaling, lack of function of 
DHRS3 also results in embryonic lethality and malformations in cranial nerves and skeleton. Rearing 
Dhrs3+/- dams on VAD diet successfully corrected most of the phenotypes in Dhrs3-/- embryos and 
allowed the Dhrs3-null mutant to survive postnatally. 
2.4. Discussion 
DHRS3 plays critical roles in RA metabolism in vivo. 
Genetic mutation of Dhrs3 increases RA signaling during early embryogenesis at E10.5. Homeostasis 
of RA is controlled by many critical enzymes to safeguard normal embryogenesis. DHRS3 was reported  
to reduce retinaldehyde in a NADPH-dependent manner in vitro (Haeseleer et al., 1998) and non-
mammalian models demonstrated that deletion of dhrs3 causes elevated levels of RA signaling and 
results in defects in early embryogenic pattering. Our lab previously reported that ablation of Dhrs3 in 
mouse model led to increases in the embryonic level of RA and results in alteration in the extent of RA 
signaling during mid-gestation. In the current study, we continued our investigation of the necessity of 
Dhrs3 in embryogenesis at E10.5. The expression of the RARE-driven reporter LacZ was detected in an 
expanded pattern in the frontonasal area and along the spine in the Dhrs3-/- embryos at E10.5, indicating 
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that DHRS3 is required to prevent the accumulation of RA as early as E10.5. The expansion in RA 
signaling in the frontal nasal area in the Dhrs3 mutant mice is consistent with the observed craniofacial 
defects observed at E14.5 (Billings et al., 2013) and the alterations in the patterning of the vibrissae as 
noted in studies performed in collaboration with Dr. Denis Headon from the Roslin Institute (manuscript 
in preparation). The increased RA signaling in the heart of Dhrs3-/- embryos is consistent with the role of 
RA in heart development and with the etiologic role of altered RA in congenital heart diseases and is the 
subject of the following chapters. Though it is possible that the heart defects associated with Dhrs3 
deletion play a role in the mid- to late-gestational lethality observed in the Dhrs3-/- embryos but we 
cannot exclude other causes (Papaioannou & Behringer, 2005). Quantification of the levels of ATRA at 
E12.5 demonstrates that deletion of Dhrs3 causes accumulation of RA and agrees with our previous 
report of RA increases in this model at E14.5.  
Proper levels of RA are required for neuronal development. 
Dhrs3-/- embryos exhibit defective formation of cranial nerve at E10.5. Previously, several reports 
have demonstrated the importance of proper levels of RA signaling in the embryonic development of 
cranial nerves. Rat embryos derived from vitamin A deficient dams display a loss of posterior cranial 
nerves (IX-XII), which can be corrected by maternal administration of all-trans-RA or retinol (J. C. 
White et al., 1998; Jeffrey C. White et al., 2000). Similar defects were observed in mice lacking sufficient 
RA synthesis as a result of genetic mutation of Raldh2 (Niederreither et al., 2003). The posterior regions 
in the hindbrain of embryos deficient in vitamin A signaling were found to show abnormal expression of 
markers of anterior regions, which might contribute to the defects in the posterior cranial nerves (Jeffrey 
C. White et al., 2000). In the present study, deficiency of Dhrs3 causes malformations in hindbrain-
derived cranial nerves (V-XII). 89% examined mutant embryos display reduced nerve density or 
alteration in the shape of the nerves. In Dhrs3-/- embryos, the most affected nerve was the hypoglossal 
nerve (XII) and the second most frequently observed defect was fusion between glossopharyngeal (IX) 
and vagus (X) nerves, which is consistent with previous studies indicating that the posterior somatic 
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motor nerves are sensitive to altered levels of RA signaling. In addition, Dhrs3-/- embryos share similarity 
with the Pax6 mutant embryos in the observed phenotypes in XII cranial nerve. Pax6 was found to be 
RA-responsive and the eccentric expression and signaling of Pax6 induced by anteriorly expanding RA 
signaling might be detrimental to the well-organized development of the hindbrain and the hindbrain-
derived cranial nerves (Ericson et al., 1997; Osumi et al., 1997). In addition, over half of the examined 
Dhrs3-/- embryos show reduced density of cranial nerve fibers and lack of sufficient outgrowth of cranial 
nerves. Previous studies of the effects of RA on neurite outgrowth employed RA-deficient models; the 
current study provides evidence indicating that excess RA also causes deleterious effect of in the growth 
of nerve fibers. 
Embryonic defects as well as mid-gestational lethality in Dhrs3-/- mice are attributed to excess RA. 
Depletion of dietary vitamin A in the dam corrected most of the defects in the Dhrs3-/- embryos and 
successfully rescued Dhrs3 mutants to survive postnatally. Previously, we have reported that Dhrs3-/- 
embryos possess malformations and fusions of the C1 and C2 cervical vertebrae t and delayed 
ossification in the skull at E17.5 (Billings et al., 2013). Rearing the Dhrs3+/- dam on VAD diet effectively 
prevented the fusion of the C1 and C2 vertebrae but also altered the identity and characteristics of C2 and 
C3 vertebrae. In the Dhrs3-/- embryos, and anteriorizing homeotic transformation (C2 to C1 and C3 to C2) 
was observed in the VAD-rescued Dhrs3-/- embryos. It is known that vertebrae display unique 
morphological characteristics according to their identities, which are determined by their localization 
relative to the anteroposteriorly patterned body axis. RA has been known to regulate the embryonic 
patterning of several organs as well as the whole body and homeotic transformation has been observed in 
animal models exposed to inappropriate levels of RA signaling. Exogenous treatment of RA to mouse 
embryos caused anteriorly enlarged expression domain of posterior Hox genes, which indicated the 
expansion of posterior somatic regions at the expense of anterior somites in response to activation of RA 
signaling (Kessel & Gruss, 1991). Thus it is plausible that anterior transformation in C2 and C3 vertebrae 
might be due to altered body patterning in response to changed levels of RA signaling.  
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Deficiency of Dhrs3 also delays the ossification of ribs at E14.5, which is consistent with previous 
observation in the case of skull ossification at E17.5 (Billings et al., 2013). Similar to the defects in 
cervical vertebrae, this phenotype in rib skeleton ossification is also restore by reduced maternal intake of 
vitamin A. Most importantly, by feeding Dhrs3+/- dams on a VAD diet allowed us to circumvent the 
embryonic lethality associated with Dhrs3 deletion. Dhrs3-/- pups survived to adulthood with normal body 
weight. More importantly, these findings suggest that the lethal defects observed in Dhrs3-/- embryos are 
truly due to excessive accumulation of RA and that lack of Dhrs3 in adult mice is compatible with a 
normal growth and lifespan. However, several potential postnatal effects of Dhrs3 deletion were noted. 
Adult Dhrs3-/- mice seemed to exhibit a minimal responsiveness to light stimulation. It is therefore 
possible that DHRS3, first described as retinal SDR1, retSDR1 which carries out the reduction of 
retinaldehyde may play a role in the regeneration of visual chromophore in the retina (Haeseleer et al., 
1998). Further studies of the visual responses of the rescued Dhrs3-/- mice or retina-specific Dhrs3 
conditional knockout are warranted. Another observation is that when reared on VAS diet after weaning, 
Dhrs3-/- mice display spontaneous circling behavior, resembling defects observed in mice with vestibular 
dysfunction and striatal asymmetry. Further investigation of the neurological development and visual 
functions of adult Dhrs3 deficient mice is needed to understand the postnatal roles of DHRS3 in vitamin 
A metabolism. 
In summary, DHSR3 is required to safeguard embryonic development against the excess formation of 
RA during early and mid-gestation. DHSR3 via its effects on RA signaling plays critical, nonredundant 
roles in the development of the cranial nerves and the axial skeleton. Our results provide evidence 
supporting the physiological role of Dhrs3 in the metabolism of RA in vivo and of the teratogenic effects 






Figure 2.1 Determination of mouse estrus cycle. 
Examination of vaginal cytology indicates that A) proestrus is characterized by the presence of 
nucleated epithelial cells (yellow arrow); B) nucleous-free conified epithelial cells dominate in estrus (red 
arrow); C) cells in metestrus contain both cornified epithelial cells and leukocytes (blue arrow); D) 
vaginal cells are primirily leukocytes during diestrus. Visualization of the cellular composition of vaginal 





Figure 2.2 Ablation of Dhrs3 causes expansion of RARE-driven RA signaling domains in 
E10.5 mouse embryos. 
Wildtype (A-C) and Dhrs3 knockout (D-F) embryos carrying RARE-LacZ transgene were collected at 
E10.5 and processed for X-Gal staining to visualize β-Galactosidase (LacZ) activity. Dhrs3-/- ;RARE-
LacZ embryos display broader and more intense staining color in the dorsal body trunk and frontal nasal 
area (yellow arrows), suggesting an expansion of RARE-driven RA signaling domains in developing 
mutant embryos. Red dashed line marks the first pharyngeal arch. The expansion of LacZ expressing 
domain in Dhrs3-/- embryos reaches the posterior end of the first pharyngeal arch, which is in evident 
contrast to the wildtype. Scale bars represent 200μm. Images are representative of three individual 






Figure 2.3 Mutation of Dhrs3 leads to alterations in the levels of retinoids in developing 
embryos at E12.5. 
Measurements were performed using LC-MS/MS and normalized by the weight of sample. At least 4 






Figure 2.4 Wholemount immunostaining of Neurofilament reveals defective cranial nerve 
formation with partial penetrance in Dhrs3-/- mice. 
Severity of neuronal defects varies in 9 examined Dhrs3 mutant mice (A vs. B, C) and 89% mutant 
mice display malformations in the cranial nerves. Morphology of each individual cranial nerve was 
differentially affected by the ablation of Dhrs3. The percentage of mutant mice exhibiting a certain defect 
in a specific nerve is quantified and listed in D. V, trigeminal nerve; VII, facial nerve; VIII, 
vestibulocochlear nerve; IX, glossopharyngeal nerve; X, vagus nerve; XI, accessory nerve; and XII, 






Figure 2.5 Wholemount immunostaining of neuron-specific Tubulin β 3 (Tuj1) in E10.5 
embryos reveals the deleterious effect of ablation of Dhrs3 on neuronal development. 
Abnormal assembly and growth of hypoglossal nerve (XII) was observed in all examined Dhrs3 
mutant mice (C vs. D, n=4). Scale bars represent 500μm. Images are representative of 3 individual 






Figure 2.6 Malformations in cervical vertebrae and delayed ossification in Dhrs3-/- embryos 
are attributed to excessive accumulation of RA and can be rescued by reducing maternal 
intake of vitamin A. 
Genetic deletion of Dhrs3 causes evident fusion of C1 and C2 cervical vertebrae cartilage (yellow 
arrow) as well as delayed bone ossification (red arrow) in the rib cage of developing mouse embryos (A 
vs. B). Maternal vitamin A deficient (VAD) diet was able to partially correct the abnormal vertebrae 
fusion on one side of the body (yellow arrow in C) and restore the level of bone formation (red arrow in 
C) in Dhrs3-/- embryos. Yet, the VAD diet leaded to the transformation of the C3 cervical vertebrae into 
C2-like morphology with bifurcated extremity (B vs. C) in Dhrs3-/- mice, which indicates the requirement 
of tightly controlled amount of RA during skeletal development. Scale bars represent 500μm. Images are 






Figure 2.7 Maternal VAD diet rescued embryonically lethal Dhrs3 mutant embryos to 
adulthood. 
Rescued Dhrs3-/- mice display normal growth on vitamin A sufficient diet when compared to their 










Supplementary Fig  2.1 Deletion of Dhrs3 in mouse embryos altered hepatic functions at E14.5 
Microarray analysis of genes that are differentially expressed in Dhrs3-/- vs. Dhrs3+/+ embryos is 
presented as pie chart showing the gene ontology distribution of liver functions. Two embryos per 




Supplementary Fig  2.2 KEGG analysis of genes involved in complement and coagulation cascades 
in Dhrs3-/- embryos. 
Complement and coagulation cascades were found to be broadly activated in the Dhrs3-/- embryos 
when compared to wildtype controls at E14.5. Pink represents genes that are induced by the deficiency of 





Chapter 3 : Retinoic Acid Regulates Cytoskeletal Reorganization in Epithelial 
to Mesenchymal Transition of Embryonic Epicardial Cells 
Abstract 
The epicardium is the main source of RA in the embryonic heart. Yet, the cardiogenic functions of 
epicardial-produced RA are not fully understood. Here, we investigated the roles of RA-signaling in the 
embryonic epicardium using in vivo and in vitro models of excess or deficiency of RA. Our results 
suggested that RA plays a critical role in regulating the cytoskeletal rearrangement required for the 
epicardial-to-mesenchymal transition (EpiMT) of epicardial-derived precursor cells (EPDCs). In vivo, 
treatment with an inhibitor of RA synthesis delayed the migration of EPDCs into the myocardium. In 
contrast, the opposite was seen in the case of Dhrs3-/- embryos, a mouse model of RA excess, in which 
EPDCs were localized deeper into the myocardium than in wild type controls. To understand the 
molecular mechanisms by which RA regulates EpiMT, we employed a whole transcriptome profiling 
approach which in combination with pull-down and inhibition assays demonstrated that the RhoA 
pathway is required for the morphological changes induced by RA in epicardial cells. Collectively, these 
data demonstrate that RA regulates EpiMT via a signaling cascade which involves the RhoA pathway. 
3.1. Introduction 
There are few therapeutic options for coronary vascular disease (CVD), despite it being the leading 
cause of death worldwide. The minimal regenerative capacity of the adult human heart is an important 
roadblock in the treatment of CVD. Species capable of effective cardiac regeneration rely on fast 
revascularization to supply nutrients and restore oxygen to the injured area (Marin-Juez et al., 2016). 
Thus, a better understanding of the developmental processes that guide the formation of coronary 
vasculature could help in the design of therapies to assist the formation of new vessels. 
The epicardium is an epithelial layer of cells that covers the surface of the heart and plays a critical 
role in its development and regeneration. The main developmental contributions of the epicardium consist 
of cardiotrophic factors and epicardial-derived precursor cells (EPDCs) which give rise to several cardiac 
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lineages (reviewed in (Carmona et al., 2010)). Formed by a process of epicardial-to-mesenchymal 
transition (EpiMT), EPDCs migrate into the myocardium and differentiate mainly into vascular smooth 
muscle cells (VSMCs) and cardiac fibroblasts (reviewed in (Fang, Xiang, Braitsch, & Yutzey, 2016; 
Ruiz-Villalba & Perez-Pomares, 2012; von Gise & Pu, 2012)). Following birth, the epicardium becomes 
quiescent but, upon injury, its regulatory functions can be reactivated to sustain the wound repair process 
(Lepilina et al., 2006; B. Zhou et al., 2011). EpiMT is thus an integral process that leads to the generation 
of key precursor cells necessary for both the late development of the embryonic heart and for the response 
to injury in the adult heart.  
All-trans-retinoic acid (RA), a metabolite of vitamin A, acting as a ligand of its cognate RA receptor 
(RAR), plays an important regulatory role in development of the heart (reviewed in (Stefanovic & 
Zaffran, 2017; Xavier-Neto et al., 2015)). RA produced by the lateral mesoderm determines the size of 
the cardiac progenitor pool and specifies the cells that contribute to the inflow versus the outflow tract (T. 
Hochgreb et al., 2003). After the heart forms, it becomes enveloped with a visceral pericardial layer of 
cells called the epicardium. The embryonic epicardium is the major source of cardiac RA as it expresses 
both the enzymes involved in the synthesis of RA (J. B. Moss et al., 1998; Niederreither, McCaffery, 
Drager, Chambon, & Dolle, 1997; Xavier-Neto et al., 2000) as well as the receptors for RA and 9-cis-RA, 
namely, RAR and RXR (Dolle, 2009; Merki et al., 2005). In fact, the embryonic RA biosynthetic 
enzyme, retinaldehyde dehydrogenase type II (RALDH2, officially designated ALDH1A2) is often used 
as a specific marker for the epicardium in the developing heart (J. M. Perez-Pomares et al., 2002; Xavier-
Neto et al., 2000). Visualization of RA signaling in the embryonic heart has also revealed enriched RA 
signaling activity in the epicardium (Matt et al., 2005). However, in spite of earlier reports suggesting 
epicardial-derived RA to be required for the secretion of epicardial-derived trophic factors (T. Chen et al., 
2002; Merki et al., 2005; Ingo Stuckmann et al., 2003), it appears that epicardial-mediated myocardial 
growth relies primarily on non-epicardial RA sources (Thomas Brade et al., 2011; Shen et al., 2015). This 
raises the question: what is the role of the RA produced by the epicardium in cardiogenesis? 
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The roles of epicardial-derived RA in heart development are still poorly understood. Studies from 
mouse models provide evidence of the requirement of Retinoid X Receptor-α (RXRα) in EpiMT (Merki 
et al., 2005) and of the involvement of RA-signaling in EpiMT mediated by Wilms-tumor 1 (WT1) (von 
Gise et al., 2011). Results based on avian models also suggest that epicardial-derived RA plays a role in 
the differentiation of EPDCs into VSMCs (Azambuja et al., 2010; Caitlin M. Braitsch et al., 2012). In 
adults, epicardial RA-signaling is required for the regeneration of the zebrafish heart and is involved in 
the injury response of the adult mammalian heart (D. Bilbija et al., 2012). In conclusion, several lines of 
evidence suggest that epicardial-derived RA may play important roles in cardiac developmental and 
regenerative processes but many of the mechanistic details of this regulation are still missing.  
Here, we report that RA-signaling plays a critical role in the development and migration of EPDCs. 
These conclusions are derived from complementary models of excess or deficient RA-signaling which 
show that RA-signaling is required for the cytoskeletal reorganization of epicardial cells to facilitate cell 
movement. Our data clarifies a less well understood aspect of the role of RA-signaling in the 
development of the epicardial-derived cell lineages. 
3.2. Materials and Methods 
Mice  
Heterozygote crosses of the previously described Dhrs3+/- mouse strain (Billings et al., 2013) were 
used to generate Dhrs3-/- homozygotes and Dhrs3+/+ control embryos. The RARE-LacZ reporter mouse 
strain (Rossant et al., 1991) was obtained from Jackson Laboratories identified as strain RARE-
hsp68LacZ, stock 008477. The mice were maintained on a regular chow diet Teklad 2018 (Envigo, 
Cambridgeshire, UK) that contains 15 IU vitamin A/ gram diet and housed in rooms providing controlled 
temperature and humidity on a 12-hour light-dark cycle. Female mice were examined daily for estrus 
cycle stages by vaginal smear and those at proestrus stage were mated to male mice overnight. Matings 
were broken the next morning and that noon was considered to be embryonic day (E0.5). Caesarean 
sections were performed at designated embryonic stages to harvest pups or embryonic tissues. The age of 
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the harvested embryos was also verified based on having achieved specific developmental milestones for 
each stage. All animal protocols were approved by the Institutional Animal Care and Use Committee at 
the University of Kansas. 
Establishment of an RA-deficient mouse model 
N’N’-bis(dichloroacetyl)-1,8-octamethylenediamine (Tocris Bioscience, Cat# 4736, CAS Number: 
1477-57-2) also known as WIN18,446 (WIN), was dissolved in DMSO (ACROS Organics, Cat #61097-
1000) to form a stock solution. Pregnant RARE-LacZ mice were orally gavaged with 51.6 mg/kg WIN 
mixed in corn oil once per day from E9.5 to E13.5. At E14.5 caesarean sections were performed to 
harvest embryos for various analyses. 
Histology 
Mouse embryos harvested at various developmental stages were fixed overnight in 4% 
paraformaldehyde at 4°C and then embedded in paraffin and cut as 7µm transversal sections using a 
Leica RM2255 microtome. The slides were stained using hematoxylin and eosin according to previously 
published protocol (Fischer, Jacobson, Rose, & Zeller, 2008) and documented by a dissecting microscope 
equipped with a digital camera. The heart morphology was evaluated as described in (Billings et al., 
2013) to assess the effect of WIN treatment on heart tube elongation, looping and chamber formation. 
RT-PCR 
RNA was isolated using the QIAGEN RNeasy micro kit (Qiagen, Cat # 74104) according to 
manufacturer’s instructions. 1µg of RNA was first treated with DNase I (New England Biolabs, Cat # 
M0303S) and then reverse-transcribed using SuperScript III reverse transcriptase (Invitrogen, Cat# 
18080051) into complementary DNA (cDNA). Quantitative real-time PCR analysis using the Power 
SYBR Green Master Mix (Applied Biosystems, Cat# 4367659) was performed on an Applied Biosystems 
StepOnePlus Real-Time PCR system (Applied Biosystems, Foster City, CA). The primer sequences for 
each target gene are listed in Supplementary Table 3.2. The amplified regions of all used qRT-PCR 
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primer sets have been mapped and validated by UCSC In-Silico PCR database [Dec. 2011 
(GRCm38/mm10), mouse genome] and the products have been examined by agarose gel electrophoresis 
to confirm the specificity of the primers. The relative expression levels of a gene have been calculated 
using the ∆∆Ct method and normalized to that of Gapdh as an internal control.  
Immunofluorescent staining 
The embryos were fixed in 4% PFA overnight at 4°C and embedded in paraffin and then transversal 
sections were cut at 7µm. The slides were first deparaffinized and rehydrated at room temperature. 
Antigen retrieval was performed and endogenous horseradish peroxidase (HRP) activity was quenched 
with 3% H2O2 for 10 minutes. Slides were then blocked for an hour with blocking buffer (5% normal goat 
serum/ 0.1% Tween20/ PBS) at room temperature for an hour. The primary antibody was diluted in 
blocking buffer and applied to slides for overnight incubation at 4°C. After being washed in 0.1% 
Tween20/ PBS, HRP-conjugated secondary antibody recognizing the species of the primary antibody was 
applied to the slides. Detailed information of antibodies and dilution ratios are reported in Table 2. The 
specificity of the primary antibodies has been validated by western blotting revealing in each case 
recognition of a single protein band migrating at the expected molecular weight for the respective antigen. 
Subsequently, a tyramide-based signal amplification (TSA) method using the TSA Plus Fluorescein 
Evaluation Kit (PerkinElmer, Cat# NEL741E001KT) was used to amplify the fluorescent signal 
according to manufacturer’s protocol. 1µM of DAPI (Life Technologies) was applied to counterstain the 
nuclei and the slides were mounted in Vectashield (Vector Laboratories, Cat# H-1000).  
For WT1 immunofluorescent staining, slides were deparaffinized, rehydrated and boiled in pH6 
10mM sodium citrate buffer containing 0.05% Tween 20 for 20 minutes. The sections were incubated 
with blocking buffer (5% BSA/ 0.2% Triton X-100/ PBS) for an hour, followed by overnight incubation 
with primary antibody (anti-Wilm’s Tumor 1, Cat# ab89901, abcam) in antibody diluent (5% BSA/0.1% 
Triton X-100/PBS) at 4°C. The slides were then washed in PBS for 15 minutes and incubated with 
secondary antibody (Alexa Fluor 568-conjugated goat anti-rabbit antibody, Cat# A-11011, Invitrogen) in 
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antibody diluent for 1.5 hours at room temperature. After washing off excess secondary antibody, 
sections were mounted with Vectashield mounting medium supplemented with DAPI (Vector 
Laboratories, Cat# H-1200). 
The fluorescent images were acquired on an inverted epifluorescent microscope (Olympus IX-81 
with ZDC, Olympus Scientific Solutions Americas) using 10x air objective (0.3NA, Olympus Scientific 
Solutions Americas) and equipped with a Hamamatsu Flash 4.0 v1 CMOS camera (Hamamatsu 
Corporation). The images at higher magnification were collected on an Olympus 3I spinning disk 
confocal microscope (Olympus IX-81, Olympus Scientific Solutions Americas) using 40x oil objective 
(1.3NA, Olympus Scientific Solutions Americas) equipped with an Andor Zyla 4.2 CMOS camera 
(Andor Technology Ltd). Using SlideBook 6.0 (Intelligent Imaging Innovations) a Look-up table (LUT) 
tool was applied to adjust the images to the same level to facilitate a fair comparison of intensities of 
fluorescence between images. 
Immunocytochemistry staining 
For immunocytochemistry staining, the cultured cells were rinsed with warm phosphate-buffered 
saline (PBS) 3 times and fixed in 4% PFA for 10 minutes at room temperature. The cells were then 
blocked with blocking buffer (5% normal goat serum/ 0.1% Tween20/ PBS) and incubated with diluted 
primary antibody (dilution ratios are listed in Supplementary Table 3.1) at 4°C overnight. After being 
washed in 0.1% Tween20/ PBS, the cells were incubated with the respective secondary antibody diluted 
in blocking buffer and counterstained with 1µM of DAPI. The cells were mounted in mounting medium 
(glycerol: PBS=9:1). The immunostaining results were visualized and documented on an inverted 
epifluorescent microscope (Olympus IX-81 with ZDC, Olympus Scientific Solutions Americas) using 
20x air objective (0.3NA, Olympus Scientific Solutions Americas) and Hamamatsu Flash 4.0 v1 CMOS 
camera (Hamamatsu Corporation). Images at higher magnification were collected on an Olympus 3I 
spinning disk confocal microscope (Olympus IX-81, Olympus Scientific Solutions Americas) using 40x 
oil objective (1.3NA, Olympus Scientific Solutions Americas) equipped with an Andor Zyla 4.2 CMOS 
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camera (Andor Technology Ltd). The LUT of each image was adjusted to the same level using SlideBook 
6.0 (Intelligent Imaging Innovations) to facilitate a fair comparison of intensity of fluorescence. 
Quantification of the number of cells retaining tight cell-to-cell contact was performed by a blinded 
observer. Images (at least 4 separate fields per biological replicate) were scrambled and presented to an 
observer for counting the number of tightly contacting epithelial cells. At least 200 cells were counted for 
primary epicardial cells and 400 cells were counted for MEC1 cells for each biological replicate.  
Primary explant culture 
The isolation of primary epicardial cells has been performed according to a previously reported 
protocol (Amy M. Mellgren et al., 2008). In brief, embryonic mouse hearts were collected at E12.5 in 
Hanks buffered salt solution and incubated on collagen coated iBidi plates (Cat # 80826, iBidi, 
Martinsried, Germany) in explant medium (DMEM:M199=1:1) supplemented with 10% heat-inactivated 
FBS. 12 to 15 hr later the hearts were removed to leave a monolayer of primary epicardial cells attached 
to the plate. The morphology and identity of isolated primary cells has been assessed by immunostaining 
of the epicardial marker WT1 to confirm their epicardial origin. Only wells with sufficient numbers of 
attached epicardial cells and no mesenchymal-like cells were used for experiments.  
Assessment of EpiMT 
Primary epicardial cells isolated from C57BL/6 embryos were cultured with explant medium 
supplemented with 5% heat-inactivated FBS and 1% antibiotic-antimycotic reagent (Gibco, Cat # 
15240062) and pretreated with 2.5µM ALK5 inhibitor (SB431542, Cat # 616461, Calbiochem, San 
Diego, CA, USA) for 5 hr to synchronize and restore the colony to a minimal level of EpiMT. After the 
removal of the ALK5 inhibitor, primary epicardial cells were either treated with vehicle (DMSO) vs. 10 
nM TTNPB (Sigma, Cat # T3757) for an additional 48 hr or pretreated with vehicle (DMSO) vs. 8µM 
WIN for 5 hr to inhibit the enzymatic activity of RALDH enzymes. Cells pretreated with vehicle 
(DMSO) or WIN were then cultured in the presence of 50ng/ml PDGFBB (R&D systems, Cat # 220-BB) 
to induce EpiMT. Primary cells were cultured with PDGFBB alone or PDGFBB in combination with 
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8µM of WIN for additional 48 hr and then subjected to immunocytochemistry staining or scratch wound 
migration assay. 
Similar treatments were also applied to the MEC1 epicardial cells. MEC1 cells were cultured with 
DMEM supplemented with 10% FBS and 1% antibiotic-antimycotic reagent. After being plated in culture 
chambers, MEC1 cells were pretreated with 2.5µM ALK5 inhibitor (SB431542, Cat # 616461, 
Calbiochem, San Diego, CA, USA) for up to 24 hr. In the experiment depicted in Fig 3.1, MEC1 cells 
were pretreated with either vehicle (DMSO) or 8µM WIN for up to 24 hr followed by induction of 
EpiMT with 50ng/ml PDGFBB (R&D systems, Cat # 220-BB) for an additional 72 hr. Alternatively, in 
experiments depicted in Fig 3.5 and 3.6 aiming to examine the effect of TTNPB on EpiMT, MEC1 cells 
were pretreated with 2.5µM ALK5 inhibitor for 24 hr and then stimulated with either vehicle (DMSO) vs. 
10 nM TTNPB for additional 72 hr. Cell were examined by scratch wound migration assay or 
immunocytochemistry staining to assess their migratory capacity and level of EpiMT. 
In the case of primary epicardial cells derived from Dhrs3+/+ and Dhrs3-/- mice, these explants were 
incubated in serum-reduced explant medium supplemented with 1% heat-inactivated FBS to minimize the 
basal EpiMT process and to allow us to assess their inherent migratory capacity. Following 48 hr 
incubation in serum-reduced explant medium the migratory capacity of Dhrs3+/+ and Dhrs3-/- primary 
epicardial cells as assesses by a scratch wound migration assay in conjunction with immunocytochemistry 
staining.  
Scratch wound migration assay 
The migratory capacity of primary epicardial cells derived from Dhrs3+/+ and Dhrs3-/- mice or from 
C57BL/6 mice was assessed by scratch wound migration assay. For this, a scratch was made through the 
monolayer of epicardial cells to create a cell-free zone. The width of the gap was measured at 0 hrs and 
12 hrs after the scratch was made and the percentage of wound closure was calculated to evaluate the 
migratory capacity of primary epicardial cells. In the case of the MEC1 cell line, the width of the gap was 
measured every 2 hours after the scratch was created. As in the case of primary epicardial cells, the 
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migration ability of MEC1 cells was calculated by comparing the percentage of wound closure. Statistical 
analysis of the results was based on three independent biological replicates per experimental group. 
LacZ staining 
The embryos or fetal hearts harvested from RARE-LacZ reporter mice were isolated at various 
developmental stages to assess the activity of the LacZ-reporter as per previously described protocols 
(Billings et al., 2013). The X-gal stained slides were counterstained with eosin Y. The samples in both 
experimental and control groups were processed simultaneously using identical protocols to avoid 
artifacts due to staining and the images were documented using a Leica DMS300 Dissection Microscope 
equipped with a digital camera. 
Western blotting 
Treated cultures of MEC1 cells were rinsed twice with ice-cold Hank's Balanced Salt Solution 
(HBSS) and lysed with radioimmunoprecipitation assay buffer (RIPA) buffer composed of 25mM Tris 
pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS and containing a protease 
inhibitor cocktail (cOmplete ULTRA Tablet, Roche; Cat # 05892791001). The cell lysate was sonicated 
three times on ice. After centrifugation, the protein concentration in the supernatant was quantified by 
Coomassie Protein Assay Reagent (Thermo scientific, Cat #1856209). Samples were prepared by mixing 
protein supernatants (10 µg protein per sample) with NuPAGE LDS sample buffer (Invitrogen, Cat # 
NP0007) and reducing agent (Invitrogen, Cat # NP0004) and heating at 70°C for 10 minutes to denature 
the proteins. Protein samples were loaded on a 4-12% SDS-PAGE gradient gel (Invitrogen, Cat # 
NP0321BOX). Protein electrophoresis and transfer to PVDF membranes were performed according to 
manufacturer’s protocol (Invitrogen, CA). Immunoblotting and signal detection was conducted using the 
WesternBreeze Chemiluminescent Immunodetection System (Novex, Cat # WB7104). The primary 
antibodies used in western blotting include anti-RND3 (1:1000, ab50316; Abcam) and anti-β-actin 
(1:4000, sc-47778; Santa Cruz Biotechnology). Alkaline phosphatase- conjugated secondary antibodies 
include anti-rabbit (Invitrogen, Cat # WP20007) and anti-mouse (Invitrogen, Cat # 46-7006). 
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RhoA pull-down assay 
Affinity purification of RhoA-GTP from the lysates of TTNPB- or DMSO-treated MEC1 cells was 
performed using the Rho activation assay kit (MD Millipore; Cat #17-294) following manufacturer’s 
protocol. Lysis of TTNPB- or DMSO-treated MEC1 in 125mM HEPES, pH 7.5, 750mM NaCl, 5% 
Igepal CA-630, 50mM MgCl2, 5mM EDTA and 10% glycerol (Mg2+ Lysis/Wash Buffer; Cat # 20-168, 
EMD Millipore) was performed in the presence of phosphatase inhibitors, 25mM NaF and 1mM 
orthovanadate, and protease inhibitors, 10µg/ml leupeptin and 10µg/ml aprotinin. The GTP-bound Rho 
proteins were purified from the lysates using recombinant Rhotekin Rho Binding Domain (RBD) -bound 
agarose beads. The resulting purified fractions from each treatment were loaded on a 4-12% SDS-PAGE 
gradient gel (Invitrogen, Cat # NP0323BOX) transferred to PVDF membranes and immunoblotted with 
anti-RhoA antibody (NewEast Biosciences, Cat # 26007) to detect RhoA-GTP. Non-hydrolyzable GTPγS 
was used to induce the association and purification of all available Rho protein from the lysate. We 
confirmed that we used the same amount of starting protein from each of the lysates by immunoblotting 
of each lysate with anti-actin antibody (SantaCruz Biosciences, Cat # sc-47778). 
LC-MS/MS 
Embryos were collected at E12.5 or E14.5, snap frozen in liquid nitrogen and stored in -80°C till 
extraction. The levels of RA were measured using a previously published protocol (Kane, Chen, Sparks, 
& Napoli, 2005). For E12.5 embryos, RA levels were measured using 4 Dhrs3+/+, 5 Dhrs3+/- and 5 Dhrs3-
/- embryos. RA levels present in E14.5 embryos WIN-treated embryos were established using 5 embryos 
for each the DMSO or WIN-treated groups. 
Transcriptome analysis 
MEC1 cells were treated with vehicle (DMSO) or 10nM TTNPB for 48 hours and total RNA was 
isolated using TRIZOL reagent according to manufacturer’s protocol. RNA was pretreated with DNA-
free™ DNA Removal Kit (Invitrogen, Cat # AM1906) before submission for cDNA library assembly. 
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Image analysis using CellProfiler 
All the immunostaining-based images were acquired non-biasedly on the same day under identical 
conditions (identical microscope and camera; same laser intensity, exposure time and 1x1 Binning mode). 
Cells were double-labeled with wheat germ-agglutinin (WGA) that marks the cell membrane, and the 
target protein for measurement and comparison, namely ZO-1. Relative expression of ZO-1 on cell 
membrane was measured and represented by the relative fluorescent intensity of ZO-1 localized on the 
cell border marked by WGA. The quantification of membranous expression of ZO-1 was performed by 
three main steps in CellProfiler: identification of whole cells using whole-cell-stained images (WGA-
based), identification of border of each cell (edge of cell membrane) using WGA-based images, and 
measurements of relative fluorescent intensity of ZO-1 on the edge of cell membrane. Detailed pipeline 
and module settings are provided in supplementary materials and the identical quantification pipeline was 
applied non-biasedly to all cases. To be more specific, after whole cell was identified based on WGA 
staining, intracellular area that was 0.39µm (5 pixel) away from the cell boundary was subtracted and the 
remaining area (a 0.39µm-wide loop) was defined as the edge of a cell membrane. Mean intensity of ZO-
1 fluorescence in this defined membranous region was subsequently quantified and used to compare the 
relative localization of ZO-1 on cell membrane between different experimental groups. 
Statistical analysis 
Each experiment contains at least three biological replicates. For assays containing two experimental 
groups, the statistical analysis was performed using unpaired Student’s t-test between groups. For tests 
that contain more than two experimental groups, one way ANOVA was performed followed by post-hoc 





Inhibition of RA synthesis impairs the response of epicardial cells to PDGFBB 
We began our investigation of the role of RA in EpiMT using a well-characterized epicardial cell 
line, MEC1, derived from the ventricular epicardium of E13.5 embryos of the ICR/CD1 outbred mouse 
strain (P. Li et al., 2011). When plated at 60-80% confluency and in the absence of EpiMT inducers, the 
MEC1 cells retained many of the features of resting embryonic epicardial cells. This included the 
expression of the epicardial markers, WT1 and transcription factor 21 (TCF21, also known as POD-1, or 
epicardin) (Supplementary Fig 3.1A-B), and the epithelial markers ZO-1 and beta-catenin at their cell 
border (Fig 3.1A for ZO-1, Supplementary Fig 3.1C for beta-catenin). Uninduced MEC1 cells had a 
cobblestone epithelial morphology, with tight cell-to-cell contact, and showed minimal formation of 
stress fibers, and no detectable expression of markers of VSMC differentiation (Supplementary Fig 3.1E 
and Fig 3.1F). Importantly, MEC1 cells also expressed the dehydrogenase/reductase 3 (DHRS3) 
(Supplementary Fig 3.1D), an enzyme required for controlling the formation of embryonic RA (Billings 
et al., 2013). This observation was consistent with the existence of ongoing RA metabolism within MEC1 
cells, just as previously described in the case of epicardial cells (J. B. Moss et al., 1998; Niederreither et 
al., 1997; Xavier-Neto et al., 2000).  
PDGFR-signaling is a critical regulator of EpiMT. Epicardial-specific ablation of PDGFRA or 
PDGFRB, or of both PDGFRA/B, leads to compromised EpiMT and reduced migration of EPDCs into 
the myocardium (Bax et al., 2010; Amy M. Mellgren et al., 2008; C. Rudat, Norden, Taketo, & Kispert, 
2013; C. L. Smith, Baek, Sung, & Tallquist, 2011). Addition of the PDGFRA/PDGFRB ligand, 
PDGFBB, to epicardial cells induces EpiMT and EPDC differentiation into VSMCs (Lu et al., 2001). 
Upon addition of PDGFBB at 50ng/ml MEC1 cells efficiently underwent EpiMT-relevant programs 
including cytoskeletal reorganization, as evidenced by the loss of the expression of the epithelial marker, 
ZO-1 (Fig 3.1A vs. B) and the formation of smooth muscle α-actin (SMAα)-positive stress fibers (Fig 
3.1K vs. L). In order to examine the expression level and the intracellular localization of ZO-1 relative to 
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the cell membrane, we performed double labeling of ZO-1 and wheat germ agglutinin (WGA), which 
binds glycoproteins on the cell membrane, on MEC1 cells (Fig 3.1 D-I). Relative expression of ZO-1 on 
cell membrane was evaluated and represented by the fluorescent intensity of ZO-1 on the cell membrane 
marked by WGA. Measurement of relative expression of ZO-1 on cell membrane revealed that PDGFBB 
caused 50% of reduction in ZO-1 immunofluorescence on the cell membrane, shown in Fig 3.1 J, 
suggesting that PDGFBB can induce the loss of epithelial characteristics. 
Due to the critical roles of PDGFR-signaling in EpiMT in embryogenesis and in heart regeneration 
(Kim et al., 2010), we studied the role of RA-signaling in PDGFBB-induced EpiMT. To test whether RA-
signaling is necessary for the process of PDGFBB-induced EpiMT in vitro, we blocked RA synthesis in 
MEC1 cells using WIN18,446 (WIN), a potent bis-dichloroacetyldiamine inhibitor of the enzymes of the 
aldehyde dehydrogenase 1A family (ALDH1A). The ALDH1A family includes the enzymes ALDH1A1, 
ALDH1A2, and ALDH1A3, also known as RALDH1, RALDH2 and RALDH3, respectively, RALDH2 
being the main RA synthetic enzyme during embryogenesis (Arnold et al., 2015; Niederreither et al., 
2001; Paik et al., 2014). Using WIN to treat cells prior to PDGFBB-induction, we found that WIN 
pretreatment effectively counteracted the morphological changes induced by PDGFBB in MEC1 cells 
based on ZO-1 staining (Fig 3.1B vs. C, expression levels of ZO-1 on cell membrane was quantified in J). 
This suggests that production of RA was required for the loss of the epithelial marker caused by 
PDGFBB. In addition, WIN pretreatment also prevented the accumulation of SMAα-positive stress fibers 
induced by PDGFBB (Fig 3.1L-M).  
Using a scratch wound migration assay, we next assayed the effect of WIN on the migration of 
PDGFBB-induced MEC1 cells. The level of wound closure was examined every 2 hours over 12 hr 
period following PDGFBB treatment to estimate the extent of cell migration (Supplementary Fig 3.2 A-
F). PDGFBB treatment significantly accelerates the closure of scratch wound when compared with 
DMSO group, starting from 2 hours post-scratch. In comparison to MEC1 cells stimulated with PDGFBB 
alone, MEC1 cells treated with PDGFBB+WIN displayed reduction in percentage of wound closure over 
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time (Supplementary Fig G). To understand the reasons for the slower gap closure in the PDGFBB+WIN 
group versus the PDGFBB group, we performed Ki67 immunostaining to assess the effect of WIN on the 
rate of cell proliferation. Quantification of Ki67-positive proliferating cells suggested that WIN did not 
affect PDGFBB-induced cell proliferation (Supplementary Fig 3.3D). Thus, the reduced migration in 
response to PDGFBB+WIN versus PDGFBB alone cannot be attributed to reduced proliferation and was 
most likely caused by a reduced level in cytoskeletal reorganization due to WIN treatment.  
To investigate the cause of reduced epicardial cell migration in WIN-treated cells, we next examined 
the cytoskeletal structure and formation of focal adhesions that are a site of interaction of cells with the 
extracellular matrix during the process of cell migration (Couchman & Rees, 1979). By phalloidin 
staining of migrating cells 5 hr after the scratch was made, we observed that PDGFBB alone treatment 
increased F-actin bundle formation presumably facilitating the formation of stress fibers. In the case of 
PDGBB-alone treated cells, the stress fibers were aligned with the direction of cell migration, i.e. towards 
the closure of the wound (Fig 3.1N vs. O). Meanwhile, focal adhesion proteins, which mediate the 
interaction between cells and the extracellular matrix, accumulated and relocated to the leading edge of 
the PDGFBB alone treated cells, as visualized by vinculin staining (Fig 3.1Q vs. R). In contrast, MEC1 
cells treated with PDGFBB+WIN formed F-actin stress fibers that were disorganized and not aligned 
with the direction of cell migration (Fig 3.1O vs. P), while vinculin-positive focal adhesions remained 
diffusely distributed throughout the cell (Fig 3.1R vs. S). Taken together these data suggest that RA is 
required for reorganization of the cytoskeleton and the loss of epithelial morphology which is necessary 
to facilitate the process of EpiMT and cell migration. 
To confirm that the effects of WIN on EpiMT were due to a reduced level of RA-signaling, we 
stimulated the PDGFBB+WIN-treated cells with 10 nM TTNPB, a stable pan-RAR agonist (Beard et al., 
1995), and we tested whether addition of TTNPB can recover the ability of PDGFBB+WIN-treated 
MEC1 cells to undergo EpiMT. Immunostaining results demonstrated that addition of TTNPB to 
PDGFBB+WIN led to reduced expression of ZO-1 at cell border and a loss of cell-to-cell contact 
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(Supplementary Fig 3.4A-D), and a similar restoration of the formation of stress fibers (Supplementary 
Fig 3.4E-H). This was indicative of a higher level of cytoskeletal reorganization in MEC1 cells treated 
with TTNPB in addition to PDGFBB+WIN when compared to cells treated with PDGFBB+WIN. 
Therefore, while WIN prevented the response of MEC1 cells to PDGFBB, the addition of TTNPB 
restored the response of WIN-pretreated MEC1 cells to PDGFBB suggesting that the effects of WIN were 
indeed caused by a reduction in the levels of RA-signaling.  
The interference of WIN treatment with the PDGFBB-induced response of MEC1 cells could also be 
observed by examining the expression of genes involved in RA-signaling and EpiMT (Fig 3.1T). First, 
qRT-PCR analysis using mRNA isolated from MEC1 cells treated with PDGFBB alone or 
PDGFBB+WIN demonstrated that WIN treatment reduced RA-signaling by down-regulation of the direct 
RAR target, Rarb. Secondly, cells treated with PDGFBB and WIN had a higher expression level of the 
epithelial marker Cdh1 than MEC1 cells treated with PDGFBB alone. WIN-pretreatment also led to a 
reduced level of the canonical Wnt target, Axin2, which was proposed to be involved in EpiMT (von Gise 
et al., 2011), Taken together, our data suggest that RA-signaling is critical and indispensable for the loss 
of epithelial characteristics and the process of cytoskeletal reorganization during EpiMT. 
We next examined whether the effects of reduced RA signaling on PDGFBB-induced EpiMT 
observed in MEC1 cells are relevant to the EpiMT of primary epicardial cultured cells. Primary epicardial 
cells isolated from E12.5 C57BL/6 embryos and treated with PDGFBB at 50 ng/ml exhibited a reduction 
in surface expression of the epithelial marker ZO-1, together with formation of stress fibers as visualized 
via phalloidin staining (Supplementary Fig 3.5A, C). As in the case of the MEC1 cell model, we 
pretreated primary epicardial cells with WIN to block RA synthesis and modulate RA-signaling. In 
comparison to treatment with PDGFBB-alone, PDGFBB+WIN treatment led to preservation of the 
epithelial characteristics of primary epicardial cells. This included a cobblestone-like morphology with 
evident cell-to-cell contact, maintenance of ZO-1 expression at the cell border, together with minimal 
accumulation of stress fibers (Supplementary Fig 3.5A-D). Based on ZO-1 staining the WIN-pretreated 
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group had a 45-fold higher percentage of epithelial-like cell, maintaining tight cell-to-cell contact than the 
cells treated solely with PDGFBB (Supplementary Fig 3.5G). In addition, we also observed that 
PDGFBB+WIN treatment resulted in reduced formation of SMAα-positive stress fibers in primary 
epicardial cells (Supplementary Fig 3.5E vs. F) when compared to PDGFBB-treated controls. Consistent 
with the reduced formation of stress fibers, we found that primary epicardial cells treated with 
PDGFBB+WIN exhibited an 80% reduction in their ability to close a wound when compared to PDGFBB 
alone group (Supplementary Fig 3.5H). Thus, our data derived from primary epicardial explants 
corroborate our findings using MEC1 cells, in that inhibition of RA synthesis attenuated the EpiMT of 
primary epicardial cells in response to PDGFBB. 
EpiMT and differentiation can also be induced using tumor-derived transforming growth factor-β2 
(TGFβ2) (Austin, Compton, Love, Brown, & Barnett, 2008). Therefore, we examined whether WIN 
pretreatment affected the reorganization of the cytoskeleton and differentiation of MEC1 cells in response 
to TGFβ2. MEC1 cells treated with WIN and TGFβ2 resembled MEC1 cells treated with TGFβ2 alone in 
terms of both the loss of ZO-1 surface expression (Supplementary Fig 3.6A-G) and the expression of 
stress fiber actin SMAα (Supplementary Fig 3.6H-N). Hence, RA synthesis is required for the 
reorganization of the cytoskeleton induced by PDGFBB, but not by TGFβ2. 
Both deficiency and excess of RA affect the migration of EPDCs in vivo 
Given that, in vitro, a reduction in RA-signaling prevented the cytoskeletal reorganization and 
migration of EPDCs, we decided to examine the effects of altered RA-signaling on the formation and 
migration of the EPDCs derived by EpiMT in vivo.  
To dissect the role of RA-signaling in epicardial cell behavior, we employed models of altered RA-
signaling in which epicardial-dependent cardiogenesis was affected. We initially used in vivo 
pharmacological treatment with WIN to block RA synthesis during mid-gestation. When administered 
early in pregnancy in rats WIN exposure causes various cardiac malformations and early embryonic 
lethality (Oster, Salgo, & Taleporos, 1974), however, if administered to rats at mid-gestation, WIN 
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treatment consistently results in coronary vascular defects (Hanato et al., 2011; Nishijima et al., 2000). It 
is important to note that neither the mechanism by which WIN causes congenital heart defects, nor the 
relationship of the WIN-caused heart defects and RA signaling are currently known.  
We empirically determined the optimal course of WIN-treatment necessary to result in alterations in 
RA levels and RA-signaling without causing the aforementioned WIN-associated early embryonic death 
(Oster et al., 1974). By direct measurement of embryonic RA levels by LC-MS/MS, we established that 
daily treatment of pregnant dams with 51.6 mg/kg body weight of WIN from E9.5 to E13.5 led to a 60% 
reduction in RA at E14.5 (Fig 3.2A). Using the same WIN-treatment of pregnant RARE-LacZ reporter 
mice we found that the reduced levels of embryonic RA were associated with a decrease in the extent of 
RARE-reporter activity, hence, RA-signaling, in the heart of WIN-treated embryos at E14.5 relative to 
vehicle-treated controls (Fig 3.2B, C). Consistent with this finding, the transcription of the direct RAR 
target, Rarb, was found to be down-regulated in the E14.5 fetal hearts in the WIN-treated group 
compared to controls (Fig 3.2D). Importantly, delaying WIN treatment till E9.5 allowed the embryos to 
survive to midgestation. Thus, we confirmed that daily WIN treatment from E9.5 to E13.5 embryonic led 
to reduced embryonic RA synthesis and concomitantly reduced RA-signaling in the heart of WIN-treated 
embryos without causing death or any noticeable abnormalities associated with heart tube elongation, 
looping and chamber formation which could confound our analysis. Further reductions in WIN dosage or 
less frequent treatment schedules did not result in any noticeable inhibition of RA-signaling in the heart, 
while, in contrast, an earlier time course or a higher dosage led to embryonic death and resorption of 
fetuses before E14.5.  
Next, we examined the biological consequences of the late onset RA deficiency mediated by WIN 
treatment on the migration of EPDCs. We first immunostained EPDCs using the classic epicardial marker 
WT1. Staining of WT1 in DMSO- and WIN-treated embryos demonstrated that at E14.5 inhibition of RA 
synthesis in the heart restricted most WT1-expressing cells to the surface of the heart, suggesting an 
attenuated migration of epicardial cells in WIN-treated group (Fig 3.2E vs. F). Quantification of the 
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density of WT1-positive EPDCs that are localized away from the surface of the heart suggested that WIN 
treatment resulted in a 44% reduction in the density of intramyocardial EPDCs (Fig 3.2G). We further 
utilized another set of epicardial markers PDGFRA and PDGFRB for visualization of EPDCs. Though, 
PDGFRA and PDGFRB are both expressed in embryonic epicardial cells, they mark distinct populations 
of EPDCs which employ a different timeframe for EpiMT and migration in the myocardium (Amy M. 
Mellgren et al., 2008; C. L. Smith et al., 2011). PDGFRB-positive EPDCs, which constitute the “first 
wave of migrating EPDCs”, leave the epicardium at E13.5 and differentiate into VSMCs and pericytes. 
PDGFRA-positive EPDCs migrate as the “second wave of EPDCs” at E14.5 and contribute to the 
coronary and interstitial fibroblast populations (C. Rudat et al., 2013; C. L. Smith et al., 2011). We 
observed that by E14.5, PDGFRA-positive cells in the vehicle-treated embryos had migrated into the 
myocardium, whereas in the WIN-treated group PDGFRA-positive cells remained confined to the 
epicardial epithelium and subepicardial space (Fig 3.2H vs. I). Number of PDGFRA-positive EPDCs per 
mm2 in the heart was measured and embryos treated with WIN display a 50% reduction in the density of 
PDGFRA-positive EPDCs in the myocardium (Fig 3.2J). A similar WIN-caused delay was also observed 
in the case of the myocardial invasion by the PDGFRB-positive EPDCs (not shown). We evaluated the 
expression of Pdgfra and Pdgfrb in the hearts of WIN- or vehicle-treated embryos by qRT-PCR and we 
found no significant changes in the expression of these markers. Although, we cannot rule out variations 
in the expression of these markers amongst individual cells, these results suggest that while the 
localization of PDGFRA and PDGFRB-positive EPDC was affected by WIN treatment, the overall 
expression of these markers in the embryonic heart remained the same.  
The above findings suggest that RA deficiency impairs the migration of EPDCs in vivo. As RA-
signaling is equally sensitive to both excess or deficiency of RA, we hypothesized that RA excess would 
also affect the development of EPDCs. To test this idea, we employed a genetic mouse model deficient in 
DHRS3, which maintains RA homeostasis by converting the RA precursor retinaldehyde, to retinol 
(Adams et al., 2014; Billings et al., 2013; Feng et al., 2010; R. K. Kam et al., 2013). As previously 
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described by our lab, Dhrs3-deficient embryos accumulate excess RA at E14.5 and display altered and 
expanded RA-signaling domains in conjunction with cardiac and skeletal malformations and embryonic 
lethality ((Billings et al., 2013) and Chapter 2). By examining Dhrs3-/- embryos at earlier stages of 
development, we discovered that genetic ablation of leads to the elevated levels of RA earlier than we had 
previously reported. By measuring the amount of global embryonic RA via LC-MS/MS we found that 
deletion of Dhrs3 led to an increase of 33% in the levels of RA in E12.5 Dhrs3-/- embryos when 
compared to their wild type littermates (Fig 3.3A). Next, using Dhrs3+/- mice crossed with the RARE-
LacZ reporter mouse strain, we found that Dhrs3-ablation led to increased RA-signaling based on RARE-
driven reporter activity as early as E10.5 (Fig 3.3B, and (Shannon, Moise, & Trainor, 2017)) as the heart 
becomes invested in epicardium. Thus, these data suggest that genetic deletion of Dhrs3 leads to 
consistent increases in RA-signaling during the late development of the heart.  
We next examined the effect of the increased levels of embryonic RA on the development of 
epicardial derived structures in Dhrs3-/- embryos. As reported previously, Dhrs3-/- embryos display mid- 
to late-gestational lethality accompanied by multiple severe malformations, such as double-outlet right 
ventricle, and ventricular and atrial septal defects, (Billings et al., 2013). In addition, Dhrs3-/- embryos 
display subcutaneous edema, indicative of cardiac dysfunction, a thin myocardial compact zone and 
malformations of the coronary vasculature (Chapter 4). By examining the expression and localization of 
EPDCs in Dhrs3-/- embryos, we observed that RA excess affected the migration of EPDCs into the 
myocardium. Immunostaining of the epicardial marker WT1 in embryonic hearts revealed that Dhrs3-/- 
hearts display 2-fold increase in the density of EPDCs that localized away from the surface of the heart, 
i.e. the epithelial layer of epicardium, suggesting that the delamination of WT1-positive EPDCs was 
accelerated by excessive RA signaling in the Dhrs3-/- hearts. Moreover, we observed that cells from 
another epicardial population marked by expression of PDGFRA, localized deeper in the myocardium of 
Dhrs3-/- hearts in comparison to those of littermate controls (Fig 3.3H vs. I, quantified in J) suggesting 
that excess RA present in Dhrs3-/- hearts altered the migration ability and/or timing of the invasion of 
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PDGFRA-positive cells. By examining the expression of epithelial markers in the embryonic hearts, we 
found that the classic epithelial marker Cdh1 was down-regulated by 97% in E13.5 Dhrs3-/- hearts 
compared to the hearts of Dhrs3+/+ littermates (Fig 3.3D), implying a higher level of EMT in Dhrs3-/- 
embryos. Predictably, the expression of genes which are direct targets of RAR, namely, Rarb and 
Cyp26a1, were found to be up-regulated by 1.7 and 2.6-fold respectively in the Dhrs3-/- hearts compared 
to controls. These results suggest that EPDCs undergo a higher level of EpiMT in response to excess RA 
in Dhrs3-/- embryos. 
Excess RA augments the cytoskeletal rearrangement of EPDCs 
To better understand the effect of excess RA on epicardial cells, we isolated primary epicardial cells 
from Dhrs3-/- and Dhrs3+/+ embryos. Epicardial cells isolated from Dhrs3+/+ control embryos appeared to 
have a cobblestone-like epithelial morphology. In contrast, even in the absence of PDGFBB, epicardial 
cells isolated from the Dhrs3-/- embryos displayed spindle-like mesenchymal morphology particularly at 
the border of the explant (Supplementary Fig 3.7A vs. B). Cell membrane was stained by WGA and the 
double labeling of ZO-1 and WGA on EPDCs revealed that the epithelial marker ZO-1 was not localized 
on the cell membrane but internalized in Dhrs3-/- EPDCs (Fig 3.4 A-C vs. E-G). The relative expression 
of ZO-1 on cell membrane was quantified in Fig 3.4 I and Dhrs3-/- EPDCs displayed a 65% reduction in 
the levels of ZO-1 that was localized on the cell membrane, when compared to the wildtype control. 
Formation of filopodia and gaps between cells was readily seen in Fig 3.4F marked by arrowheads. 
Similar internalization was observed in the expression of beta-catenin in Dhrs3-/- EPDCs (Fig 3.4D vs. H). 
These results suggested that the lack of Dhrs3 caused acceleration in cytoskeletal rearrangement in 
epicardial cells in vitro (Fig 3.4A-H). In addition, as evaluated by a scratch wound migration assay, 
Dhrs3-/- epicardial cells closed the wound faster than primary epicardial cells isolated from Dhrs3+/+ 
controls (Fig 3.4J). Collectively, our data suggest that the loss of Dhrs3 leads to accumulation of RA and 
a higher rate of cytoskeletal reorganization. 
By manipulating the production of RA via genetic or pharmacological approaches we found that RA-
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signaling affected the migration of EPDCs in vivo. To obtain a better mechanistic understanding of the 
role of RA in EpiMT, we investigated whether RA directly facilitates EpiMT by treating MEC1 cells with 
the pan-RAR agonist TTNPB. Using moderate levels of TTNPB approaching the physiological levels 
observed in the case of the endogenous RAR agonist, all-trans-retinoic acid (Billings et al., 2013), we 
found that 10 nM TTNPB treatment led to the increased expression of several genes known to be up-
regulated by RAR, including Dhrs3, Cyp26a1 and Rarb, and down-regulation of the expression of the RA 
synthetic enzyme, Raldh2, in accordance with the known negative feedback regulation of RA metabolism 
(Supplementary Fig 3.8A). Consistent with its increased transcription in the TTNPB-treated group, the 
level of DHRS3 protein was also found to be up-regulated (Supplementary Fig 3.8B-C). These results 
demonstrated that 10 nM TTNPB was able to activate RA-signaling in MEC1 cells.  
We next tested whether activation of RAR by 10 nM TTNPB could lead to the cytoskeletal 
reorganization in MEC1 cells. Through immunostaining for the cell junction marker proteins ZO-1 in 
combination with membrane marker WGA, we observed that TTNPB treatment resulted in their 
internalization and loss of cell-to-cell contact (Fig 3.5A vs. G for ZO-1 and B-C vs. H-I for WGA; 
filopodia are marked with arrowheds). Expression of beta-catenin on cell border was also found to be 
diminished by TTNPB (Fig D vs. J). Moreover, activation of RA-signaling by TTNPB actively regulates 
the cytoskeleton evidence by accumulation of F-actin (Fig 3.5E vs. K) as well as the increased acquisition 
of SMAα-positive stress fibers (Fig 3.5F vs. L).  Comparison of relative expression of ZO-1 on cell 
membrane between DMSO and TTNPB groups showed that TTNPB treatment significantly reduced the 
localization of ZO-1 on cellular domains on and adjacent to the cell membrane (Fig 3.5M). Besides 
morphological changes, we also found that activation of RAR resulted in down-regulation of the 
epithelial markers Cdh1, Krt17 and Ppl, and upregulation of the mesenchymal marker N-cadherin and the 
EpiMT positive regulator Axin2 (Fig 3.5N). Increased RA-signaling was also associated with induction of 
the VSMC marker Sm22α. Thus, activation of RA-signaling in MEC1 triggers events associated with 
EpiMT in MEC1 cells including repressed epithelial characteristics while concomitantly promoting 
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cytoskeletal reorganization and acquisition of VSMC markers.  
To better characterize the effect of TTNPB treatment on epicardial cells we examined primary 
epicardial cells isolated from the RARE-LacZ mouse embryos that were treated with TTNPB. We 
observed that 10nM TTNPB enhanced the expression of RARE-driven LacZ reporter gene in primary 
epicardial cells (Supplementary Fig 3.9G-I), which was indicative of RA signaling activation. 
Consequently, the number of epithelial-like cells which maintained tight cell-to-cell contact was reduced 
by 49% (Supplementary Fig 3.9H) and the area occupied by such epithelial-like cells was reduced by 
52% (Supplementary Fig 3.9A vs. D, quantified in J) in TTNPB-treated cultures compared to the vehicle 
control group.  In addition to reduced number of epithelial cells, epicardial cells treated with TTNPB also 
displayed evident reduction in the expression levels of ZO-1 and beta-catenin throughout the culture 
including the epithelial zone (Supplementary Fig 3.9B vs. E for ZO-1 staining; Supplementary Fig 3.9C 
vs. F for beta-catenin). Collectively, our results suggest that activation of RA-signaling facilitates 
cytoskeletal rearrangement in vitro in both primary epicardial cells and MEC1 cells. 
RA promotes cytoskeletal rearrangement of EPDCs via the RhoA-ROCK pathway 
Using TTNPB to induce cytoskeletal reorganization in MEC1 cells, we surveyed the effects of 
TTNPB on pathways that govern EpiMT. To globally assess the changes in gene expression elicited by 
TTNPB treatment, we performed transcriptome profiling of MEC1 cells stimulated with TTNPB 
compared with cells stimulated with vehicle alone (Fig 3.6A). This analysis revealed that RA-signaling 
affects a multitude of pathways in MEC1 cells including many previously implicated in the EpiMT and 
differentiation of EPDCs, such as cell cycle, focal adhesion, Hippo-signaling, and RAP1-signaling 
(Artamonov et al., 2015; Singh et al., 2016).  
Focusing on pathways that control cytoskeletal rearrangement, we identified several regulatory 
proteins that participate in the RhoA-Rho kinase (ROCK) pathway and whose expression was found to be 
significantly affected by TTNPB treatment. The Rho family of GTPases are primarily controlled through 
GTPase exchange factors (GEFs) or GTP activating proteins (GAPs) which activate or antagonize RhoA, 
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respectively. In addition to RhoA, Rac and Cdc42, there are also atypical Rho family members, such as 
Rnd1 and Rnd3, which are constitutively GTP bound and which inhibit RhoA-ROCK signaling (reviewed 
in (Riento, Villalonga, Garg, & Ridley, 2005)). Importantly, the Rho pathway has been shown to be a 
regulator of EpiMT (Lu et al., 2001). As summarized in the diagram depicted in Fig 3.6B, TTNPB-
treatment of MEC1 cells led to the up-regulation of the expression of genes coding for Rho-effectors such 
as, cofilin, kalirin, Limk2, Mlck1 and 3, Rhoc, Rock2, Arhgef2 and Arhgef28, or down-regulation of those 
coding for Rho-inhibitors such as, Arhgap11a, Arhgap19, Arhgap31, and Rnd 2 and 3. For a few selected 
members of the Rho pathway, we validated the findings derived from gene expression profiling by qRT-
PCR and/or immunoblotting and immunocytochemistry. Our results suggest that TTNPB treatment led to 
up-regulation of the expression of the central Rho-effector ROCK2 and suppresses the expression of the 
ROCK inhibitor, RND3 (Fig 3.6C). The decreased expression of RND3 in response to TTNPB was also 
observed by immunoblotting and immunocytochemistry of TTNPB- or vehicle treated MEC1 cells (Fig 
3.6D; Supplementary Fig 3.10). Therefore, our results suggest that one of the mechanisms by which RA-
signaling modulates cytoskeletal reorganization and EpiMT involves activation of the Rho pathway 
through transcriptionally regulation of the expression of critical Rho regulatory proteins. 
To further investigate the involvement of the Rho pathway in the RA-mediated cytoskeletal 
reorganization of epicardial cells, we first determined the effect of TTNPB treatment on the formation of 
active GTP-bound RhoA. The levels of RhoA-GTP formed in TTNPB- versus DMSO-treated cells were 
determined by affinity purification of Rho-GTP using agarose beads coupled to the Rhotekin-RBD and by 
immunoblotting of the purified fractions with anti-RhoA antibody. Our results suggest that TTNPB 
induces the binding of GTP to RhoA and hence the activation of RhoA signaling pathway (Fig 3.6E). To 
explore the necessity of the active RhoA-ROCK pathway in RA-induced morphological changes in 
MEC1 epicardial cells, we tested whether a selective p160ROCK inhibitor, Y-27632, would interfere 
with the morphological changes induced by TTNPB. Through immunostaining of ZO-1 and beta-catenin, 
we observed that Y-27632 prevented the cytoskeletal reorganization induced by TTNPB and restored the 
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expression of epithelial markers at the cell junctions (Fig 3.6G-O, relative expression of ZO-1 on cell 
membrane was quantified in F). We also observed that activation of RA-signaling no longer induced the 
expression of SMAα-positive stress fibers in the presence of the ROCK inhibitor (Fig 3.6P-R), suggesting 
that ROCK plays a critical role downstream of RA-signaling in promoting cytoskeletal reorganization and 
the loss of epithelial characters in MEC1 cells. Altogether, our results suggest that the RhoA-ROCK 
pathway is activated by RA and that its activation is required for the RA-induced morphological changes 
in MEC1 cells.  
Analysis of transcriptomic changes in MEC1 cells in response to activated RA signaling 
Our RNAseq analysis revealed that activation of RA signaling leads to broad and vast alternation in 
gene expression pattern in MEC1 cells (Fig 3.6A). In summary, 3493 genes were found to be down-
regulated while 3438 up-regulated by 48hr TTNPB treatment (Fig 3.7A), amongst which multiple gene 
pathways were concluded by KEGG analysis and noticed to be evidently altered in response to elevated 
RA signaling. Both GO term (Fig 3.6A) and KEGG pathway analysis (Fig 3.7B) identified that Hippo 
pathway was found to be activated, evidenced by the transcriptional induction of key components of 
Hippo pathway, for example Mst1/2, Lats1/2 and Yap/Taz, as well as up-regulation of multiple known 
downstream target genes of Hippo pathway, including Ctgf and Smad genes. Moreover, genes that are 
known to retain Yap/Taz from the nucleus were suppressed by the activated RA signaling, such as 14-3-3 
and α-Catenin. An overview of all the affected genes involved in Hippo pathway demonstrated that the 
transcription of many Hippo effectors and/or regulators was found to be changed in the TTNPB-treated 
group, suggesting an interesting interaction of Hippo pathway with RA signaling (Fig 3.7C, altered genes 
are listed in Supplementary Table 3.3). Besides the Hippo pathway, another developmentally important 
pathway, the serum response factor (SRF) signaling, has been observed to be broadly initiated by the 
activation of RAR in MEC1 cells (Fig 3.7D). SRFs have been known to work with other nuclear 
receptors and function as co-regulator to mediate multiple developmental processes including the epiMT 
as well as the coronary vessel formation; its function depends on the specific transcription factor that 
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SRFs interact with. Additionally, we have observed that the multiple key metalloproteases (MMPs), 
which digest the extracellular matrix to prime the microenvironment for mesenchymal-like cells to 
migrate and thus facilitate EMT, were detected to be significantly up-regulated by the activation of RA 
signaling (Fig 3.7E), which cooperates with the ongoing cytoskeletal reorganization orchestrated by RA 
to accelerate the gain of migratory capacity of epicardial cells. Last but not the least, our results from 
RNAseq revealed that, instead of promoting epicardial cell differentiation to both VSMCs and fibroblasts, 
RA signaling interestingly favors VSMC differentiation and suppresses the development of mature 
fibroblasts (Fig 3.7F). Collagen production, which is a hallmark of fibroblast, was found to be 
significantly down-regulated by the activation of RA signaling, while the expression of every established 
marker for mature VSMCs was detected to be drastically induced. The imbalance between VSMC and 
fibroblast differentiation could possibly leads to alterations in heart functionality as well as coronary 
vessel formation in embryos experiencing excess or deficiency of RA, thus may provide clue of the 
teratogenic effects of altered RA signaling in the heart maturation. 
3.4. Discussion 
In findings presented here, we demonstrate that RAR activation plays an important role in the 
development and migration of EPDCs. Our results derived from in vitro models of RA deficiency suggest 
that proper synthesis of RA in the epicardium is required for the morphological changes associated with 
the process of EpiMT. Conversely, RA excess induces the down-regulation of epithelial markers and 
reorganizes cytoskeletal actin to potentiate the migration of epicardial cells. Our conclusions were 
substantiated by data derived from in vivo models. In Dhrs3-/- mouse embryos, a model of RA excess 
(Billings et al., 2013), PDGFRA-positive EPDCs penetrate deeper into the myocardium than in wild-type 
controls. When cultured in vitro, primary Dhrs3-deficient EPDCs also manifest a higher intrinsic rate in 
cytoskeletal remodeling and enhanced migration capacity. The opposite is seen in the case of WIN-
treated embryos, a model of RA deficiency, where PDGFRA-positive EPDCs remain close to the 
epicardium. Finally, through transcriptome profiling we found that RAR activation leads to changes in the 
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expression of factors that control the RhoA-ROCK pathway, the activation of which mediates the effects 
of RA on epicardial cells. In conclusion, our findings suggest that RA-signaling is critical for the EpiMT 
and the migration of EPDCs during mouse heart development.  
Epicardial RA plays a critical role in the cytoskeletal reorganization of EPDCs 
Our results provide evidence that the EpiMT is influenced by epicardium mediated RA-signaling. 
Since our results are based on isolated explants, this role could be attributed to the local production of RA 
by the epicardium. But even though it seems plausible that RA mediates the initial events of EpiMT via a 
cell-autonomous signaling mechanism, it is likely that the migration and differentiation of EPDCs is 
mediated by a non-cell autonomous RA-signaling from the undifferentiated epithelial epicardium. This 
mode of signaling can be invoked based on the well-established fact that epicardial cells cease to express 
RALDH2 after having undergone EpiMT and differentiation (J. M. Perez-Pomares et al., 2002). In this 
case, RA produced by the undifferentiated epicardium would promote the migration of EPDCs to distance 
themselves from the epicardial layer before settling in the myocardium or being recruited by vessels to 
differentiate into fibroblasts and VSMCs, as previously proposed by Azambuja et al. and Braitsch et al. 
(Azambuja et al., 2010; Caitlin M. Braitsch et al., 2012). 
Cytoskeletal remodeling is a critical step in EpiMT, providing a scaffold of extending protrusions and 
creating the mechanical force needed to facilitate the movement of cells. Our results suggest that 
inhibition of the synthesis of RA abolishes the bundle aggregation of F-actin, proper alignment of focal 
adhesion actin and the formation of filopodia in transitioning EPDCs whereas activation of RA-signaling 
facilitates the accumulation of F-actin and the formation of stress fibers. Similar effects on cytoskeletal 
remodeling have been observed in neurons where RA-signaling stimulated dendritic protrusions (N. Chen 
& Napoli, 2008). The EpiMT-promoting role of RA described here is supported by the previous 
observation that supplementation with RA can partially correct the EpiMT defect caused by epicardial-
specific ablation of WT1 (von Gise et al., 2011) and by the observation that epicardial-specific RXRα-
ablation impairs EpiMT (Merki et al., 2005). 
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EpiMT is necessary for the subsequent differentiation of EPDCs into VSMCs and fibroblasts. In both 
mouse primary epicardial cells and the mouse epicardial cell line MEC1, we observed that RA-signaling 
not only promoted EpiMT but also to higher expression of VSMC markers. Depending on the precursor 
cells involved, RA-signaling has been associated with either induction of repression of SMC marker 
expression (F. Chen et al., 2014; Manabe & Owens, 2001). In the case of avian epicardial and 
proepicardial cells, RA was reported to block their differentiation into VSMCs by activating TCF21 
(Azambuja et al., 2010; Caitlin M. Braitsch et al., 2012). Indeed, we also observed up-regulation of the 
expression of TCF21 in the TTNPB-treated MEC1 cells, yet, this was accompanied by an increased 
expression of multiple VSMC markers based on both their transcript and protein levels. Since, we did not 
observe an increase in the expression of mature VSMC markers in response to higher levels of RA in vivo 
in Dhrs3-/- embryos, we propose that the differentiation-promoting effects of RA observed in our in vitro 
studies should still be interpreted with caution. Further analyses of vessel-mural cell communication 
and/or recruitment are required to achieve a better understanding of the mechanisms by which RA 
regulates VSMC differentiation in vivo. Nevertheless, both our in vitro and in vivo data argue strongly 
that epicardial-derived RA is required for EpiMT through promoting the cytoskeletal reorganization of 
EPDCs. 
RA mediates epicardial cytoskeletal reorganization via RhoA-ROCK  
Findings presented here suggest that RA-mediated cytoskeletal rearrangement of epicardial cells 
requires activation of the Rho pathway (Fig 3.6). Rho family small GTPases, including Rho, modulate 
actin filaments in the cytoskeleton, cell contractility, and polarity to facilitate cell movement (Amano et 
al., 1997). Specifically, the RhoA pathway has been implicated in EpiMT as it is induced by PDGFBB 
(Kim et al., 2010; Lu et al., 2001). Results from our in vitro model suggest that RA-signaling activates the 
Rho pathway, and that this pathway is required for the morphological changes induced by RA in 
epicardial cells.  Amongst the RA-responsive genes in epicardial cells, we identified several critical Rho 
pathway factors, namely ROCK2 and RND3, both of which been implicated in the Rho-signaling 
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pathways that drive EpiMT (Artamonov et al., 2015). Notably, ChIP-sequencing studies have identified 
direct binding of RAR to RA-response elements (RARE), within the promoters of Rock2, Rnd3 and other 
Rho effectors, implicating the Rho-signaling pathway as a direct target of RAR (Delacroix et al., 2010; E. 
Moutier et al., 2012) and suggesting a potential mechanism for the effect of RA-signaling on EpiMT.  
Experimental models to study the role of RA in late heart development 
The approaches described here are relevant in understanding the roles of RA-signaling in the 
development of the EPDCs, a role which, thus far, has been difficult to discern. The reason for this is that 
many of the existing mouse models deficient in enzymes involved in RA synthesis or breakdown either 
manifest early lethality (S. Abu-Abed et al., 2001; K. Niederreither et al., 1999), precluding the analysis 
of the effect of RA on late heart development or have no discernible cardiac defects as a result of 
redundant enzyme activities or tissue specificity of the enzymes involved (reviewed in (Metzler & 
Sandell, 2016)).  
By employing the previously described Dhrs3-/- mouse, a model of modest RA excess which exhibits 
globally altered RA-signaling in most tissues including the heart (Fig 3.3 and (Billings et al., 2013)), we 
could obtain Dhrs3-null embryos surviving to late gestation. This allowed us to examine the effects of 
RA excess on late events in heart development.  Conversely, by taking advantage of a well characterized 
inhibitor of RALDH2, we could observe the effects of RA deficiency on late stages of cardiogenesis. As 
previously shown in the case of WIN-exposed rat embryos (Hanato et al., 2011), WIN-treatment causes 
coronary vascular defects associated with a reduction in the migration and differentiation of EPDCs. 
Although, the reasons for impaired myocardial infiltration of EPDCs in WIN-treated rats was not 
understood, our data presented here suggest that WIN-treatment results in reduced RA-signaling causing 
deficits in EpiMT and ensuing differentiation of EPDCs. 
An important precaution in the use of any RA-treated or genetic model of RA excess or deficiency is 
that it should always include a careful evaluation of the levels of retinoids and RA-signaling patterns in 
the particular model.  In both mice and zebrafish, RA-supplementation or enhanced RA-signaling can 
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paradoxically lead to RA deficiency and loss of RA-signaling through excessive negative feedback (Lee 
et al., 2012; A. Rydeen et al., 2015). To confirm that the WIN-treated and Dhrs3-/- embryos represent 
models of embryonic RA deficiency or excess, respectively, we directly examined the levels of RA and 
the patterns of RA-signaling.  Additionally, by correcting the EpiMT defect induced by WIN-treatment 
through provision of an RAR agonist, we causally implicated reduced RA signaling in the effects of WIN 
on EPDCs. 
Role of EPDC derived cell lineages in embryonic development and in the adult heart 
EpiMT is necessary for the development of EPDC-derived cell lineages which include the pericytes 
and VSMCs that stabilize the coronary vasculature and the cardiac fibroblast population. The data 
presented here suggest that RA produced by the epicardium acts to promote reorganization of epicardial 
cytoskeleton and the migration of EPDCs deep into the myocardium. In addition to the altered behavior 
of EPDCs exposed to sub- or supraoptimal levels of RA, both WIN-treated and Dhrs3-/- mouse models 
exhibit defects in coronary vascular development ((Hanato et al., 2011; Nishijima et al., 2000) and Wang 
et al. manuscript in preparation).  
The adult epicardium is an important tissue in mediating the wound repair and regeneration following 
cardiac injury (reviewed in (Kennedy-Lydon & Rosenthal, 2015)). In zebrafish, which have a remarkable 
cardiac regenerative capacity, the epicardium is critical in mediating the regeneration of the heart relying 
on PDGF and RA-signaling to do so (K. Kikuchi et al., 2011; Kim et al., 2010). With the exception of 
neonates, postnatal mammalian hearts have a very modest regenerative response following cardiac injury, 
yet, even in this case, epicardial RA-signaling may play a key role in the post-ischemic remodeling and 
repair (D. Bilbija et al., 2012). Though wound repair is an important component of heart regeneration, it 
can lead to unchecked collagen deposition/fibrosis and scar formation (Fang et al., 2016; Tallquist & 
Molkentin, 2017). Importantly, the expression of RALDH2 in the epicardium is controlled by C/EBP and 
inhibition of C/EBP leads to an improvement in cardiac function following ischemia reperfusion (G. N. 
Huang et al., 2012).  Given the evidence supporting a role for RA-signaling in regulating the 
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development, migration and differentiation of embryonic EPDCs, an important future area of 
investigation should be to examine the role of RA-signaling in the function of adult EPDCs and to use of 






Figure 3.1 RA is required for the PDGFBB-cytoskeletal reorganization of MEC1 epicardial 
cells. 
Treatment with PDGFBB induced loss of expression of the epithelial marker ZO-1 (A-B) and 
enhanced the expression of stress fiber actin SMAα (K-M) in cultured MEC1 cells. Cotreatment of 
PDGFBB and WIN (PDGFBB+WIN) reverted the changes induced by PDGFBB alone (PDGFBB) (A-
C for ZO-1, K-M for SMAα). The relative expression of ZO-1 on cell membrane marked by WGA (D-F) 
was quantified in J, being normalized to the percent of contacting cells in DMSO control-treated cells. 
Compared to DMSO, PDGFBB treatment of MEC1 cells robustly induced the polymerization and fiber 
bundle formation of F-actin as shown by phalloidin immunostaining (N vs. O), and vinculin-positive 
focal adhesion (Q vs. R). Actin fibers and vinculin-positive adhesion bundles were aligned in the 
direction of cell migration in the PDGFBB-treated cells but displayed a more random distribution in cells 
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treated with PDGFBB+WIN (phalloidin in O vs. P; vinculin in R vs. S). Combination treatment of MEC1 
cells with PDGFBB+WIN led to decreased expression of the RAR-target gene Rarb and the positive 
regulator of EpiMT Axin2 and a higher expression level of the epithelial marker Cdh1 in comparison with 
MEC1 cells treated with PDGFBB alone, as assessed by qRT-PCR (T). Scale bars are 50μm in K-P and 
20μm in A-I and Q-S. * p<0.05 vs. PDGFBB, ** p<0.01 vs. PDGFBB, *** p<0.001 vs. PDGFBB, ^ 
p<0.05 vs. DMSO, ^^ p<0.01 vs DMSO, ^^^ p<0.001 vs DMSO. The error bars indicate the standard 






Figure 3.2 RA deficiency is associated with altered localization of PDGFRA-positive 
EPDCs within the myocardium. 
As quantified by LC-MS/MS, E14.5 embryos collected from dams treated daily from E9.5-E13.5 
with WIN had reduced levels of RA compared to embryos collected from dams treated with DMSO-
vehicle control (A). WIN-treatment led to reduced RA-signaling within the heart of embryos collected 
from RARE-LacZ dams treated daily from E9.5-E13.5 with either WIN versus DMSO-vehicle control as 
seen by beta galactosidase staining (seen as blue stain) of E14.5 embryonic hearts (B vs. C). WIN-
treatment also led to a reduction in the expression of the direct RAR target gene, Rarb, within the heart of 
E14.5 embryos derived from dams treated with WIN compared to DMSO-controls, however, the 
expression of Cyp26a1 was not significantly altered by the WIN treatment (D). WIN-treatment led to 
accumulation of WT1-positive epicardial cells on the surface of the heart (E-F, density of WT1+ cells 
that delaminated from the surface of the heart was quantified in G), and an altered distribution of 
PDGFRA-positive cells in the myocardium of embryos derived from WIN-treated dams compared to 
embryos harvested from DMSO-treated dams (G vs. H, density of PDGFRA+ cells that delaminated 
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from the surface of the heart was quantified in J). Scale bars in B and C are 200 μm and in E-F 20 μm. ** 
p<0.01 vs DMSO, *** p<0.001 vs DMSO. Retinoid levels were determined in n=5 of each group (WIN 
or DMSO). The error bars indicate the standard deviation for each measurement set in each experimental 






Figure 3.3 Dhrs3–deficiency leads to RA-excess and altered localization of PDGFRA-
positive EPDCs in the myocardium. 
A) E12.5 Dhrs3-/- embryos had higher levels of endogenous RA compared to the Dhrs3+/- or Dhrs3+/+ 
littermate controls as measured by LC-MS/MS analysis. RARE-LacZ; Dhrs3-/- embryos displayed more 
extensive domains of RA-signaling in the heart at E10.5 than the pattern observed in in RARE-LacZ; 
Dhrs3+/+ embryos based on the expression of the RARE-driven reporter LacZ (blue stain) (B vs. C). 
Dhrs3-ablation led to an increased expression of the direct RAR-targets Cyp26a1 and Rarb and a reduced 
expression of the epithelial marker Cdh1 in the Dhrs3-/- embryonic hearts at E13.5 as measured by qRT-
PCR (D). Both WT1-positive EPDCs (E vs. F, density of WT1+ cells that delaminated from the surface 
of the heart was quantified in G) and PDGFRA-positive EPDCs (H vs. I, density of PDGFRA+ cells that 
delaminated from the surface of the heart was quantified in J) exhibited an altered localization pattern 
within the myocardium of the Dhrs3-/- embryonic hearts versus those of wild type controls. Scale bars in 
B-C represent 200µm and 20µm in E-F as well as H-I. The yellow dashed-lines mark the outer surface of 
the heart in H and I. * p<0.05 vs. Dhrs3+/+ and ^ p<0.05 vs. Dhrs3+/-; ** p<0.01 vs. Dhrs3+/+, *** p<0.001 
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vs. Dhrs3+/+.  The error bars indicate the standard deviation for each measurement set in each 
experimental group. Retinoids levels were measured using n=4 Dhrs3+/+, n=5 Dhrs3+/- and n=5 Dhrs3-/-. 







Figure 3.4 Altered cytoskeletal rearrangement and cell migration of Dhrs3-/- primary 
epicardial cells. 
Primary epicardial cells derived from E12.5 Dhrs3-/- and Dhrs3+/+ embryonic hearts were cultured in 
the presence of 1% fetal calf serum. Double labeling of the epithelial markers ZO-1 (A vs. E) and cell 
membrane dye (WGA) revealed that the expression of ZO-1 was internalized in cultured Dhrs3-/- EPDCs 
(E-G) compared to their localization at the plasma membrane of epicardial cells isolated from wild type 
controls (A-C). Similar internalization from cell border is observed in the expression pattern of beta-
catenin (D vs. H) in Dhrs3-/- epicardial cells. Relative expression of ZO-1 on cell membrane was 
quantified in I. Formation of filopodia is indicated with yellow arrows in F and G. As evaluated by 
scratch wound migration, Dhrs3-/- epicardial cells closed the wound faster in 24 hr compared to epicardial 
cells derived from wild type littermates (J). Scale bars in A-D are 20 μm. * p<0.05 vs. Dhrs3+/+; ** 
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p<0.01 vs. Dhrs3+/+, *** p<0.001 vs. Dhrs3+/+. The images and quantification in I are based on EPDCs 
derived from 3 Dhrs3+/+ vs. 4 Dhrs3-/- embryos. Scratch wound migration assays employed 4 biological 
replicates per genotype. The error bars indicate the standard deviation for each measurement set in each 





Figure 3.5 RA-signaling promotes cytoskeletal rearrangement in MEC1 cells. 
Treatment of MEC1 cells with 10 nM TTNPB, a pan-RAR agonist, led to internalization of epithelial 
markers, ZO-1 (A vs. G) and beta-catenin (D vs. J) and increased formation of stress fibers as evidenced 
by phalloidin and SMAα staining (E vs. K for phalloidin; F vs. L for SMAα). TTNPB-treatment of 
MEC1 cells led to reduced expression of ZO-1 on cell membrane stained with WGA, which is quantified 
in M. Formation of filopodia revealed by WGA staining is indicated with yellow arrows in H and I. qRT-
PCR results in N indicated that RAR activation via TTNPB led to down-regulation of the expression of 
epithelial markers (Cdh1, Krt17, Ppl) and up-regulation of the expression of a mesenchymal marker 
(Cdh2), a VSMC marker (Sm22α) and of Axin2, a positive regulator of EpiMT. Scale bars represent 20 
μm. *p<0.05 vs DMSO, **p<0.01 vs DMSO, ***p<0.001 vs DMSO. The error bars indicate the standard 
deviation for each measurement set in each experimental group. All experiments were repeated at least 





Figure 3.6 Activation of RAR leads to cytoskeletal reorganization via the RhoA-ROCK 
pathway. 
KEGG enrichment analysis based on RNAseq data derived from MEC1 cells treated with either 
TTNPB or DMSO suggests that RA-signaling led to global changes in multiple signaling pathways in 
MEC1 cells (A). The y-value of each bubble represents the level of enrichment in each pathway while the 
size of the bubble reflects the number of genes belonging to the pathway whose expression was altered by 
TTNPB treatment (the gene count mapped to each pathway is also listed numerically besides each 
bubble). Schematic representation of the Rho pathway indicating genes whose expression was 
upregulated (red colour) or downregulated (green colour) by TTNPB treatment (B). qRT-PCR results 
indicated that RAR activation led to upregulation of Rock2 and downregulation of Rnd3 in MEC1 cells 
compared to controls (C). TTNPB treatment led to decreased expression of RND3 but not WT1 as seen 
by immunoblot analysis examined by western blotting (D). TTNPB treatment of MEC1 cells led to 
increased association of RhoA with GTP in comparison to cells treated with DMSO (E). The levels of 
GTP-RhoA were examined by affinity-purification of GTP-Rho proteins via agarose beads coupled to the 
Rhotekin-RBD. The amount of Rho-GTP purified from cell lysates incubated with non-hydrolyzable 
GTPγS was used to assess the total amount of available Rho, while immunoblotting of the lysates using 
anti-actin antibody was used to verify that the amount of starting protein in each lysate was the same. 
Addition of the pan-ROCK inhibitor, Y27632, blocked the TTNPB-induced internalization of the 
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epithelial markers, ZO-1 (G-L) and beta-catenin (M-O), as well as the TTNPB-induced expression of 
SMAα (P-R). Yellow arrowheads marks the formed filopodia evidenced by the WGA staining (K). 
Relative expression of ZO-1 on cell membrane was measured and compared amongst DMSO, TTNPB 
and TTNPB+ROCK inhibitor groups (F). Scale bars are 20 µm. * p<0.05 vs. DMSO, ** p<0.01 vs. 
DMSO, ^^^ p<0.001 vs. TTNPB. The error bars indicate the standard deviation for each measurement set 
in each experimental group. Staining results are representative from three biological replicates and have 
been repeated three times. Gene expression measurements and pull-down assays were based on three 
biological replicates. Western blotting was performed using 4 biological replicates per experimental 






Figure 3.7 Activation of RAR leads to alterations in transcriptome in MEC1 cells. 
MEC1 cells were treated with vehicle or 10nM RAR agonist TTNPB for 48 hours before RNA was 
isolated and submitted for RNAseq. Analysis of the sequencing results showed drastic changes in 
transcriptome of epicardial cells in response to RA. A. Within the significantly altered genes, 3493 are 
down-regulated (Green) and 3438 genes are induced (Red) by active RA signaling. B-C. KEGG analysis 
and volcano plot demonstrated that Hippo pathway is broadly induced by RA signaling. Green indicates 
genes that are suppressed and red indicates genes that are up-regulated by RA signaling. D-E. Activation 
of RAR induces SRF signaling pathway and expression of multiple metalloproteases. F. Elevated RA 
signaling induces the expression of mature VSMC markers while suppresses the differentiation of 




SUPPLEMENTARY FIGURE LEGENDS 
 
Supplementary Fig  3.1 MEC1 cells express epicardial markers and resemble epithelioid 
epicardial cells in the absence of induction. 
(A-D) As evidenced by immunocytochemistry with specific antibodies, the MEC1 cells express 
epicardial markers WT1 (A), POD1 (B), epithelial marker Beta-catenin (C) as well as the retinaldehyde 
reductase DHRS3 (D). Uninduced MEC1 cells also display minimal stress fiber formation as visualized 
by phalloidin staining (E). Negative control group contains MEC1 cells stained in the absence of primary 




Supplementary Fig  3.2 Inhibition of RA synthesis attenuates PDGFBB-induced cell migration in 
MEC1 cells. 
A scratch wound was made in MEC1 cells treated with DMSO (A-B), PDGFBB (C-D) and 
PDGFBB+WIN (E-F). Widths of wound were evaluated in each group every 2 hours and the percentage 
of remaining gap compared to the original scratch was plotted in G. PDGFBB accelerated the wound 
closure in MEC1 cells as early as 2 hours. From 4 hours to 12 hours after the scratch was created, WIN 





Supplementary Fig  3.3 Inhibition of RA synthesis does not alter MEC1 cell proliferation. 
PDGFBB significantly enhances MEC1 cell proliferation as evaluated by the percentage of Ki67-
positive cells (A vs. B). 8µM WIN compound does not alter the proliferation induced by PDGFBB (B vs. 
C). Scale bars represent 50µm. ^ p<0.05 vs. DMSO, ^^ p<0.01 vs. DMSO. Error bars represent standard 
deviation for each measurement set in each experimental group. Results are representative from 4 






Supplementary Fig  3.4 WIN attenuates PDGFBB-induced EMT through repressing RA 
synthesis. 
Addition of RA (TTNPB) reverses the inhibitory effect of WIN on PDGFBB-induced loss of the 
epithelial marker, ZO-1, (A-D) in MEC1 cells. TTNPB also reverses the inhibitory effect of WIN on 
PDGFBB-induced expression of the VSMC differentiation marker SMAα (E-H) in MEC1. Scale bars 







Supplementary Fig  3.5 Inhibition of RA synthesis attenuates PDGFBB-induced 
cytoskeletal rearrangement and VSMC marker expression in primary epicardial cells. 
(A-F) In cultures of primary epicardial cells, WIN treatment prevents the PDGFBB-induced 
relocalization of the epithelial marker ZO-1 (A,B), the formation of stress fibers as evidenced by 
phalloidin staining (C,D) and the expression of the VSMC marker SMAα (E,F). PDGFBB+WIN 
treatment results in a greater percentage of tightly contacting primary epicardial epithelial cells, as 
revealed by ZO-1 immunostaining in (A,B) and quantified in G and expressed as fold-change versus 
PDGFBB alone. The quantification has been performed by a blinded observer. Images (at least 3 pictures 
per biological replicate) were scrambled and presented to an observer for counting the number of 
connecting epithelial cells. Numbers of epithelial cells were normalized to the number of nuclei stained 
by DAPI. At the same time, the migratory capacity of primary epicardial cells treated with 
PDGFBB+WIN is reduced compared to PDGFBB alone controls as assessed by a scratch wound-healing 
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assay and quantification of the percentage of wound closure (H), and expressed as fold-change versus 
PDGFBB alone. Scale bars represent 20µm. ** p<0.01 vs. PDGFBB, *** p<0.001 vs. PDGFBB. Error 
bars represent standard deviation for each measurement set in each experimental group. Results are 







Supplementary Fig  3.6 Effect of WIN on TGFβ-induced EMT. 
Inhibition of RA synthesis by WIN in MEC1 cells does not affect TGFβ-induced cytoskeletal 
reorganization (A-G) or TGFβ-induced expresson of VSMC differentiation marker SMAα (H-N). MEC1 
cell treated with increasing dosages of TGFβ recombinant protein show evident loss of cell contact 
visualized by ZO-1 immunostainig, as well as VSMC differentiation shown by SMAα staining. These 
effects were not altered when RA synthesis is blocked by WIN at 16 µM.  Scale bars represent 20µm. 






Supplementary Fig 3.7 Deletion of Dhrs3 causes morphological changes in primary 
epicardial explant. 
Phase contrast images of primary epicardial cells isolated from Dhrs3+/+ vs. Dhrs3-/- hearts. Scale bars 






Supplementary Fig 3.8 TTNPB activates RAR signaling causing compensatory responses in 
RA metabolism in MEC1 cells. 
Based qRT-PCR assays, TTNPB treatment of MEC1 cells leads to increased expression of the RAR-
targets Rarb and Cyp26a1 and Dhrs3, and decreased expression of the RA synthetic enzyme Raldh1a2 
(A). The increased expression of DHRS3 is also confirmed by immunohistochemistry of DHRS3 (B,C). 
Scale bars represent 20 µm. *p<0.05 vs DMSO, **p<0.01 vs DMSO, ***p<0.001 vs DMSO. Error bars 
represent standard deviation for each measurement set in each experimental group. Analyses of gene 






Supplementary Fig 3.9 RAR-agonist TTNPB evidently reduces the epithelial 
characteristics in primary epicardial cells. 
TTNPB at 10nM effectively up-regulated the expression of the LacZ transgene in primary epicardial 
cells isolated from RARE-LacZ embryonic hearts (G vs. I ), suggesting higher levels of RA signaling in 
TTNPB-treated primary epicardial cells. Addition of TTNPB to primary epicardial cells derived from 
C57Bl/6 embryos leads to reduced expression of the epithelial markers, ZO-1 (B vs. E) and beta-catenin 
(C vs. F). Cells found in the central area of each explant culture, marked using a green line in A and D, 
exhibit clear epithelial characteristics and tight cell-to-cell contact with neighboring cells based on ZO-1 
immunostaining. The cells found outside the perimeter marked by the green line show mesothelial 
characteristics. To assess the number of cells retaining epithelial characteristics we quantified both the 
relative area of the epithelial zones in relation to the area occupied by the whole explant (H), and we also 
quantified the number of epithelial cells as a percentage of the whole explant (J). We then normalized 
these values to the area occupied by epithelial cells or number of cells with epithelial characteristics in the 
vehicle control-treated samples. The scale bars in A and D represent 200µm. Scale bars in B, C, E and F 
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represent 20µm. Scale bars in G-I represent 10µm. * p<0.05 vs. DMSO.  Error bars represent standard 
deviation for each measurement set in each experimental group. For observation and quantification 







Supplementary Fig 3.10 TTNPB decreases the expression of Rnd3 in MEC1 cells. 
Immunohistochemistry analysis of RND3 in MEC1 cells suggests reduced level of expression in 
response to TTNPB treatment. Scale bars represent 20 µm. Staining of RND3 has been repeated three 























Chapter 4 Teratogenic Effects of RA in the Development of Coronary 
Vasculature 
Abstract 
During the final stages of heart development the myocardium grows and becomes vascularized. These 
processes rely on paracrine factors and cell progenitors derived from the epicardium. It is not entirely 
clear which signaling molecules orchestrate epicardial-based developmental programming, but one 
possible regulator is a metabolite of vitamin A, namely, retinoic acid (RA), which controls gene 
expression via the RA receptors (RARs) and retinoid X receptors (RXRs). In the current study, we 
explored the developmental consequences of altered RA signaling in late cardiogenic events that involve 
the epicardium. For this, we employed a previously characterized model of embryonic RA excess based 
on mouse embryos deficient in the retinaldehyde reductase DHRS3. To confirm our findings, we also 
developed a model of embryonic RA deficiency by administering WIN 18,446, a bis-(dichloroacetyl)-
diamine inhibitor of RA synthesis, to pregnant dams. Our results demonstrated that alterations in 
embryonic RA-signaling let to a thin myocardium and aberrant coronary vessel formation and 
remodeling. Both the cardiac defects and the embryonic lethality associated with RA excess in the Dhrs3-
/- model could be mitigated by reducing the maternal vitamin A intake. In both models of altered RA-
signaling, the endothelial tubes did not become invested with epicardial-derived vascular smooth muscle 
cells (VSMCs). Through transcriptome profiling of epicardial cells, we found that RA-signaling 
influenced epicardial signaling pathways relevant to cardiac development. To sum up, we report that RA 
signaling affects epicardial signaling and plays critical roles in the development of the myocardium and 
the coronary vasculature. 
4.1. Introduction  
Retinoic acid (RA), an active metabolite of vitamin A, carries out regulatory roles in many essential 
processes during both embryonic and postembryonic life (McCollum & Davis, 1913). The activities of 
RA are mediated by ligand-activated transcription factors, known as retinoic acid receptors (RARs) and 
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retinoid X receptors (RXRs) found associated with DNA motifs, termed  RA response elements (RARE), 
in the vicinity of target genes (Båvik et al., 1996). Binding of RA to RAR/RXR heterodimers leads to the 
activation, or repression, of hundreds of genes resulting in pleiotropic effects, which influences cell-
signaling and tissue growth, differentiation and repair (Paschaki et al., 2013). RA-signaling is regulated 
by a complex transport and enzymatic pathway which controls the levels of available cellular RA 
(reviewed in (Shannon et al., 2017)). Cellular RA levels are also influenced by the health and nutritional 
status of the individual, which can affect, the dietary availability, uptake or tissue storage of retinol and 
provitamin A carotenoid precursors (Rubin, Ross, Stephensen, Bohn, & Tanumihardjo, 2017). 
Alterations in RA-signaling as a result of excess or deficiency of vitamin A or due to treatment with 
RAR agonists can lead to congenital disorders manifested as craniofacial, cardiac, limb, thymus, ear and 
neural tube malformations (Ackermans, Zhou, Carels, Wagener, & Von den Hoff, 2011; Kochhar, 1973; 
Lammer et al., 1985; Rothman et al., 1995; M. Vieux-Rochas et al., 2007). The magnitude of the 
teratogenic effects of altered RA-signaling depends on the extent of deficiency or excess and on the 
developmental stage of the fetus at the time of exposure (Collins & Mao, 1999). The development of the 
heart is very sensitive to altered RA levels during the early stages of cardiogenesis when RA controls the 
determination of the cardiogenic progenitor pool and the anteroposterior patterning of the primitive heart 
tube (reviewed in (Stefanovic & Zaffran, 2017; Xavier-Neto et al., 2015)). As a result, altered RA 
signaling can induce a series of defects related to looping, outflow tract and chamber formation 
(Ghyselinck et al., 1997; Kolodzinska et al., 2013; Lammer et al., 1985; Yasui et al., 1997). 
Paradoxically, some of the defects induced by too much RA can also be brought on by too little RA due 
to either compensatory mechanisms or for the reason that regardless of excess or deficiency perturbations 
of RA signaling ultimately result in impaired development (Frenz et al., 2010; Lee et al., 2012; A. Rydeen 
et al., 2015).  
Following the formation of the chambered heart, RA-signaling is involved in several late 
developmental processes, which include the growth of the myocardial compact zone and the formation of 
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the coronary vasculature. The main source of RA in the late heart is the epicardium, a mesothelial layer of 
cells which covers the heart starting at E9.5 in mouse embryos. In addition to producing RA, the 
epicardium secretes trophic factors which support myocardial expansion. Moreover, epicardial-derived 
precursor cells (EPDC) undergo epithelial-to-mesenchymal transition giving rise to cardiac vascular 
smooth muscle cells (VSMCs) and perivascular and interstitial fibroblasts which stabilize the coronary 
vasculature and provide functionality of the contracting heart (reviewed in (Sharma, Chang, & Red-
Horse, 2017)). The formation of the vasculature and the myocardial compaction must proceed in timely 
an orchestrated manner. Defects in the formation of epicardial derivatives are often associated with both 
compromised formation of coronary vessels and hypoplastic ventricles (Singh et al., 2016; C. L. Smith et 
al., 2011; Trembley, Velasquez, de Mesy Bentley, & Small, 2015; von Gise et al., 2011). Studies based 
on explant studies and on mouse models deficient in the RA-synthetic enzyme RAlDH2, or RXR-
signaling suggest that RA is involved in the production of cardiotrophic factors by the epicardium to 
support the proliferation of the myocardium (Thomas Brade et al., 2011; T. Chen et al., 2002; P. Li et al., 
2011; Shen et al., 2015; Ingo Stuckmann et al., 2003). The same mouse models of altered RA-signaling 
also manifested defects in the formation of the coronary vasculature (S. C. Lin et al., 2010; Merki et al., 
2005). Despite this progress many questions remain regarding the mechanism involved in the effects of 
RA on the late heart development. 
Here, we examined the effects of altered RA-signaling during the late development of the heart 
focusing on coronary vessel formation and myocardial growth Recent studies suggest that RA may 
control the epicardial EMT and the differentiation of EPDCs ((Azambuja et al., 2010; Caitlin M. Braitsch 
et al., 2012; Merki et al., 2005) and Chapter 3). Using complementary models of either excess or 
deficiency of RA we demonstrate that RA plays a role in the development of the primary endothelial 
plexus and the remodeling of the coronary vasculature. In the presence of excess RA-signaling, 
PDGFRB-positive VSMC progenitor cells are poorly recruited to the developing vessels and fewer 
mature VSMCs could be found in the hearts of Dhrs3-/- embryos. In addition, in vivo excess and 
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deficiency of RA led a reduction in the ventricular myocardial growth while in vitro RA signaling led to 
changes in the epicardial transcriptome. Taken together, our study describes the effects of altered RA on 
the development of the coronary vasculature and the myocardium and provides evidence for the 
requirement of RA during the late development of the heart. 
4.2. Materials and Methods 
Mice 
Dhrs3+/-, RARE-LacZ and Dhrs3+/-; RARE-LacZ mice have been previously described (Billings et al., 
2013). The RARE-LacZ carry a LacZ gene under the control of an RA-inducible promoter (Rossant et al., 
1991) and are available at the Jackson Laboratories identified as strain RARE-hsp68LacZ, stock 008477. 
Unless otherwise noted, mice have been maintained on 2018 chow diet (Envigo) containing 15 IU 
vitamin A/ gram and kept in rooms with controlled temperature and humidity with a 12 hour light-dark 
cycle.  
After mating female mice were checked for vaginal plugs in the morning and that noon is considered 
as embryonic day (E0.5). Caesarean sections were performed at designated embryonic stages to harvest 
pups or embryonic tissues. All animal protocols were approved by the Institutional Animal Care and Use 
Committee at the University of Kansas. 
Generation of Dhrs3-/- mice in vitamin A-deficient dams 
Dhrs3+/- parent mice were kept on vitamin A sufficient diet (VAS) and their female Dhrs3+/- 
offsprings were reared on vitamin A deficient diet (VAD) from weaning. VAD-fed female Dhrs3+/- mice 
were bred overnight with male Dhrs3+/- mice to generate VAD Dhrs3-/- embryos. Caesarean sections were 
performed at designated embryonic stages to harvest pups. Both VAS and VAD diets are derived from 
AIN-93G growing rodent diet (ref: J. Nutr. 127, 838S–841S). VAS diet contains 4 IU preformed vitamin 
Aper gram of diet (D13112B, Research Diets) whereas VAD diet is vitamin A-deficient (D13110GC, 
Research Diets).  
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Whole-mount PECAM1 staining 
Mouse embryonic hearts were isolated in PBS and fixed in 4% paraformaldehyde (PFA) at 4°C 
overnight. Hearts are dehydrated through a series of increasingly concentrated methanol/PBS. 
Endogenous horseradish peroxidase activity in the heart was quenched by Dent’s bleach (Methanol: 
DMSO: 30%H2O2=4:1:1) at room temperature for 4 hours and then rehydrated through methanol/PBS. 
Embryonic hearts were blocked in blocking buffer (5% non-fat milk/0.1% Tween 20/PBS) for 2 hours 
and then incubated with diluted primary antibody against platelet/endothelial cell adhesion molecule 1 
(PECAM1) (1:500, Cat# 553370; BD-Pharmingen) for an hour at room temperature and subsequently 
overnight at 4°C. The specificity of used antibodies has been validated by western blotting. After wash, 
hearts were incubated with HRP-conjugated secondary antibody diluted in blocking buffer for an hour. 
Detection of HRP was performed using the DAB Peroxidase substrate kit (Vector Laboratories, Cat# SK-
4100) and the stained hearts were photographed and documented by Leica DMS300 Dissection 
Microscope equipped with digital camera. For each stage, at least 3 distinct mouse embryos were 
analyzed by whole-mount PECAM1 immunostaining. 
Immunofluorescent staining 
Embryos at various developmental stages were harvested in ice-cold PBS, fixed in 4% PFA overnight 
at 4°C and processed for transversal sectioning after being embedded in paraffin. Sample sections were 
deparaffinized and rehydrated at room temperature. Distinct antigen retrieval methods were then applied 
in the case of different antigens: for CD31, sections were treated with 0.1mg/ml proteinase K for 5 
minutes at room temperature; for PDGFRA/B and COUP-TF II, heat-mediated antigen retrieval was 
utilized using established protocol. In case of double-labeling, embryonic tissues were fixed for 2 hours at 
4°C and processed for frozen section to avoid conflicting antigen retrieval methods. Tissue sections were 
incubated with 3% H2O2 for 5 min to quench endogenous HRP activity. Non-specific binding sites on 
sections were blocked with blocking buffer (5% normal goat serum/ 0.1% Tween 20/ PBS) for an hour at 
room temperature. Diluted primary antibody was subsequently added on to slides and incubated at 4°C 
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overnight. Information about primary antibody was listed in Table 1. After washing with 0.1% Tween 
20/PBS solution, Alexa Fluor-conjugated secondary antibody was applied to detect the corresponding 
primary antibody. When signal amplification is needed, HRP-conjugated secondary antibody was used 
and TSA Plus Fluorescein Evaluation Kit (PerkinElmer, Cat# NEL741E001KT) was used according to 
manufacturer’s protocol. Nuclei were stained with 1Μm DAPI (Life Technologies) and sections were 
mounted with Vectashield mounting medium (Vector Laboratories, Cat# H-1000). Images were acquired 
using either an inverted epifluorescent microscope (Olympus IX-81 with ZDC, Olympus Scientific 
Solutions Americas) with a 20x air objective (0.3NA, Olympus Scientific Solutions Americas) and 
Hamamatsu Flash 4.0 v1 CMOS camera (Hamamatsu Corporation), or an Olympus 3I spinning disk 
confocal microscope (Olympus IX-81, Olympus Scientific Solutions Americas) equipped with a 40x oil 
objective (1.3NA, Olympus Scientific Solutions Americas) and Andor Zyla 4.2 CMOS camera (Andor 
Technology Ltd). Images were representative of at least 5 images collected from each of three biological 
replicates per stage. Intensity and contrast of each image were adjusted simultaneously and globally to the 
same level to accomplish fair comparison between images. 
Histology 
Mouse embryos were isolated at E14.5 and fixed overnight in 4% paraformaldehyde at 4°C. Fixed 
embryos were embedded in paraffin and transversally sectioned at 7µm by Leica RM2255 microtome. 
The slides were stained using hematoxylin and eosin reagents according to previously published protocol 
(Fischer et al., 2008). Staining results were documented by Leica DMS300 Dissection Microscope 
equipped with digital camera. 
LacZ staining 
Dhrs3+/-; RARE-LacZ mice were mated to produce Dhrs3-/-; RARE-LacZ and Dhrs3+/+; RARE-LacZ 
embryos which were isolated at various developmental stages to evaluate the activity of LacZ using 
previously established protocol (Billings et al., 2013). Samples in both experimental and control groups 
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were processed simultaneously using identical protocol and were documented using Leica DMS300 
Dissection Microscope equipped with digital camera. 
Transcriptome analysis 
MEC1 cells were treated with vehicle (DMSO) or 10nM TTNPB for 48 hours and isolation of RNA 
using TRIZOL reagent according to manufacturer’s protocol. RNA was pretreated with Invitrogen™ 
DNA-free™ DNA Removal Kit (Cat # AM1906) before submission for cDNA library assembly.  
Statistical analysis 
Data were represented means ± standard deviation and unpaired Student’s t-test was utilized to 
evaluate statistical difference between groups. 
4.3. Results 
Excess RA affects the late development of the heart 
To test the teratogenic effect of excess RA in the development of the heart, we employed a mouse 
model lacking the enzyme, DHRS3, which reduces the RA precursor, retinaldehyde, to retinol and thus 
prevents the synthesis of excess RA. Our lab has previously shown that in the absence of DHRS3, RA 
accumulates and causes alterations in RA-signaling both globally and within the developing hearts of 
Dhrs3-/- embryos ((Billings et al., 2013) and Chapter 3). Here, we first confirmed that Dhrs3-ablation 
results in altered RA-signaling in Dhrs3-/- mice at E12.5, a stage marked by the rapid myocardial growth 
and coronary plexus development. We crossed the Dhrs3+/- mice with the RARE-LacZ mouse strain 
which expresses a LacZ reporter gene driven by a promoter controlled by a RARE derived from the Rarb 
promoter (Rossant et al., 1991). This was done to allow us to visualize the domains associated with active 
RA-signaling in the developing embryos. The detection of the activity of LacZ-encoded β-galactosidase 
revealed that at E12.5, ablation of Dhrs3 causes an evident expansion of RA-signaling domains in the 
mutant heart (Fig S1A-D), suggesting that the hearts of E12.5 Dhrs3-/- embryos, in accordance with the 
similar findings observed in E10.5 Dhrs3-/- embryos ((Shannon et al., 2017) and Chapter 2). The 
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expanded domains of RA-signaling in the hearts of Dhrs3-/- embryos at midgestation are consistent with 
the observed increases in the global levels of RA as quantified by direct analysis via LC-MS/MS at E12.5 
and E14.5 in Dhrs3-/- embryos ((Billings et al., 2013) and Chapter 3).  
Dhrs3-/- embryos display mid-gestational lethality accompanied by defects in the development of the 
heart (Supplementary Fig 4.1E vs. F). As we have previously reported, global ablation of Dhrs3 is 
associated with a membranous ventricular septal defect, a lack of atrial septum and a double outlet right 
ventricle (DORV) in E14.5 Dhrs3-/- embryos (Billings et al., 2013).  Examination of the gross 
morphology of the E14.5 Dhrs3-/- embryos indicated that Dhrs3 mutant embryos showed evidence of 
peripheral edema suggesting cardiac insufficiency. The ventricular myocardium of E14.5 Dhrs3-/- 
embryos has a 2-fold reduction in the thickness of its compact zone in comparison to wild-type littermates 
(Fig 4.2A-D, quantified in 4.2E).  A hypoplastic ventricular myocardium has been observed in other 
models with altered RA signaling (S. C. Lin et al., 2010; Merki et al., 2005; Niederreither et al., 2001). 
Therefore Dhrs3-deficiency results in ventricular hypoplasia and defects in heart septation and in 
alignment of the outflow tract. 
Ablation of Dhrs3 is associated with delays and defects in the formation of the coronary vasculature. 
Dhrs3-/- embryos displayed a 40% reduction in the coronary vessel coverage of the dorsal ventricles when 
compared to the wild-type littermates as observed at E13.5 (Supplementary Fig 4.2A-B, quantified in 
S4.2C). As the primitive plexus matures, the vessels of the wild-type heart experienced remodeling 
including pruning and branching (Fig 4.1K). However, in the Dhrs3-/- heart, the vessels remained 
tortuous, aberrantly enlarged, lacking branching from pre-existing vascular beds (Fig 4.1L). This defect is 
especially noticeable near the atrioventricular canal (AVC) of the Dhrs3-/- hearts, where the vessels 
formed a single endothelial trunk, which had very few branches (Fig 4.1L, red arrow). Additional related 
cardiovascular defects become apparent in the Dhrs3-/- hearts at E14.5. Most notably, PECAM1-positive 
endothelial nodules were observed on the ventral side of the ventricles of Dhrs3-/- hearts in larger 
numbers, of greater size and with a broader distribution than seen in wild-type littermates (Fig 4.1F vs. G, 
126 
 
quantified in 4.1I). Such epicardial nodules which may originate as ectopic blood islands have been 
observed in other mouse models that exhibit defects in the development of the coronary vasculature (A. 
M. Mellgren et al., 2008; N. Smart et al., 2012; Tian et al., 2013; H. Wu et al., 1999; S. P. Wu, Dong, 
Regan, Su, & Majesky, 2013).  
In order to validate that the coronary vessel malformations observed in the Dhrs3-/- embryos develop 
as a consequence of excessive RA, we fed the Dhrs3+/- dams with a vitamin A-deficient (VAD) diet since 
weaning; our hypothesis being that the lower vitamin A intake can reduce the levels of RA being 
generated and restore normal RA levels and development in the Dhrs3-/- embryos. Indeed, feeding dams a 
VAD diet led to the restoration of the vascular coverage of the dorsal ventricles of Dhrs3-/- embryos to 
normal levels at E14.5. Meanwhile the Dhrs3-/- embryos from dams fed a vitamin A-sufficient (VAS) diet 
experienced developmental delays and reduced coronary vessel coverage of the heart of compared to 
either wild-type littermates from dams fed on VAS diet or Dhrs3-/- embryos from  dams fed on VAD diet 
(Fig 4.1L vs. M, vessel coverage is quantified in O) . Feeding dams VAD diet led to both improved 
vascular remodeling and reduced formation of endothelial nodules in the Dhrs3-/- hearts (Fig 4.1G vs. H). 
In fact, feeding dams a VAD diet, allowed us to bypass the embryonic lethality associated with the 
Dhrs3-deficiency to obtain living viable Dhrs3-/- pups that survived into adulthood. In conclusion, our 
data suggest that increased RA formation is the cause of the developmental defects resulting from genetic 
deletion of Dhrs3. 
Analysis of the morphology of intramyocardial vessels in the Dhrs3-/- hearts indicated a loss of vessel 
hierarchy. PECAM1 immunostaining of transversal sections indicated that vessels in the Dhrs3-/- hearts 
showed little distinction between vessels, whereas wild-type hearts developed an extensive arborization 
of vessels with different calibers (Fig 4.1P vs. Q).  Both subepicardial and intramyocardial vessels in the 
Dhrs3-/- hearts were consistently enlarged compared to vessels in wild-type hearts (Fig 4.1P vs. Q, 
quantified in N). Because of their aberrant vessel size, Dhrs3-/- hearts have a significantly reduced 
vascular density per area of myocardium (Fig 4.1J). Particularly, there is an accumulation of dilated and 
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superficial vessels in the subepicardium of Dhrs3 mutant embryos, which we identified as COUP-TFII-
positive veins (Fig 4.1R vs. S). In situ hybridization of COUP-TFII in Dhrs3-/- hearts at E9.5 revealed 
relatively normal localization and expression levels of COUP-TFII in the primitive Dhrs3-/- heart tube, 
suggesting that the early patterning of the heart was normal (Supplementary Fig 4.3). The enlargement of 
coronary vessels persisted into late gestation in the few surviving E17.5 Dhrs3-/- fetuses which exhibited a 
combination of normal-sized intramyocardial arteries and very large, collapsed, superficial veins 
(Supplementary Fig 4.2D-G).  
Thus altered RA homeostasis led to perturbations in the hierarchical organization and vascular 
density of coronary vessels in mouse embryos. Taken together, our results based on suggest that 
excessive formation of RA in Dhrs3-/- embryos affects not only epicardial EMT, but also the subsequent 
development of coronary vessels. 
Excess RA does not affect vessel formation in the placenta and the embryonic yolk sac. 
Deletion of Dhrs3 has been found to cause global elevations of RA levels and expanded RA-signaling 
((Billings et al., 2013) and Chapter 3). RA-signaling plays important roles in the development of the 
placental, and yolk sac vascular plexi (Lai, Bohnsack, Niederreither, & Hirschi, 2003) and the formation 
of the hematopoietic stem cells from the hemogenic endothelium (Chanda, Ditadi, Iscove, & Keller, 
2013). Given the effects of Dhrs3-deficiency on the development of the coronary vasculature, we further 
investigated if Dhrs3-deficiency affects the development of vasculature in the placenta and yolk sac. 
Histology analysis using hematoxylin and eosin revealed normal placental morphology in Dhrs3-/- 
mice when compared with wild-type littermates at E13.5 and E14.5 (Supplementary Fig 4.4A-D). 
Quantification of the thickness and density of the vascular labyrinth, did not find any significant 
difference between wild-type and Dhrs3 mutant embryos (Supplementary Fig 4.4E,J). Deletion of Dhrs3 
did not impede the formation and branching of vascular tubes from the chorionic plate; neither did it 
affect the placental vascular patterning (Supplementary Fig 4.4F-I). Hence, the excess RA formed in 
Dhrs3-/- mice has minimal influences on the placental vascular development in mouse embryos. 
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In addition to the placental vascular system, the vessels in yolk sac have also been found to be critical 
for embryonic development especially at early embryonic stages (Dominguez et al., 2007). Both Dhrs3 
mutant mice and their stage-matched wild-type littermates had an intact embryonic yolk sac plexus 
composed of a finely branched and properly developed network as observed by whole-mount PECAM1 
immunostaining (Supplementary Fig 4.5A-B). Therefore, the deleterious effects of altered RA-signaling 
in Dhrs3-/- embryos do not affect the vasculogenesis and remodeling of placental and yolk sac plexus. 
Excess RA interferes with the recruitment and differentiation of VSMC progenitors 
VSMCs and pericytes are critical for coronary vessel morphogenesis and function (Amy M. Mellgren 
et al., 2008; Trembley et al., 2015). Coronary vascular mural cells, which are derived primarily from the 
epicardium via EMT, migrate into the myocardium where they are required in vascular stabilization and 
remodeling (C. L. Smith et al., 2011). We and others have shown that RA-signaling plays a critical role in 
both the epicardial EMT and the differentiation of VSMC progenitors ((Azambuja et al., 2010; Caitlin M. 
Braitsch et al., 2012) and Chapter 3). Specifically, Dhrs3-/- EPDC were found to migrate deeper into the 
myocardium of E14.5 Dhrs3-/- mice. Studies described herein suggest that Dhrs3-/- mice have 
compromised coronary vessel as a result of RA excess. Therefore, we investigated if the recruitment of 
VSMC by the coronary plexus is affected in Dhrs3-/- hearts. 
We investigated the localization and recruitment of VSMC progenitors to the endothelial tubes by 
double-immunostaining of both PDGFRB and PECAM1 in the wild-type and Dhrs3-/- hearts. The staining 
results suggested that most vessels are associated with PDGFRB-positive vessels in both wild-type 
control embryos and mutant hearts (Fig 4.2A-H). However, there are more PDGFRB-positive cells not 
found to be associated with any vessels in the Dhrs3-/- hearts. At the same time there are PECAM1-
positive endothelial tubes devoid of VSMC progenitors in the Dhrs3-/- hearts (Fig 4.2C vs. G, yellow 
arrow). We examined the recruitment of PDGFRB-positive VSMC progenitors in surviving E17.5 
embryos. Consistent with earlier stages, PECAM1 immunostaining revealed that Dhrs3-/- hearts consisted 
of malformed, large caliber vessels. Though at E14.5, some VSMC progenitors were found to be in the 
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vicinity of endothelial tubes, PDGFRB immunostaining at E17.5 revealed a surprising absence of VSMC 
progenitors near the PECAM1-positive vessels in the Dhrs3 mutant hearts (Fig 4.2I-P) suggesting that 
excess RA-signaling affects the recruitment and stability of VSMC progenitors on the endothelial tubes. 
The large subepicardial veins still observable in Dhrs3-/- hearts at E17.5 (Supplementary Fig 4.2E, G) 
were the most severely affected and found to be devoid of mural PDGFRB-positive cells (Fig 4.2O-P). 
PDGFRB marks not only progenitors of VSMCs but also pericytes that are recruited to capillaries and 
postcapillary venules. In contrast to larger vessels, PDGFRB-positive mural cells were found to be in 
direct contact with the PECAM1-positive endothelial cells of capillaries (Fig 4.2J vs. N) though this 
colocalization does not provide information about whether the two types of cells have established proper 
communication. Furthermore, VSMC progenitors failed to differentiate into mature VSMC in Dhrs3-/- 
hearts when compared to wild-type hearts, as revealed by the lack of expression of SM22α in mural cells 
around major vessels (Fig 4.3). Thus, excess RA influences the recruitment, stabilization and 
differentiation of PDGFRB-positive VSMC progenitors.  
RA deficiency leads to defective formation of the myocardium and the coronary vessels 
Previously we have described the establishment of the mid-gestational RA deficiency model by by 
administration of Win 18, 446 (WIN), an inhibitor of the aldehyde dehydrogenase 1A family of enzymes 
which convert retinaldehyde to RA. WIN, previously investigated as a potential male contraceptive 
(Heller, Moore, & Paulsen, 1961), is a potent inducer of congenital heart defects including coronary 
defects, yet, the cause for such defects remains poorly understood (Binder, 1985; Fujino et al., 2005; 
Hanato et al., 2011; Ito et al., 1992; Jackson, Connell, Smith, Drury, & Anderson, 1995; Kilburn, Hess, 
Lesser, & Oster, 1982; Kise et al., 2005; Kuribayashi & Roberts, 1993; Nishijima et al., 2000; Okamoto 
et al., 2004; Okishima, Takamura, Matsuoka, Ohdo, & Hayakawa, 1992; Oster et al., 1974; Tasaka et al., 
1991). We found that administration of WIN between E9.5 and E13.5 dramatically reduced the amount of 
RA and alters RA-signaling in developing mouse embryos and their heart (Chapter 3). Importantly, we 
found that administration of WIN affects the epicardial EMT and migration of EPDC into the 
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myocardium (Chapter 3). Examination of the gross morphology of WIN-treated embryos showed signs of 
imminent heart failure as evidenced by the accumulation of body fluid on the back of the embryo (Fig 
4.4A vs. B). Histology analysis of vehicle- or WIN-treated embryos suggested a normal development of 
the heart chamber in response to WIN-treatment at mid-gestation, yet, the WIN-treated animals had 
myocardial hypoplasia manifested as a 50% thinner myocardium compact zone when compared to the 
vehicle control-treated group (Fig 4.4C vs. D, quantified in 4K).  
We next investigated if inadequate formation of RA during mid-gestation can affect coronary 
development. Whole-mount immunostaining of endothelial cells via PECAM1 suggested that whereas 
vessels developed and sprouted normally in the vehicle control group, coronary vessels failed to fully 
expand to the ventricular apices in the WIN-treated hearts (Fig 4.4E vs. F). Quantification of vessel 
coverage revealed a 20% reduction in the hearts of the WIN-treated group compared to the control (Fig 
4.4L). In addition, RA deficiency also altered the vascular hierarchy of the coronary plexus. At E14.5, 
vehicle-treated embryonic hearts displayed a well-organized coronary vessel network with several major 
vessels developing from the AVC coursing towards the apex and branching out to smaller vessels. In 
contrast, WIN-treated embryos showed evidence of defects in the formation and maturation of the 
vascular network marked by few clearly distinguishable major branches and a conspicuous absence of the 
interventricular artery (Fig 4.4M). Upon examining intramyocardial vessel morphology we found that 
WIN treatment led to excessive formation of vessels of small diameter (Fig 4.4G-J, quantified in 4N). 
Consistent with the reduced vascular coverage observed with the whole-mount PECAM1 staining, the 
myocardium near the apices in E14.5 WIN-treated embryos is devoid of vessels and the density of 
intramyocardial vessels is overall reduced (Fig 4.4H vs. J, density quantified in 4O).  
We next investigated the recruitment of VSMC progenitors to the coronary vessels at E14.5 in 
vehicle and WIN-treated embryos. Endothelial cells and VSMC progenitors were visualized by double 
immunostaining of PECAM1 (green) and PDGFRB (red) at E14.5 in embryonic hearts (Fig 4.5). 
Previously, we reported reduced migration of EPDC in response to WIN treatment in both in vivo and in 
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vitro models (Chapter 3). As a consequence, there are fewer PDGFRB-positive cells in the myocardium 
surrounding coronary vessels of WIN-treated embryos (Fig 4.5A vs. E). However, the PDGFRB-positive 
EPDCs that have infiltrated the myocardium were found to be near or adjacent to the endothelial tubes, 
which indicates that the initial recruitment of VSMC progenitors to the coronary vessels is not severely 
affected by the reduced RA formation in the WIN-treated group.  
RA-signaling regulates the epicardial transcriptome 
Both fetal and postnatal epicardium secretes signaling molecules that stimulate the growth and repair 
of the heart (Olivey & Svensson; B. Zhou et al., 2011). RA-signaling can stimulate epicardial cells to 
produce trophic factors to enhance the proliferation of cardiomyocytes (Thomas Brade et al., 2011; T. 
Chen et al., 2002; Merki et al., 2005; Shen et al., 2015; Ingo Stuckmann et al., 2003).  
To define the effects of altered RA-signaling on epicardial cell signaling we performed transcriptome 
profiling on a ventricular epicardial cell line, MEC1, treated for 48 hours with 10nM TTNPB, a stable 
RAR pan-agonist (Chapter 3). Upon analysis we identified 6,931 genes being differentially regulated in 
MEC1 cells by TTNPB treatment compared to the vehicle control-treated group. TTNPB led to the RA-
signaling by up-regulating the expression of multiple known RA-modulated genes, including Rarβ, Rbp1 
and Hoxa1 (Fig 4.6A). TTNPB treatment also induced compensatory responses in RA metabolism to 
inhibit its synthesis and activate its degradation; such an effect is commonly seen in models of excessive 
RA-signaling. Within the list of differentially expressed genes, we also found the RAR-agonist treatment 
of MEC1 cells induced the expression of cardiotrophic factors such as Fgf2 and Fgf9 as well as mediators 
of FGF signaling (Fig 4.6B; altered genes are listed in Supplementary Table 4.1). Activation of RAR in 
MEC1 epicardial cells leads to down-regulation of the expression of Igf2 by over 75% (Fig 4.6C) which 
supports the regulation of this particular cardiotrophic pathway by extra-cardiac RA signaling. Pathway 
analysis of the transcriptome data derived from TTNPB-treated MEC1 cells versus control revealed that 
HIF-1α signaling was broadly attenuated by activation of RAR in epicardial cells. This was evident as a 
down-regulation of Hif1α as well as multiple known effectors of HIF-1α signaling, such as Vegfα, Tgfα 
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and Hyou1 (Fig 4.6D). The expression of several angiopoietin and angiopoietin-like proteins known to be 
hypoxia-responsive were also observed to be altered in response to TTNPB-treatment in MEC1 epicardial 
cells. Therefore, analysis of the RNAseq data revealed that RA alters the gene expression profile of 
MEC1 resulting in alterations in growth-promoting and angiogenic pathways. Collectively, our results 
suggest that besides its better understood roles in early cardiogenesis, RA-signaling also plays critical 
roles in the regulation of the growth of the myocardium and the formation and maturation of the coronary 
vasculature. 
4.4. Discussion 
We report here that alterations of RA-signaling can cause defects and delays in the formation of the 
coronary vasculature. These defects are observable in the case of either excess or deficiency of RA. First, 
using Dhrs3-/- embryos, a mouse model exhibiting mildly elevated embryonic RA (Billings et al., 2013), 
we showed that excess RA caused delays in the formation of the coronary vascular plexus and 
abnormalities in coronary vessel morphology and branching. The most severe consequences of Dhrs3-
ablation were the formation of ectopic endothelial nodules and of large aberrant subepicardal veins, the 
latter of which persisted in the few Dhrs3-/- embryos surviving to late gestation. The defects seen in 
Dhrs3-/- embryos could be averted by reducing the maternal vitamin A intake of the dam, thus, 
demonstrating that the effects of Dhrs3-ablation on heart development were indeed the result of excess 
RA. In a second approach, starting at midgestation, we administered WIN to block RA synthesis. By 
doing so, we avoided the lethality and early cardiogenic defects resulting from RA deficiency and 
observed in early WIN-treated embryos (Oster et al., 1974). Late WIN-treated embryonic hearts were 
properly chambered and had similar gross morphology when compared to the vehicle-treated group, yet, 
experienced a 60% reduction in the global levels of all-trans-RA and showed very restricted RA-
signaling in the E14.5 heart (Chapter 3). Importantly, RA deficiency caused by WIN administration led to 
the formation of predominantly small-caliber vessels with few major arterial branches. Both deficiency 
and excess of RA caused defects in coronary vascular remodeling leading to alterations in coronary vessel 
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hierarchy and the intramyocardial vascular density. Important many of the intramyocardial vessels failed 
to become invested with mural cells expressing markers of mature VSMCs. Our results therefore 
establish a critical role for RA in the formation, remodeling and maturation of the coronary vasculature.  
Both deficiency and excess RA can result in various cardiovascular malformations in developing 
embryos (Lammer et al., 1985; Niederreither et al., 2001; L. Ryckebusch et al., 2008). Due to the 
essential roles of RA during early embryogenesis, extensive changes in embryonic RA-signaling often 
result in embryonic lethality. As a result, the role of RA in the later stages of heart development is less 
well understood. The main source of cardiac RA in the late heart development of the heart is the 
epicardium (J. B. Moss et al., 1998; Niederreither, Fraulob, Garnier, Chambon, & Dolle, 2002; J. M. 
Perez-Pomares et al., 2002). The epicardium is responsible for the growth of the myocardial compact 
zone and for generating precursors of primarily VSMCs, and cardiac fibroblasts.  Therefore, alterations in 
RA formation during late heart development affect primarily epicardial RA-signaling and have the 
potential of influencing important epicardial-related events in late heart development.  
RA generated from cardiac (epicardial) and extra-cardiac sources influences the secretion of 
cardiotrophic factors by the epicardium. The ventricular myocardium grows during mid-gestation and has 
been found to be sensitive to altered levels of RA-signaling in the heart (S. C. Lin et al., 2010; Lohnes et 
al., 1994; Merki et al., 2005). The growth of the myocardium is dependent among other factors on 
cardiotrophic factors, such as IGF2, first proposed to be secreted by the epicardium in response to cell-
autonomous RA-signaling (T. Chen et al., 2002; Merki et al., 2005; Ingo Stuckmann et al., 2003), but 
later shown to be secreted in response to RA-signaling in extra-cardiac (liver and placental) tissues 
(Thomas Brade et al., 2011; Shen et al., 2015). One possible explanation of thinned myocardium in 
Dhrs3-/- mice is that aberrant RA-signaling in either cardiac or extra-cardiac tissues causes alterations in 
the epicardial transcriptome. In our transcriptome analysis of RAR agonist-treated epicardial MEC1 cells 
we observed that RA-signaling causes the up-regulation of the expression of several mitogenic proteins, 
including FGF2 and FGF9 and follistatin-like 1 (FSTL1), previously proposed to be involved in 
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myocardial growth and coronary vascularization (K. J. Lavine et al., 2005; D. J. Pennisi & Mikawa, 2005; 
Vega-Hernandez, Kovacs, De Langhe, & Ornitz, 2011; Wei et al., 2015). The expression of the epicardial 
secreted cardiotrophic factor, IGF2, as well as its receptor IGFR2 was down-regulated in response to 
induction of RA-signaling in epicardial cells (Supplementary Fig 5) suggesting that IGF2 secretion relies 
on secondary signaling from RA produced by extra-cardiac sources (Thomas Brade et al., 2011; Shen et 
al., 2015). In addition, the expression of proteins antagonizing IGF functions, namely IGF binding 
proteins, was found to be highly induced in RAR agonist-treated MEC1 cells. The possibly reduced IGF 
signaling might contribute to the teratogenic effects of altered RA in the myocardial growth. 
RA affects the development of EPDCs and epicardial-derived lineages which are necessary for the 
proper development of the coronary vasculature. We have previously shown that RA signaling controls 
the cytoskeletal reorganization of epicardial cells via Rho-signaling (Chapter 3). In vivo, both excess or 
deficiency of RA affect the extent and timing of the infiltration of the myocardium by EPDCs. In 
addition, RA-signaling acting via TCF21 delays the differentiation of VSMCs (Azambuja et al., 2010; 
Caitlin M. Braitsch et al., 2012). Recruitment of mural cells in the form of VSMCs and pericytes is 
required for the proper angiogenic remodeling and maturation of vessels (reviewed in(Gaengel, Genove, 
Armulik, & Betsholtz, 2009)) and defects in VSMC/pericyte formation or recruitment often lead to 
endothelial defects and vascular abnormalities and decreased ventricular vascular coverage (Hellstrom et 
al., 2001; Hellstrom, Kalen, Lindahl, Abramsson, & Betsholtz, 1999; A. M. Mellgren et al., 2008; C. L. 
Smith et al., 2011; Trembley et al., 2015; Volz et al., 2015Trembley, 2015 #3852). Likewise, defects in 
VSMC/pericyte formation or recruitment observed in the hearts of Dhrs3-/- or WIN-treated embryos could 
account for the compromised coronary vessel remodeling and maturation seen in these models. However, 
these interesting possibilities require further investigation.  
Alterations in RA-signaling during the late heart development often translate into defects or delays in 
both myocardial growth and the formation of the coronary vasculature. For example, a hypoplastic 
ventricle and coronary vascular defects have been observed in mice with either an epicardial-ablation of 
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RXR (Merki et al., 2005) and in mice deficient in the RA synthetic enzyme RALDH2 (S. C. Lin et al., 
2010). Here, we show that embryos affected by RA excess or RA deficiency had defects and delays in the 
formation and the primary coronary vessels and that their coronary vessels did not become invested with 
mature VSMCs. In all above mentioned examples the coronary vascular defects are accompanied by 
hypoplastic myocardium and, in some cases, by other cardiac defects in outflow tract formation, chamber 
formation and septation ((S. C. Lin et al., 2010; Lohnes et al., 1994) and Chapter 4). Since the growth of 
the compact zone of the myocardium is dependent on the proper provision of oxygen and nutrients 
provided by the coronary vasculature, the hypoxia resulting from coronary defects may compromise its 
growth (Ream, Ray, Chandra, & Chikaraishi, 2008). Nonetheless, induction of HIF1α-signaling is 
important for fetal growth and angiogenesis and for proper coronary vessel formation (Tomanek, Lund, & 
Yue, 2003; Tomanek, Ratajska, Kitten, Yue, & Sandra, 1999; Wikenheiser, Doughman, Fisher, & 
Watanabe, 2006; Yue & Tomanek, 1999). In addition, we observed that RA treatment of MEC1 
epicardial cells caused alterations in the expression of factors involved in HIF1α-signaling and 
angiopoiesis. The causal relationship among congenital coronary anomalies and other congenital cardiac 
defects is not understood but it is quite possible that they share common pathogenic mechanisms and that 
they influence each other through reciprocal interactions (Cano et al., 2016).  
In summary, our results demonstrate the importance RA-signaling in the development of the coronary 
vasculature and ventricular myocardium. RA-signaling influences the secretion of epicardial 
cardiotrophic factors and the development, recruitment and differentiation of EPDCs. Sharing a common 
signaling mediator allows the aforementioned cardiogenic pathways to simultaneously orchestrate the 
growth and vascularization of the heart. Future studies focused on the downstream effectors of RA-
signaling will be able to differentiate its mitogenic and angiogenic pathways. Deficiency of vitamin A or 
administration of retinoid-based therapies during pregnancy can expose fetuses to high risks of congenital 
heart diseases with the most sensitive window having been proposed to be during early embryogenesis 
(Lammer et al., 1985). Studies presented here and elsewhere caution that mid-gestation exposure to 
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retinoid therapies or to excess or vitamin A deficiency could lead to late heart maturation defects 
including congenital coronary anomalies and hypoplastic myocardium and therefore these considerations 






Figure 4.1 Ablation of Dhrs3 compromises myocardial growth and coronary vessel 
formation via excess formation of RA. 
Examination of heart morphology at E14.5 revealed an evident reduction in myocardial thickness in 
ventricles of Dhrs3-/- (-/-) embryos when compared to wild-type (+/+) controls (A-D enlarged and marked 
by black bars in C vs. D quantified in E). Whole-mount PECAM1 staining (purple) of endothelial cells 
suggest that E14.5 Dhrs3-/- embryos developed more numerous and larger ectopic endothelial nodules on 
the ventral side of the heart (F vs. G, yellow arrow, numbers of nodules quantified in I). At E14.5 Dhrs3-/- 
embryos had a compromised vascular network morphology as well as reduced vascular expansion 
towards the apices (K vs. L, quantified in O; red dashed lines mark the apical edges of the plexi). Near 
the AVC of Dhrs3-/- hearts, the vessels fused to form a large diffuse endothelial trunk (Fig 2L, red 
arrow). Feeding VAD diet to the dam restored the vascular coverage of E14.5 Dhrs3-/- embryos and 
decreased size and number of endothelial blisters compared to Dhrs3-/- embryos from dams on VAS diet 
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(L vs. M, G vs H, vascular coverage quantified in O). At E14.5 Dhrs3-deficiency resulted in enlargement 
of both intramyocardial and subepicardial coronary vessels (P vs. Q, white arrowhead, lumen sizes are 
quantified in N), accumulation of superficially localized-veins (R vs. S, yellow dashed line marks the 
surface of the heart) and reduced intramyocardial vessel density (J) as observed via PECAM1 (in P, Q, 
green) and COUP-TFII (in R,S, violet) immunostaining of sections of transversal sections. Analyses were 
performed based on at least three biological replicates. Scale bars represent 200μm in A-D, 400μm in F-H 
and K-M, 20μm in P-S. Error bars represent standard deviation. * p<0.05 vs. VAS-WT; ** p<0.01 vs. 






Figure 4.2 Dhrs3-deficiency affects the recruitment of PDGFRB-positive VMSC progenitor 
cells to endothelial tubes. 
At E14.5, PDGFRB-positive (red) cells were found to be near PECAM1-positive (green) endothelial 
tubules of wild-type (+/+) embryos (A-D). In Dhrs3-/- (-/-) embryos, PDGFRB-positive cells were found 
near the superficially-localized vessels (E-H) including close juxtaposition with vascular endothelia (G, 
red arrow) but there are vessels devoid of PDGFRB-positive cells (G, yellow arrow). At E17.5 large-
caliber intramyocardial vessels in the wild-type embryos were surrounded by a layer of PDGFRB-
positive, VMSC progenitor cells (I-L yellow dashed line marks the surface of the heart). In contrast, 
vessels of similar sizes in Dhrs3-/- embryos had a thin, sparse coverage of PDGFRB-positive cells. Many 
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of the abnormally enlarged superficial, subepicardial vessels were found to be devoid of coverage by 
VMSCs (M-P). Scale bars represent 50μm in A-B, E-F, I-J and M-N; 20μm in C-D, G-H, K-L and O-P. 






Figure 4.3 Dhrs3-deficiency affects the differentiation and recruitment of VSMCs. 
Double labeling of PECAM1 (green) and VSMC marker SM22A (red) in Dhrs3-/- (-/-) and wild-type 
(+/+) embryonic hearts at E17.5 revealed a reduced expression of SM22A in the mural vascular cells of 
Dhrs3-/- embryos in contrast to the presence of SM22A-positive around vessels in the wild-type hearts (C, 
yellow arrow). A yellow dashed line marks the surface of the heart. Scale bars represent 100um. Images 






Figure 4.4 RA deficiency compromises myocardial growth and coronary vessel formation. 
Embryos from dams treated with vehicle (DMSO) or WIN 18,446 (WIN) from E9.5 to E13.5 were 
isolated at E14.5. Embryos from the WIN-treated group showed evident subcutaneous edema (A vs. B), 
and significantly compromised growth of the ventricular myocardium as visualized by Hematoxylin and 
Eosin staining (C vs. D, quantified in K). Whole-mount PECAM1 immunostaining (E, F, purple) 
indicated that vehicle control-treated embryos develop a finely branched and a well-organized vascular 
network (E vs. F, number of major branches was quantified in M). In comparison, WIN treatment 
drastically altered the number and localization of the major branches of vessels that sprout towards the 
apex of the heart including the absence of the interventricular coronary artery branch (E vs. F, marked by 
yellow arrow in E). WIN treatment resulted in a 20% reduction in vascular coverage of the ventricles 
when compared to the vehicle group (E vs. F, quantified in L, a red dashed line marks the apical edge of 
the vascular network on the dorsal side of ventricles) leading to avascular areas near the ventricular apices 
(I vs. J). Administration of WIN led to a reduction in the density and caliber of intramyocardial vessels 
(G vs. H, lumen sizes quantified in N, vessel density per area in the myocardium quantified in O) as 
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revealed by PECAM1 (G,I, green) immunostaining of transversal sections (yellow dashed line marks the 
surface of the heart). Scale bars represent 2mm in A-B , 200μm in C-F , 20μm in G-J. Images are 






Figure 4.5 RA deficiency affects the migration of epicardial-derived VSMC progenitor cells 
in WIN-treated embryonic hearts. 
Endothelial cells and VSMC progenitors were visualized by double immunostaining of PECAM1 
(green) and PDGFRB (red) at E14.5 in embryonic hearts. When compared to vehicle control group, 
WIN-treated embryos have evidently thinned myocardium and fewer coronary vessels in the 
myocardium, accompanied with decreased number of PDGFRB-positive VSMC progenitor cells in the 
myocardium (B vs. F; D vs. H). Though lower in number, the intramyocardial PDGFRB-positive cells in 
WIN-treated embryos were found to either surround or in adjacent to vessels, similar to the vehicle 
control group, suggesting that the initial recruitment of VSMC cells to immature endothelial tubes is 
minimally affected by deficiency of RA during heart development. Scale bars in A-B and E-F represent 







Figure 4.6 RNAseq analysis in MEC1 cells treated with RA for 48 hours. 
Differentially regulated genes with adjusted p-value smaller than 0.05 are mapped in volcano plot. 
Genes involved in FGF signaling are color-coded blue (B), those belonging to IGF signaling are in green 








Supplementary Fig  4.1 Dhrs3-/- hearts have increase RA signaling and edema. 
Genetic ablation of Dhrs3 leads to expansion of RA-signaling domains in the developing heart at 
E12.5 (A-D) and subcutaneous edema at E14.5 (E-F). The domains associated with active RA-signaling 
were visualized through the X-gal staining RARE-LacZ dams Scale bars represent in 200μm in A-D, and 
2mm in E-F. Observation was derived from at least three biological replicates per genotype at each 






Supplementary Fig 4.2 Dhrs3-/- embryos have defects in coronary vessels. 
Dhrs3-/- mice exhibited reduced vessel coverage on ventricles at E13.5 and aberrantly enlarged 
vessels at E17.5 (marked by white arrow head), when compared to wild-type littermates. Scale bars 
represent 200μm in A-B, and 20μm in D-G. Images are representative of at least three embryos per 






Supplementary Fig 4.3 Deletion of Dhrs3 did not alter COUP-TFII expression at early 
stages. 
In situ hybridization of COUP-TF II demonstrated that the early patterning of heart tube was not 
affected by the ablation of Dhrs3. Scale bars represent 500μm. Images are representative of at least three 






Supplementary Fig  4.4 Development of placenta is minimally affected by the ablation of 
Dhrs3.   
Histology of placenta from Dhrs3-/- and wildtype embryos at E13.5 (A vs. C) and E14.5 (B vs. D). 
Analysis of the thickness of labyrinth suggested that mutation of Dhrs3 does not significantly alter the 
development of vascular labyrinth layer (E). Vascularization of placenta was observed to be sufficient in 
both wildtype and mutant embryos, revealed by PECAM1 immunostaining of transversal section of 
placenta. Vessel density was quantified in J and found to be comparable between Dhrs3-/- and wildtype 
embryos. Scale bars in F-I represent 50µm. Images are representative of at least three embryos per 






Supplementary Fig  4.5 Analysis of the development of vessels in the yolk sac at E13.5. 
Vessel morphology was analyzed by whole-mount PECAM1 staining of yolk sac membranes 
collected from Dhrs3-/- and wild-type embryos. The branching pattern and vessel density were compared 
between Dhrs3-/- and wildtype embryos and found to be comparable. Images are representative of three 













Chapter 5 : Conclusions and Future Directions 
Role of DHRS3 in preventing excess formation of RA and embryogenesis  
The indispensability of DHRS3 in RA metabolism during embryogenesis was reported in Chapter 2. 
Based on the expression of RARE-LacZ transgene in Dhrs3+/+ and Dhrs3-/- embryos at various 
developmental stages, the data demonstrated that deficiency of Dhrs3 led to an increased RA signaling in 
mouse embryos as early as E10, and such an increase persisted to E12.5 as well as E14.5 (Chapter 2 and 
(Billings et al., 2013)). Measurement of endogenous retinoids further validated the accumulation of RA in 
Dhrs3-/- embryos at E12.5, which agrees with my lab’s previously published observation of altered RA 
metabolism in E14.5 Dhrs3-/- embryos (Billings et al., 2013). These data collectively support a non-
redundant role of Dhrs3 in RA metabolism in preventing excessive accumulation of RA and RA 
signaling. 
DHRS3 plays critical roles in the development of multiple fetal organs, specifically via regulating RA 
metabolism. Dhrs3-/- embryos die during mid- to late-gestation and were found to possess a spectrum of 
malformations, most of which resembling defects induced by teratogenic doses of RA. During early 
developmental stages, ablation of Dhrs3 disrupted the outgrowth and patterning of hindbrain-derived 
cranial nerves with incomplete penetrance. Similar neuronal defects have been reported previous in 
animals with altered RA signaling due to genetic manipulation or pharmacological treatment. When 
examined at mid-gestation, Dhrs3-null mutant mice were found to show evident subcutaneous edema, 
which indicates cardiac dysfunction and is consistent with previous observation of multiple defects in the 
heart, i.e. DORV, VSD as well as ASD (Billings et al., 2013). A detailed analysis of cardiac development 
was carried out in Chapter 3 and 4. Dhrs3-/- embryos also display skeletal defects including defective 
formation of cervical vertebrae and delayed ossification in the skull as well as rib cage. Importantly, 
treating Dhrs3+/- dam with a vitamin A deficient diet was found to partially correct the defect in cervical 
vertebrae as well as ossification process. A prolonged VAD treatment successfully corrected most of the 
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congenital defects in Dhrs3-/- embryos and rescued the embryonically lethal Dhrs3-null mice to fully 
grown adults with normal growth rate. These results, together with our lab’s previous observations made 
at E14.5, consistently support that DHRS3 is physiologically important for normal embryogenesis due to 
its critical role in preventing the formation of excess RA (Billings et al., 2013). This finding would not 
only enrich the current understanding of the molecular mechanisms regulating RA metabolism, but also 
be relevant in the case of patients who present symptoms as a result of Dhrs3 mutation. 
Roles of RA in regulating the migration of epicardial cell  
Studies presented in Chapter 3 focus on understanding the biological functions of RA in the 
epicardium and migrating EPDCs. Though the major synthetic enzyme of RA, i.e. RALDH2, is 
exclusively expressed in the epicardium and has been widely used as an epicardial marker, the 
physiological roles played by RA in epicardial cells remains an important, yet, unsolved question. In the 
current dissertation, multiple in vivo and in vitro models were employed to address this question. In both 
primary epicardial explant culture and MEC1 cell line, inhibition of RA synthesis greatly attenuated 
PDGFBB-induced phenotypes associated with EMT such as loss of epithelial characteristics and 
polymerization of F-actin. Deficiency of RA signaling also disrupted the assembly of focal adhesion 
junctions and the formation of filopodia that are essential components of remodeling cytoskeleton and are 
indispensable for cellular movement. As a result of the failure in cytoskeletal reorganization, epicardial 
cells that are deficient in RA migrated poorly, which further demonstrated that RA is functionally 
required for the EMT of epicardial cells. Activation of RA signaling in epicardial cells in vitro induced a 
series of morphological changes that are directly linked with elevated EMT, such as accumulation of 
stress fibers, formation of filopodia and the loss of expression of epithelial markers. The conclusion of 
RA being able to facilitate the cytoskeletal rearrangement and the epicardial EMT was further supported 
by data derived from in vivo models. Epicardial cells experiencing high RA signaling migrated deeper 
into the myocardium in Dhrs3-/- embryos whereas those in RA deficient environment move slower in 
WIN-treated embryos. Consistent observations derived from complementary models of RA signaling, 
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establish that epicardial RA signaling affects epicardial EMT through modulating cytoskeletal actin 
remodeling. The influence of RA signaling on the delamination of EPDCs from the epicardium and their 
migration is represented in Figure 5.1. 
Further molecular analysis argues that RA signaling primes cytoskeleton remodeling in epicardial 
cells through the RhoA-ROCK pathway. RhoA and its downstream effectors have been well-established 
as classic modulators of cytoskeletal actin in the event of EMT (Amano et al., 1997; Maekawa et al., 
1999). Activation of the RhoA pathway leads to the formation of stress fiber, filopodia and lamellipodia, 
which was also observed in epicardial cells with elevated RA signaling (Amano et al., 1997). Upon more 
in-depth studies, we not only noted that up-regulation of RA signaling potently induced the binding of 
GTP to RhoA but we also noted that RA signaling potently induced the expression of numerous RhoA 
effectors, whose roles are directly linked with the EMT and the remodeling of the cytoskeleton. 
Specifically, within these altered RhoA effectors, ROCK2 and RND3 were previously reported to be 
potential RA direct target genes due to the identification of RARE in the promoter regions of these gene 
(Delacroix et al., 2010; E. Moutier et al., 2012). To further identify epicardial expressed RA target genes 
that that involved in the RhoA pathway and/or epicardial EMT, future studies employing chromatin-
immunoprecipitation based techniques are warranted. 
Interestingly, activation of RA in MEC1 cells was observed to induce cell differentiation 
preferentially towards VSMCs over fibroblasts. In response to treatment of RAR agonist, several mature 
VSMC markers were highly induced meanwhile the expression of collagens was suppressed in RA-
treated MEC1 cells. However, inhibition of RA signaling was previously reported to enhance the 
differentiation of proepicardial cells into VSMC and Braitsch et al. proposed that RA suppresses VSMC 
differentiation via inducing Tcf21, which favors differentiation towards fibroblasts (Azambuja et al., 
2010; C. M. Braitsch, M. D. Combs, S. E. Quaggin, & K. E. Yutzey, 2012). The discrepancy between our 
observations and the previous reports might be explained by the difference in the types of progenitors 
found in the proepicardium versus epicardium. The proepicardium is a heterogenous progenitor pool that 
155 
 
gives rise to the epicardium and multiple other cell lineages that collectively facilitate the late cardiogenic 
events (Carmona et al., 2010; Katz et al., 2012; Perez-Pomares & de la Pompa, 2011). Cells isolated from 
these two tissues do not necessarily behave completely the same: proepicardial cells migrate as a sheet (in 
chick) or as a cluster of epithelial cells (in mouse) to the myocardium whereas the epicardial cells 
transform into mesenchymal cells and delaminate individually into the myocardium (Reese, Mikawa, & 
Bader, 2002). Though the epicardium develops from the proepicardium, the epicardial cells may not 
follow exactly the same morphogenic signals. To fully address the question about the roles of RA in 
epicardial differentiation, future studies should be carried out to determine if proepicardial cells and 
epicardial cells respond similarly to the same level of RA signaling and more importantly, to test the 
effect of RA in VSMC/fibroblast differentiation in more physiological settings.  
Lastly, a transcriptomic approach revealed potential interaction of RA signaling with 
developmentally important pathways in epicardial cells. Several developmentally important signaling 
pathways were identified as RA-responsive, including IGF and Hippo signaling pathways. These data 
suggest additional molecular mechanisms of regulation of epicardial cell behavior, and subsequent 
epicardial-regulated cardiogenic events, by RA. It would be highly informative and interesting if future 
studies could combine models deficient in signaling of, for example Hippo pathways, with RA 
deficiency/excess models to gain an more in-depth understanding of the molecular regulatory mechanism 
of cardiogenesis. 
Role of RA in the development of coronary vessels 
Congenital heart diseases (CHDs) are some of the most common causes of embryonic or newborn 
lethality (Hoffman, 1995). Among the maternal risk factors of CHDs one is the fetal excess or deficiency 
of vitamin A (Lammer et al., 1985). As a critical signaling molecule, RA has been known to regulate 
early cardiogenesis with evidence reported by numerous excellent studies (reviewed in (Stéphane Zaffran, 
Robrini, & Bertrand, 2014)). However, the exact involvement and the regulatory functions of RA in heart 
maturation remain elusive, hindering the progress in understanding the mechanisms underlying the 
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teratology of RA. In the current study, I employed novel mouse models that allowed for the investigation 
of the role of RA signaling in the late developmental stages of the heart. 
Results presented in Chapter 4 demonstrate the importance of proper levels of RA signaling in 
coronary vessel formation and are depicted in Figure 5.1. The establishment of coronary vasculature is 
highly sensitive to changes in the microenvironment of the heart and perturbations of RA signaling have 
been observed to be related to defects in coronary vessel formation (S. C. Lin et al., 2010; Merki et al., 
2005). When RA synthesis is inhibited only during mid-gestation, the formation of coronary vessel 
hierarchy was evidently compromised, shown as a lack of major vascular branches and tightly restrained 
vascular calibers (Chapter 4). In the opposite model, excess RA signaling in Dhrs3-/- embryos severely 
impairs vessel budding and branching, rendering the coronary vessels ubiquitously enlarged and lack of 
proper structure. Since the formation of coronary vessels requires molecular guidance and signaling cues 
from various tissues, it would be important to understand the spatial and temporal distribution of 
endogenous RA signaling in terms of both vasculogenesis and angiogenesis and by examining both the 
angiogenic environment and cellular components of the developing coronary vasculature.  
Failure of remodeling the endothelial network in both RA excess and RA deficiency models is further 
accompanied with a lack of perivascular supporting cells, which may acerbate the existing vascular 
defects. The interaction between immature endothelial cells and perivascular supporting cells in both 
models with coronary defects needs further investigation. Based on the current data it is not entirely clear 
if the vascular defects seen in the case of altered RA signaling are attributable to either defects in the 
formation of the primary endothelial plexus or due to remodeling defects related to the lack of 
perivascular cells. In addition, as reported both here and elsewhere, RA affects the arteriovenous identity 
of coronary vessels with a preference towards venous characteristics. However, COUP-TFII staining at 
E10.5 revealed no changes in inflow/outflow partitioning. To understand the effect of RA on vascular 
identity it would require a more detailed molecular analysis utilizing various atrial or venous markers and 
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genes that have been found to be involved in arteriovenous decision can be screened for RA downstream 
target genes in regulating coronary vessel formation. 
Besides the direct influence of altered RA signaling on endothelial cells/perivascular cells, another 
possible cause of coronary defects could be a defect in epicardial-derived developmental signaling 
pathways. One of the most affected is the hypoxia-related pathway in response to elevated RA signaling 
in the epicardial cells. Hif1α signaling, as well as genes that were previously identified to be hypoxia-
responsive, was broadly down-regulated by the activation of RA signaling in epicardial cells. A 
physiologically hypoxic environment is critical for the proper development of vessels and embryonic 
growth (Nanka, Valasek, Dvorakova, & Grim, 2006; Patterson & Zhang, 2010; Ream et al., 2008). Thus, 
perturbation of hypoxia-related signaling pathways could be a contributing factor to the defective 
angiogenesis and thin myocardium seen in the Dhrs3-/- embryos. Another possibility is the SRF signaling 
pathway that is highly up-regulated by RA signaling. SRF pathway actively participates and is required in 
multiple aspects of cardiogenesis including the epicardial EMT, coronary vessel development as well as 
cardiomyocyte proliferation (Parlakian et al., 2004; Trembley et al., 2015). Over-activation of the SRF a 
pathway by RA might disrupt the physiological homeostasis of signaling network which orchestrates the 
various processes of heart maturation. Though the causal relationship between abnormally altered 
hypoxia or SRF-signaling pathways and defective heart development in Dhrs3-/- and WIN-models remain 
to be tested in in vivo settings, these interesting observations provide clues of how RA modulates 
epicardial-dependent cardiogenic events and might contribute to the mechanisms of the teratology of RA 
during heart maturation.  
Role of RA in the development of myocardium 
Concomitant with coronary defects are ventricular hypoplasia in response to perturbation of normal RA 
signaling in the heart. In both in vivo models of RA deficiency and RA excess, the ventricular 
myocardium was observed to be critically thin (Chapter 4 and (S.-C. Lin et al., 2010)). The fact that both 
excess and deficiency of RA results in a similar range of congenital defects has been previously 
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documented and discussed, yet the mechanism remains elusive (Billings et al., 2013; Davis & Sadler, 
1981; Frenz et al., 2010; Lee et al., 2012; A. Rydeen et al., 2015). In the case of the thin myocardium 
seen in Dhrs3-/- and WIN models, poor vascular nourishment resulting from malformations in coronary 
vessels observed in both models could be one plausible explanation for these co-occurring phenotype (S. 
C. Lin et al., 2010; Merki et al., 2005; Olivey & Svensson, 2010). First, it would be important to establish 
that the connection between the coronary vasculature and the aorta is properly established in the Dhrs3-/- 
and WIN models. Further studies focusing on the levels of hypoxia in the myocardium of the Dhrs3-/- and 
WIN models could also help us understand whether the thin myocardium is caused by the poor 
vascularization. 
Another possible cause of the thin myocardium in response to altered RA signaling could be related to 
changes in the secretion of RA-dependent epicardial-derived trophic factors. Numerous studies have 
demonstrated that RA stimulates the epicardium to produce peptide-based molecule(s) that can boost 
cardiomyocyte proliferation (T. Brade et al., 2011; T. Chen et al., 2002; I. Stuckmann, S. Evans, & A. B. 
Lassar, 2003). Our RNA-seq analysis revealed cardiogenic-relevant transcriptomic changes in ventricular 
epicardial cells (MEC1) in response to activation of RA signaling. For example, RA caused the up-
regulation of FGF signaling and inhibition of IGF pathway (Chapter 4). FGF as well as IGF proteins have 
been previously identified to be epicardial-derived trophic factors involved in boosting cardiomyocyte 
proliferation (K. J. Lavine et al., 2005; P. Li et al., 2011). The expression of several FGF proteins, 
including FGF2 and FGF9, were positively related to RA signaling and, thus, could account for the 
myocardial thinning seen in the WIN-treated model. Surprisingly, expression of IGFs, especially IGF2, 
was found to be dramatically down-regulated by RA signaling (Chapter 4). Elevated RA signaling also 
strongly induced the expression of IGF binding protein 1 (IGFBP1) in Dhrs3-/- embryos, revealed by 
microarray analysis. IGF2 is required for cardiomyocyte proliferation and has been proposed as a critical 
epicardial-derived trophic factor in the myocardial development (T. Brade et al., 2011; Y. Huang et al., 
2013). Changes in the expression of these previously identified trophic factors might contribute 
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considerably to the defective myocardial compact zone morphogenesis seen in the Dhrs3-/- and WIN 
models. However, the involvement and the precise roles of FGF and IGF pathways in RA-induced 
cardiac malformations require further studies. Furthermore, as mentioned above, hypoxia-related genes 
were seen to be down-regulated in the presence of an RAR agonist. Hypoxia was found to be 
indispensable for the proliferation of embryonic cardiomyocytes and suppression of hypoxia-induces 
transcriptional responses in the heart by altered RA signaling may be a cause of the defective myocardial 
growth (Guimarães-Camboa et al., 2015).  
Potential roles of RA in the post-injury heart regeneration 
Heart is one of the least regenerative organs in adult mammals, in contrast to the robust 
cardioregenerative potential of zebrafish and neonatal mouse models. Studying what makes the latter 
models successful in recovering cardiac function could provide a fruitful roadmap to discovering new 
treatments for myocardial infarction/injury(K. Kikuchi et al., 2011; Poss, Wilson, & Keating, 2002). 
Hearts of zebrafish and neonatal mice form fully a functional myocardium and vasculature in the injured 
area instead of forming a fibrotic scar as observed in adult mammals. Interestingly enough, the 
regenerative capacity of neonatal mice is rapidly lost after a week of postnatal life, which is consistent 
with the observation that human infants have the highest potential to recover cardiac functions from 
surgery early rather than later (Michielon et al., 2003). An increasing number of studies have started to 
adopt neonatal mice as models to understand the mechanism underlying heart regeneration due to the 
clinical relevance of this mammalian model suggested by its similarity in loss of regenerative capacity to 
human cases. 
It is believed that by re-activating the developmentally important pathways that govern the heart 
maturation, adult zebrafish hearts may revisit embryonic growth and thus accelerate their recovery. Work 
in zebrafish model indicated that the post-injury heart regeneration program involves reactivation of the 
epicardial markers (Wt1, Tbx18 and Raldh2), cardiomyocyte proliferation and revascularization of newly 
formed myocardium, which largely recapitulates the late development of the heart (Marin-Juez et al., 
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2016; Masters & Riley, 2014). Relevant to our work, synthesis of RA via RALDH2 is significantly 
elevated in the epicardium of non-regenerative adult mouse hearts but such an increase was found to be in 
both endocardium and epicardium of regenerative zebrafish hearts (D. Bilbija et al., 2012; K. Kikuchi et 
al., 2011). Since mammals do not express RA synthetic enzymes in the endocardium it might interesting 
to conditionally overexpress Raldh2 in adult mouse endocardium and explore the biological consequences 
of elevation of endocardial RA production in a mouse myocardial infarction model. As RA signaling is 
activated in post-injury hearts of both neonatal (capable of cardioregeneration) and adult mouse hearts 
(not capable of cardioregeneration), a future comprehensive comparison of the targets and distribution of 
RA signaling between these two developmental stages models would be a good starting point in 
deciphering the roles of RA during wound healing in adult mouse hearts. Considering RA signaling 
appears to be activated but ineffectively so in the post-injury hearts of adult mice, this knowledge would 
also be beneficial for the studies aiming at accelerating tissue recovery in wounded adult hearts. 
It remains unclear if activated epicardial cells delaminate and migrate into the wounded area and if 
so, whether such a migration follows similar developmental signaling pathways. In the regenerative 
hearts of zebrafish, the activated epicardium gives rise to migratory EPDCs via EMT and those EPDCs 
were observed to invade into the wounded area and contribute to endothelial cells and perivascular cells 
(Lepilina et al., 2006). In adult mice however, activation of epicardium only induces thickening of 
epicardium in adult mice, as reported by Zhou et al.(B. Zhou et al., 2011). Interestingly, in neonatal mice, 
heart injury leads to activation of Wnt pathway and infiltration of migratory EPDCs in the subepicardial 
space (Mizutani, Wu, & Nusse, 2016). Based on these data, it is reasonable to speculate that the increased 
regenerative capacity is associated with increased EPDC formation and migration. This observation needs 
to be validated in models by investigating the level of heart regeneration when epicardial EMT is 
blocked. Based on data presented in Chapter 3 in this dissertation, RA is found to regulate cytoskeleton 
remodeling and migration of EPDCs during embryonic development. Since activation of RA signaling 
along in the adult mouse heart is not associated with increased EPDC formation or migration (B. Zhou et 
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al., 2011), it would be interesting to investigate 1) if RA plays conserved role in epicardial EMT during 
heart regeneration in neonatal mice as it does in embryogenesis; and 2) if RA can potentiate the pro-
migratory effects of other EMT inducers on EPDCs in the adult heart. Aside from the epicardial EMT, it 
is clear that both injury response and regenerative response includes the secretion of epicardial derived 
signaling molecules but the composition of epicardial secretome remains unclear (Masters & Riley, 2014; 
Raya et al., 2003; B. Zhou et al., 2011). Through the implementation of system biology approaches we 
can envision a discovery process based on studying the success of the highly regenerative zebrafish or 
neonatal mouse models, or the differences between epicardial cells from regenerative and non-
regenerative hearts. RNAseq analysis of MEC1 cells treated with RAR agonist suggested that activation 
of RA signaling affects multiple developmentally important pathways, several of which have been found 
to be critically involved in heart regeneration program. For example, Hippo pathway was found to impede 
heart regeneration and is revealed by RNAseq data presented here to be highly activated by RA in MEC1 
cells. This link of Hippo pathway and RA signaling pathway should be emphasized in the future and 
needs to be investigated in depth (Heallen et al., 2013).  
In summary, this dissertation provides new insight into the teratology of RA by revealing novel roles 
of RA in the formation of coronary vasculature and the myocardial growth during the late development of 
the heart. Results presented here show indispensable roles for RA in regulating the intramyocardial 
migration of epicardial cells. A better understanding of the regulatory functions of RA in epicardial EMT, 
coronary vessel formation and cardiomyocyte proliferation during embryogenesis can shed light into 
future studies of post-injury heart regeneration in adulthood and contribute to the identification of novel 





Figure 5.1 Conclusion of roles of RA in late heart development. 
During normal embryogenesis, mesenchymal EPDCs delaminate from the epicardium and migrate to 
support the maturation of coronary vasculature. Epicardium also functions to support the growth and 
compaction of myocardium. RA promotes the loss of epithelial characteristics and regulates cytoskeletal 
rearrangement in epicardial cells, thus facilitating the migration of EPDCs. Status of RA correlates with 
the caliber of intramyocardial vessels, and aberrant RA signaling disrupts vascular hierarchy. Consistent 
with the development of coronary vessels, the thickening of ventricular myocardium is also sensitive to 
alterations in RA signaling. Paradoxically, excess or deficiency in RA can result in hypoplastic 
myocardium in mouse embryos. In addition, RA signaling regulates the recruitment of VSMCs to 
immature endothelia in coronary vessels, as well as the differentiation of mature perivascular cells. 





Abu-Abed, S., Dolle, P., Metzger, D., Beckett, B., Chambon, P., & Petkovich, M. (2001). The retinoic 
acid-metabolizing enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral 
identity, and development of posterior structures. Genes Dev, 15(2), 226-240.  
Abu-Abed, Suzan, Dollé, Pascal, Metzger, Daniel, Beckett, Barbara, Chambon, Pierre, & Petkovich, 
Martin. (2001). The retinoic acid-metabolizing enzyme, CYP26A1, is essential for normal 
hindbrain patterning, vertebral identity, and development of posterior structures. Genes & 
Development, 15(2), 226-240. doi: 10.1101/gad.855001 
Abu-Abed, Suzan S., Beckett, Barbara R., Chiba, Hideki, Chithalen, James V., Jones, Glenville, Metzger, 
Daniel, . . . Petkovich, Martin. (1998). Mouse P450RAI (CYP26) Expression and Retinoic Acid-
inducible Retinoic Acid Metabolism in F9 Cells Are Regulated by Retinoic Acid Receptor γ and 
Retinoid X Receptor α. Journal of Biological Chemistry, 273(4), 2409-2415. doi: 
10.1074/jbc.273.4.2409 
Abu-Issa, Radwan, Smyth, Graham, Smoak, Ida, Yamamura, Ken-ichi, & Meyers, Erik N. (2002). Fgf8 is 
required for pharyngeal arch and cardiovascular development in the mouse. Development, 
129(19), 4613-4625.  
Acharya, A., Baek, S. T., Huang, G., Eskiocak, B., Goetsch, S., Sung, C. Y., . . . Tallquist, M. D. (2012). 
The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast 
progenitors. Development, 139(12), 2139-2149. doi: 10.1242/dev.079970 
Ackermans, M. M., Zhou, H., Carels, C. E., Wagener, F. A., & Von den Hoff, J. W. (2011). Vitamin A 
and clefting: putative biological mechanisms. Nutr Rev, 69(10), 613-624. doi: 10.1111/j.1753-
4887.2011.00425.x 
Adams, M. K., Belyaeva, O. V., Wu, L., & Kedishvili, N. Y. (2014). The retinaldehyde reductase activity 
of DHRS3 is reciprocally activated by retinol dehydrogenase 10 to control retinoid homeostasis. J 
Biol Chem, 289(21), 14868-14880. doi: 10.1074/jbc.M114.552257 
164 
 
Agarwal, P., Wylie, J. N., Galceran, J., Arkhitko, O., Li, C., Deng, C., . . . Bruneau, B. G. (2003). Tbx5 is 
essential for forelimb bud initiation following patterning of the limb field in the mouse embryo. 
Development, 130(3), 623-633.  
Alapatt, P., Guo, F., Komanetsky, S. M., Wang, S., Cai, J., Sargsyan, A., . . . Graham, T. E. (2013). Liver 
retinol transporter and receptor for serum retinol-binding protein (RBP4). J Biol Chem, 288(2), 
1250-1265. doi: 10.1074/jbc.M112.369132 
Amano, M., Chihara, K., Kimura, K., Fukata, Y., Nakamura, N., Matsuura, Y., & Kaibuchi, K. (1997). 
Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science, 275(5304), 
1308-1311.  
Arnold, S. L., Kent, T., Hogarth, C. A., Griswold, M. D., Amory, J. K., & Isoherranen, N. (2015). 
Pharmacological inhibition of ALDH1A in mice decreases all-trans retinoic acid concentrations 
in a tissue specific manner. Biochem Pharmacol, 95(3), 177-192. doi: 10.1016/j.bcp.2015.03.001 
Artamonov, M. V., Jin, L., Franke, A. S., Momotani, K., Ho, R., Dong, X. R., . . . Somlyo, A. V. (2015). 
Signaling pathways that control rho kinase activity maintain the embryonic epicardial progenitor 
state. J Biol Chem, 290(16), 10353-10367. doi: 10.1074/jbc.M114.613190 
Austin, Anita F., Compton, Leigh A., Love, Joseph D., Brown, Christopher B., & Barnett, Joey V. 
(2008). Primary and immortalized mouse epicardial cells undergo differentiation in response to 
TGFβ. Developmental Dynamics, 237(2), 366-376. doi: 10.1002/dvdy.21421 
Azambuja, A. P., Portillo-Sanchez, V., Rodrigues, M. V., Omae, S. V., Schechtman, D., Strauss, B. E., . . 
. Xavier-Neto, J. (2010). Retinoic acid and VEGF delay smooth muscle relative to endothelial 
differentiation to coordinate inner and outer coronary vessel wall morphogenesis. Circ Res, 
107(2), 204-216. doi: 10.1161/CIRCRESAHA.109.214650 
Båvik, C., Ward, S. J., & Chambon, P. (1996). Developmental abnormalities in cultured mouse embryos 
deprived of retinoic by inhibition of yolk-sac retinol binding protein synthesis. Proceedings of the 
National Academy of Sciences of the United States of America, 93(7), 3110-3114.  
165 
 
Bax, N. A., Bleyl, S. B., Gallini, R., Wisse, L. J., Hunter, J., Van Oorschot, A. A., . . . Gittenberger-de 
Groot, A. C. (2010). Cardiac malformations in Pdgfralpha mutant embryos are associated with 
increased expression of WT1 and Nkx2.5 in the second heart field. Dev Dyn, 239(8), 2307-2317. 
doi: 10.1002/dvdy.22363 
Beard, R. L., Chandraratna, R. A., Colon, D. F., Gillett, S. J., Henry, E., Marler, D. K., . . . et al. (1995). 
Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with 
heteroaromatic carboxylic acids. J Med Chem, 38(15), 2820-2829.  
Berry, D. C., Jacobs, H., Marwarha, G., Gely-Pernot, A., O'Byrne, S. M., DeSantis, D., . . . Ghyselinck, 
N. B. (2013). The STRA6 receptor is essential for retinol-binding protein-induced insulin 
resistance but not for maintaining vitamin A homeostasis in tissues other than the eye. J Biol 
Chem, 288(34), 24528-24539. doi: 10.1074/jbc.M113.484014 
Bertrand, N., Roux, M., Ryckebusch, L., Niederreither, K., Dolle, P., Moon, A., . . . Zaffran, S. (2011). 
Hox genes define distinct progenitor sub-domains within the second heart field. Dev Biol, 353(2), 
266-274. doi: 10.1016/j.ydbio.2011.02.029 
Biesalski, H. K., Frank, J., Beck, S. C., Heinrich, F., Illek, B., Reifen, R., . . . Zrenner, E. (1999). 
Biochemical but not clinical vitamin A deficiency results from mutations in the gene for retinol 
binding protein. Am J Clin Nutr, 69(5), 931-936.  
Bilbija, D., Haugen, F., Sagave, J., Baysa, A., Bastani, N., Levy, F. O., . . . Valen, G. (2012). Retinoic 
acid signalling is activated in the postischemic heart and may influence remodelling. PLoS One, 
7(9), e44740. doi: 10.1371/journal.pone.0044740 
Bilbija, Dusan, Haugen, Fred, Sagave, Julia, Baysa, Anton, Bastani, Nasser, Levy, Finn Olav, . . . Valen, 
Guro. (2012). Retinoic Acid Signalling Is Activated in the Postischemic Heart and May Influence 
Remodelling. PLoS ONE, 7(9), e44740. doi: 10.1371/journal.pone.0044740 
Billings, S. E., Pierzchalski, K., Butler Tjaden, N. E., Pang, X. Y., Trainor, P. A., Kane, M. A., & Moise, 
A. R. (2013). The retinaldehyde reductase DHRS3 is essential for preventing the formation of 
166 
 
excess retinoic acid during embryonic development. FASEB J, 27(12), 4877-4889. doi: 
10.1096/fj.13-227967 
Binder, M. (1985). The teratogenic effects of a bis(dichloroacetyl)diamine on hamster embryos. Aortic 
arch anomalies and the pathogenesis of the DiGeorge syndrome. Am J Pathol, 118(2), 179-193.  
Bouillet, Philippe, Sapin, Vincent, Chazaud, Claire, Messaddeq, Nadia, Décimo, Didier, Dollé, Pascal, & 
Chambon, Pierre. (1997). Developmental expression pattern of Stra6, a retinoic acid-responsive 
gene encoding a new type of membrane protein. Mechanisms of Development, 63(2), 173-186. 
doi: http://dx.doi.org/10.1016/S0925-4773(97)00039-7 
Brade, T., Kumar, S., Cunningham, T. J., Chatzi, C., Zhao, X., Cavallero, S., . . . Duester, G. (2011). 
Retinoic acid stimulates myocardial expansion by induction of hepatic erythropoietin which 
activates epicardial Igf2. Development, 138(1), 139-148. doi: 10.1242/dev.054239 
Brade, Thomas, Kumar, Sandeep, Cunningham, Thomas J., Chatzi, Christina, Zhao, Xianling, Cavallero, 
Susana, . . . Duester, Gregg. (2011). Retinoic acid stimulates myocardial expansion by induction 
of hepatic erythropoietin which activates epicardial Igf2. Development (Cambridge, England), 
138(1), 139-148. doi: 10.1242/dev.054239 
Braitsch, C. M., Combs, M. D., Quaggin, S. E., & Yutzey, K. E. (2012). Pod1/Tcf21 is regulated by 
retinoic acid signaling and inhibits differentiation of epicardium-derived cells into smooth muscle 
in the developing heart. Dev Biol, 368(2), 345-357. doi: 10.1016/j.ydbio.2012.06.002 
Braitsch, Caitlin M., Combs, Michelle D., Quaggin, Susan E., & Yutzey, Katherine E. (2012). 
Pod1/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardium-
derived cells into smooth muscle in the developing heart. Developmental Biology, 368(2), 345-
357. doi: http://dx.doi.org/10.1016/j.ydbio.2012.06.002 
Bruneau, B. G. (2008). The developmental genetics of congenital heart disease. Nature, 451(7181), 943-
948. doi: 10.1038/nature06801 
167 
 
Bruneau, B. G., Logan, M., Davis, N., Levi, T., Tabin, C. J., Seidman, J. G., & Seidman, C. E. (1999). 
Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. Dev 
Biol, 211(1), 100-108. doi: 10.1006/dbio.1999.9298 
Cai, C. L., Liang, X., Shi, Y., Chu, P. H., Pfaff, S. L., Chen, J., & Evans, S. (2003). Isl1 identifies a 
cardiac progenitor population that proliferates prior to differentiation and contributes a majority 
of cells to the heart. Dev Cell, 5(6), 877-889.  
Cai, C. L., Martin, J. C., Sun, Y., Cui, L., Wang, L., Ouyang, K., . . . Evans, S. M. (2008). A myocardial 
lineage derives from Tbx18 epicardial cells. Nature, 454(7200), 104-108. doi: 
10.1038/nature06969 
Calmont, A., Ivins, S., Van Bueren, K. L., Papangeli, I., Kyriakopoulou, V., Andrews, W. D., . . . 
Scambler, P. J. (2009). Tbx1 controls cardiac neural crest cell migration during arch artery 
development by regulating Gbx2 expression in the pharyngeal ectoderm. Development, 136(18), 
3173-3183. doi: 10.1242/dev.028902 
Cano, Elena, Carmona, Rita, Ruiz-Villalba, Adrián, Rojas, Anabel, Chau, You-Ying, Wagner, Kay D., . . 
. Pérez-Pomares, José M. (2016). Extracardiac septum transversum/proepicardial endothelial cells 
pattern embryonic coronary arterio–venous connections. Proceedings of the National Academy of 
Sciences, 113(3), 656-661. doi: 10.1073/pnas.1509834113 
Carmona, R., Guadix, J. A., Cano, E., Ruiz-Villalba, A., Portillo-Sanchez, V., Perez-Pomares, J. M., & 
Munoz-Chapuli, R. (2010). The embryonic epicardium: an essential element of cardiac 
development. J Cell Mol Med, 14(8), 2066-2072. doi: 10.1111/j.1582-4934.2010.01088.x 
Chablais, F., & Jazwinska, A. (2012). The regenerative capacity of the zebrafish heart is dependent on 
TGFbeta signaling. Development, 139(11), 1921-1930. doi: 10.1242/dev.078543 
Chanda, B., Ditadi, A., Iscove, N. N., & Keller, G. (2013). Retinoic acid signaling is essential for 




Chapman, D. L., Garvey, N., Hancock, S., Alexiou, M., Agulnik, S. I., Gibson-Brown, J. J., . . . 
Papaioannou, V. E. (1996). Expression of the T-box family genes, Tbx1-Tbx5, during early 
mouse development. Dev Dyn, 206(4), 379-390. doi: 10.1002/(sici)1097-
0177(199608)206:4<379::aid-aja4>3.0.co;2-f 
Chawla, B., Schley, E., Williams, A. L., & Bohnsack, B. L. (2016). Retinoic Acid and Pitx2 Regulate 
Early Neural Crest Survival and Migration in Craniofacial and Ocular Development. Birth 
Defects Res B Dev Reprod Toxicol, 107(3), 126-135. doi: 10.1002/bdrb.21177 
Chazaud, C., Chambon, P., & Dolle, P. (1999). Retinoic acid is required in the mouse embryo for left-
right asymmetry determination and heart morphogenesis. Development, 126(12), 2589-2596.  
Chen, F., Marquez, H., Kim, Y. K., Qian, J., Shao, F., Fine, A., . . . Cardoso, W. V. (2014). Prenatal 
retinoid deficiency leads to airway hyperresponsiveness in adult mice. J Clin Invest, 124(2), 801-
811. doi: 10.1172/JCI70291 
Chen, Felicia, Marquez, Hector, Kim, Youn-Kyung, Qian, Jun, Shao, Fengzhi, Fine, Alan, . . . Cardoso, 
Wellington V. (2014). Prenatal retinoid deficiency leads to airway hyperresponsiveness in adult 
mice. The Journal of Clinical Investigation, 124(2), 801-811. doi: 10.1172/JCI70291 
Chen, J., Kubalak, S. W., & Chien, K. R. (1998). Ventricular muscle-restricted targeting of the RXRalpha 
gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. 
Development, 125(10), 1943.  
Chen, N., & Napoli, J. L. (2008). All-trans-retinoic acid stimulates translation and induces spine 
formation in hippocampal neurons through a membrane-associated RARalpha. FASEB J, 22(1), 
236-245. doi: 10.1096/fj.07-8739com 
Chen, T., Chang, T. C., Kang, J. O., Choudhary, B., Makita, T., Tran, C. M., . . . Sucov, H. M. (2002). 
Epicardial induction of fetal cardiomyocyte proliferation via a retinoic acid-inducible trophic 
factor. Dev Biol, 250(1), 198-207.  
169 
 
Chou, C. M., Nelson, C., Tarle, S. A., Pribila, J. T., Bardakjian, T., Woods, S., . . . Glaser, T. (2015). 
Biochemical Basis for Dominant Inheritance, Variable Penetrance, and Maternal Effects in RBP4 
Congenital Eye Disease. Cell, 161(3), 634-646. doi: 10.1016/j.cell.2015.03.006 
Christoffels, Vincent M, Grieskamp, Thomas, Norden, Julia, Mommersteeg, Mathilda TM, Rudat, 
Carsten, & Kispert, Andreas. (2009). Tbx18 and the fate of epicardial progenitors. Nature, 
458(7240), E8-E9.  
Clagett-Dame, M., & DeLuca, H. F. (2002). The role of vitamin A in mammalian reproduction and 
embryonic development. Annu Rev Nutr, 22, 347-381. doi: 
10.1146/annurev.nutr.22.010402.102745E 
Collins, Michael D, & Mao, Gloria E. (1999). Teratology of retinoids. Annual review of pharmacology 
and toxicology, 39(1), 399-430.  
Collop, A. H., Broomfield, J. A., Chandraratna, R. A., Yong, Z., Deimling, S. J., Kolker, S. J., . . . 
Drysdale, T. A. (2006). Retinoic acid signaling is essential for formation of the heart tube in 
Xenopus. Dev Biol, 291(1), 96-109. doi: 10.1016/j.ydbio.2005.12.018 
Cordero, Dwight R., Brugmann, Samantha, Chu, Yvonne, Bajpai, Ruchi, Jame, Maryam, & Helms, Jill A. 
(2011). CRANIAL NEURAL CREST CELLS ON THE MOVE: THEIR ROLES IN 
CRANIOFACIAL DEVELOPMENT. American journal of medical genetics. Part A, 155(2), 
270-279. doi: 10.1002/ajmg.a.33702 
Couchman, J. R., & Rees, D. A. (1979). The behaviour of fibroblasts migrating from chick heart explants: 
changes in adhesion, locomotion and growth, and in the distribution of actomyosin and 
fibronectin. J Cell Sci, 39, 149-165.  
Cukras, Catherine, Gaasterland, Terry, Lee, Pauline, Gudiseva, Harini V., Chavali, Venkata R. M., 
Pullakhandam, Raghu, . . . Ayyagari, Radha. (2012). Exome Analysis Identified a Novel 
Mutation in the RBP4 Gene in a Consanguineous Pedigree with Retinal Dystrophy and 
Developmental Abnormalities. PLOS ONE, 7(11), e50205. doi: 10.1371/journal.pone.0050205 
170 
 
D'Aniello, E., & Waxman, J. S. (2014). Input overload: contributions of retinoic acid signaling feedback 
mechanisms to heart development and teratogenesis. Dev Dyn. doi: 10.1002/dvdy.24232 
Davis, L. A., & Sadler, T. W. (1981). Effects of vitamin A on endocardial cushion development in the 
mouse heart. Teratology, 24(2), 139-148. doi: 10.1002/tera.1420240205 
de Paiva, Sergio Alberto Rupp, Zornoff, Leonardo Antonio Mamede, Okoshi, Marina Politi, Okoshi, 
Katashi, Matsubara, Luiz Shiguero, Matsubara, Beatriz Bojikian, . . . Campana, Alvaro Oscar. 
(2003). Ventricular remodeling induced by retinoic acid supplementation in adult rats. American 
Journal of Physiology - Heart and Circulatory Physiology, 284(6), H2242-H2246.  
Delacroix, L., Moutier, E., Altobelli, G., Legras, S., Poch, O., Choukrallah, M. A., . . . Davidson, I. 
(2010). Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic 
fibroblasts and embryonic stem cells. Mol Cell Biol, 30(1), 231-244. doi: 10.1128/MCB.00756-
09 
Deltour, L., Foglio, M. H., & Duester, G. (1999). Metabolic deficiencies in alcohol dehydrogenase Adh1, 
Adh3, and Adh4 null mutant mice. Overlapping roles of Adh1 and Adh4 in ethanol clearance and 
metabolism of retinol to retinoic acid. J Biol Chem, 274(24), 16796-16801.  
Dersch, H., & Zile, M. H. (1993). Induction of normal cardiovascular development in the vitamin A-
deprived quail embryo by natural retinoids. Dev Biol, 160(2), 424-433. doi: 
10.1006/dbio.1993.1318 
Dickman, Eileen D., & Smith, Susan M. (1996). Selective regulation of cardiomyocyte gene expression 
and cardiac morphogenesis by retinoic acid. Developmental Dynamics, 206(1), 39-48. doi: 
10.1002/(SICI)1097-0177(199605)206:1<39::AID-AJA4>3.0.CO;2-1 
Dolle, P. (2009). Developmental expression of retinoic acid receptors (RARs). Nucl Recept Signal, 7, 
e006. doi: 10.1621/nrs.07006 
Dolle, P., Fraulob, V., Gallego-Llamas, J., Vermot, J., & Niederreither, K. (2010). Fate of retinoic acid-
activated embryonic cell lineages. Dev Dyn, 239(12), 3260-3274. doi: 10.1002/dvdy.22479 
171 
 
Dominguez, Melissa G., Hughes, Virginia C., Pan, Li, Simmons, Mary, Daly, Christopher, Anderson, 
Keith, . . . Gale, Nicholas W. (2007). Vascular endothelial tyrosine phosphatase (VE-PTP)-null 
mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. 
Proceedings of the National Academy of Sciences, 104(9), 3243-3248. doi: 
10.1073/pnas.0611510104 
Duim, S. N., Kurakula, K., Goumans, M. J., & Kruithof, B. P. (2015). Cardiac endothelial cells express 
Wilms' tumor-1: Wt1 expression in the developing, adult and infarcted heart. J Mol Cell Cardiol, 
81, 127-135. doi: 10.1016/j.yjmcc.2015.02.007 
Eggenschwiler, Jonathan, Ludwig, Thomas, Fisher, Peter, Leighton, Philip A., Tilghman, Shirley M., & 
Efstratiadis, Argiris. (1997). Mouse mutant embryos overexpressing IGF-II exhibit phenotypic 
features of the Beckwith–Wiedemann and Simpson–Golabi–Behmel syndromes. Genes & 
Development, 11(23), 3128-3142. doi: 10.1101/gad.11.23.3128 
Emoto, Y., Wada, H., Okamoto, H., Kudo, A., & Imai, Y. (2005). Retinoic acid-metabolizing enzyme 
Cyp26a1 is essential for determining territories of hindbrain and spinal cord in zebrafish. Dev 
Biol, 278(2), 415-427. doi: 10.1016/j.ydbio.2004.11.023 
Ericson, J., Rashbass, P., Schedl, A., Brenner-Morton, S., Kawakami, A., van Heyningen, V., . . . Briscoe, 
J. (1997). Pax6 controls progenitor cell identity and neuronal fate in response to graded Shh 
signaling. Cell, 90(1), 169-180. doi: https://doi.org/10.1016/S0092-8674(00)80323-2 
Fang, M., Xiang, F. L., Braitsch, C. M., & Yutzey, K. E. (2016). Epicardium-derived fibroblasts in heart 
development and disease. J Mol Cell Cardiol, 91, 23-27. doi: 10.1016/j.yjmcc.2015.12.019 
Feng, L., Hernandez, R. E., Waxman, J. S., Yelon, D., & Moens, C. B. (2010). Dhrs3a Regulates Retinoic 
Acid Biosynthesis through a Feedback Inhibition Mechanism. Developmental biology, 338(1), 1-
14. doi: 10.1016/j.ydbio.2009.10.029 
Fischer, Andrew H., Jacobson, Kenneth A., Rose, Jack, & Zeller, Rolf. (2008). Hematoxylin and Eosin 




Franco, P. J., Farooqui, M., Seto, E., & Wei, L. N. (2001). The orphan nuclear receptor TR2 interacts 
directly with both class I and class II histone deacetylases. Mol Endocrinol, 15(8), 1318-1328. 
doi: 10.1210/mend.15.8.0682 
Frenz, D. A., Liu, W., Cvekl, A., Xie, Q., Wassef, L., Quadro, L., . . . Shanske, A. (2010). Retinoid 
signaling in inner ear development: A "Goldilocks" phenomenon. Am J Med Genet A, 152A(12), 
2947-2961. doi: 10.1002/ajmg.a.33670 
Fujino, H., Nakagawa, M., Nishijima, S., Okamoto, N., Hanato, T., Watanabe, N., . . . Takeuchi, Y. 
(2005). Morphological differences in cardiovascular anomalies induced by bis-diamine between 
Sprague-Dawley and Wistar rats. Congenit Anom (Kyoto), 45(2), 52-58. doi: 10.1111/j.1741-
4520.2005.00063.x 
Gaengel, K., Genove, G., Armulik, A., & Betsholtz, C. (2009). Endothelial-mural cell signaling in 
vascular development and angiogenesis. Arterioscler Thromb Vasc Biol, 29(5), 630-638. doi: 
10.1161/atvbaha.107.161521 
Gallego, O., Ruiz, F. X., Ardevol, A., Dominguez, M., Alvarez, R., de Lera, A. R., . . . Pares, X. (2007). 
Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker 
AKR1B10. Proc Natl Acad Sci U S A, 104(52), 20764-20769. doi: 10.1073/pnas.0705659105 
Galli, D., Dominguez, J. N., Zaffran, S., Munk, A., Brown, N. A., & Buckingham, M. E. (2008). Atrial 
myocardium derives from the posterior region of the second heart field, which acquires left-right 
identity as Pitx2c is expressed. Development, 135(6), 1157-1167. doi: 10.1242/dev.014563 
Ghatpande, S., Brand, T., Zile, M., & Evans, T. (2006). Bmp2 and Gata4 function additively to rescue 
heart tube development in the absence of retinoids. Dev Dyn, 235(8), 2030-2039. doi: 
10.1002/dvdy.20836 
Ghatpande, Satish K., Zhou, Hui-Ren, Cakstina, Inese, Carlson, Christopher, Rondini, Elizabeth A., 
Romeih, Mahmoud, & Zile, Maija H. (2010). Transforming growth factor β2 is negatively 
regulated by endogenous retinoic acid during early heart morphogenesis. Development, Growth 
& Differentiation, 52(5), 433-455. doi: 10.1111/j.1440-169X.2010.01183.x 
173 
 
Ghyselinck, N. B., Dupe, V., Dierich, A., Messaddeq, N., Garnier, J. M., Rochette-Egly, C., . . . Mark, M. 
(1997). Role of the retinoic acid receptor beta (RARbeta) during mouse development. Int J Dev 
Biol, 41(3), 425-447.  
Ghyselinck, N. B., Wendling, O., Messaddeq, N., Dierich, A., Lampron, C., Decimo, D., . . . Mark, M. 
(1998). Contribution of retinoic acid receptor beta isoforms to the formation of the conotruncal 
septum of the embryonic heart. Dev Biol, 198(2), 303-318.  
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987). Identification of a receptor for the morphogen 
retinoic acid. Nature, 330(6149), 624-629. doi: 10.1038/330624a0 
Giovannone, Dion, Reyes, Michelle, Reyes, Rachel, Correa, Lisa, Martinez, Darwin, Ra, Hannah, . . . de 
Bellard, Maria Elena. (2012). Slits Affect the Timely Migration of Neural Crest Cells via Robo 
Receptor. Developmental dynamics : an official publication of the American Association of 
Anatomists, 241(8), 1274-1288. doi: 10.1002/dvdy.23817 
Gittenberger-de Groot, Adriana C., Vrancken Peeters, Mark-Paul F.M., Mentink, Monica M.T., Gourdie, 
Robert G., & Poelmann, Robert E. (1998). Epicardium-Derived Cells Contribute a Novel 
Population to the Myocardial Wall and the Atrioventricular Cushions. Circulation Research, 
82(10), 1043-1052. doi: 10.1161/01.res.82.10.1043 
Glover, J. C., Renaud, J. S., & Rijli, F. M. (2006). Retinoic acid and hindbrain patterning. J Neurobiol, 
66(7), 705-725. doi: 10.1002/neu.20272 
Grandel, H., Lun, K., Rauch, G. J., Rhinn, M., Piotrowski, T., Houart, C., . . . Brand, M. (2002). Retinoic 
acid signalling in the zebrafish embryo is necessary during pre-segmentation stages to pattern the 
anterior-posterior axis of the CNS and to induce a pectoral fin bud. Development, 129(12), 2851-
2865.  
Grieskamp, Thomas, Rudat, Carsten, Lüdtke, Timo H.-W., Norden, Julia, & Kispert, Andreas. (2011). 
Notch Signaling Regulates Smooth Muscle Differentiation of Epicardium-Derived Cells. 
Circulation Research, 108(7), 813-823. doi: 10.1161/circresaha.110.228809 
174 
 
Guadix, J. A., Ruiz-Villalba, A., Lettice, L., Velecela, V., Munoz-Chapuli, R., Hastie, N. D., . . . 
Martinez-Estrada, O. M. (2011). Wt1 controls retinoic acid signalling in embryonic epicardium 
through transcriptional activation of Raldh2. Development, 138(6), 1093-1097. doi: 
10.1242/dev.044594 
Guadix, Juan A, Carmona, Rita, Muñoz‐Chápuli, Ramón, & Pérez‐Pomares, José M. (2006). In vivo and 
in vitro analysis of the vasculogenic potential of avian proepicardial and epicardial cells†. 
Developmental dynamics, 235(4), 1014-1026.  
Guadix, Juan A., Carmona, Rita, Muñoz-Chápuli, Ramón, & Pérez-Pomares, José M. (2006). In vivo and 
in vitro analysis of the vasculogenic potential of avian proepicardial and epicardial cells†. 
Developmental Dynamics, 235(4), 1014-1026. doi: 10.1002/dvdy.20685 
Guimarães-Camboa, Nuno, Stowe, Jennifer, Aneas, Ivy, Sakabe, Noboru, Cattaneo, Paola, Henderson, 
Lindsay, . . . Zambon, Alexander C. (2015). HIF1α Represses Cell Stress Pathways to Allow 
Proliferation of Hypoxic Fetal Cardiomyocytes. Developmental Cell, 33(5), 507-521. doi: 
https://doi.org/10.1016/j.devcel.2015.04.021 
Haeseleer, F., Huang, J., Lebioda, L., Saari, J. C., & Palczewski, K. (1998). Molecular characterization of 
a novel short-chain dehydrogenase/reductase that reduces all-trans-retinal. J Biol Chem, 273(34), 
21790-21799.  
Hale, Fred. (1937). The relation of maternal vitamin A deficiency to microphthalmia in pigs. Texas State 
Journal of Medicine, 33, 228-232.  
Hanato, T., Nakagawa, M., Okamoto, N., Nishijima, S., Fujino, H., Shimada, M., . . . Imanaka-Yoshida, 
K. (2011). Developmental defects of coronary vasculature in rat embryos administered bis-
diamine. Birth Defects Res B Dev Reprod Toxicol, 92(1), 10-16. doi: 10.1002/bdrb.20279 
Heallen, T., Morikawa, Y., Leach, J., Tao, G., Willerson, J. T., Johnson, R. L., & Martin, J. F. (2013). 




Hector, A. Marquez, Felicia, Chen, Yuxia, Cao, & Wellington, V. Cardoso. (2013). Regulation Of 
Airway Smooth Muscle Differentiation By Retinoic Acid In The Developing Lung C69. 
PATHWAYS TO LUNG DEVELOPMENT AND DISEASE (pp. A4776-A4776): American 
Thoracic Society. 
Heine, U. I., Roberts, A. B., Munoz, E. F., Roche, N. S., & Sporn, M. B. (1985). Effects of retinoid 
deficiency on the development of the heart and vascular system of the quail embryo. Virchows 
Arch B Cell Pathol Incl Mol Pathol, 50(2), 135-152.  
Heller, C. G., Moore, D. J., & Paulsen, C. A. (1961). Suppression of spermatogenesis and chronic toxicity 
in men by a new series of bis(dichloroacetyl) diamines. Toxicol Appl Pharmacol, 3, 1-11.  
Hellstrom, M., Gerhardt, H., Kalen, M., Li, X., Eriksson, U., Wolburg, H., & Betsholtz, C. (2001). Lack 
of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J Cell Biol, 
153(3), 543-553.  
Hellstrom, M., Kalen, M., Lindahl, P., Abramsson, A., & Betsholtz, C. (1999). Role of PDGF-B and 
PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic 
blood vessel formation in the mouse. Development, 126(14), 3047-3055.  
Hessel, S., Eichinger, A., Isken, A., Amengual, J., Hunzelmann, S., Hoeller, U., . . . Wyss, A. (2007). 
CMO1 deficiency abolishes vitamin A production from beta-carotene and alters lipid metabolism 
in mice. J Biol Chem, 282(46), 33553-33561. doi: 10.1074/jbc.M706763200 
Hochgreb, T., Linhares, V. L., Menezes, D. C., Sampaio, A. C., Yan, C. Y., Cardoso, W. V., . . . Xavier-
Neto, J. (2003). A caudorostral wave of RALDH2 conveys anteroposterior information to the 
cardiac field. Development, 130(22), 5363-5374. doi: 10.1242/dev.00750 
Hochgreb, Tatiana, Linhares, Vania L., Menezes, Diego C., Sampaio, Allysson C., Yan, Chao Y. I., 
Cardoso, Wellington V., . . . Xavier-Neto, José. (2003). A caudorostral wave of RALDH2 
conveys anteroposterior information to the cardiac field. Development, 130(22), 5363-5374.  
Hoffman, J. I. (1995). Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol, 
16(3), 103-113. doi: 10.1007/BF00801907 
176 
 
Hoffman, J. I., & Kaplan, S. (2002). The incidence of congenital heart disease. J Am Coll Cardiol, 
39(12), 1890-1900.  
Hoover, L. L., Burton, E. G., Brooks, B. A., & Kubalak, S. W. (2008). The expanding role for retinoid 
signaling in heart development. ScientificWorldJournal, 8, 194-211. doi: 10.1100/tsw.2008.39 
Huang, G. N., Thatcher, J. E., McAnally, J., Kong, Y., Qi, X., Tan, W., . . . Olson, E. N. (2012). C/EBP 
transcription factors mediate epicardial activation during heart development and injury. Science, 
338(6114), 1599-1603. doi: 10.1126/science.1229765 
Huang, Y., Harrison, M. R., Osorio, A., Kim, J., Baugh, A., Duan, C., . . . Lien, C. L. (2013). Igf 
Signaling is Required for Cardiomyocyte Proliferation during Zebrafish Heart Development and 
Regeneration. PLoS One, 8(6), e67266. doi: 10.1371/journal.pone.0067266 
Hutson, M. R., & Kirby, M. L. (2007). Model systems for the study of heart development and disease. 
Cardiac neural crest and conotruncal malformations. Semin Cell Dev Biol, 18(1), 101-110. doi: 
10.1016/j.semcdb.2006.12.004 
Ilagan, Roger, Abu-Issa, Radwan, Brown, Doris, Yang, Yu-Ping, Jiao, Kai, Schwartz, Robert J., . . . 
Meyers, Erik N. (2006). Fgf8 is required for anterior heart field development. Development, 
133(12), 2435-2445.  
Ishiguro, A., Inagaki, M., & Kaga, M. (2007). Stereotypic circling behavior in mice with vestibular 
dysfunction: asymmetrical effects of intrastriatal microinjection of a dopamine agonist. Int J 
Neurosci, 117(7), 1049-1064. doi: 10.1080/00207450600936874 
Isken, A., Golczak, M., Oberhauser, V., Hunzelmann, S., Driever, W., Imanishi, Y., . . . von Lintig, J. 
(2008). RBP4 disrupts vitamin A uptake homeostasis in a STRA6-deficient animal model for 
Matthew-Wood syndrome. Cell Metab, 7(3), 258-268. doi: 10.1016/j.cmet.2008.01.009 
Ito, H., Iwasaki, K., Ikeda, T., Sakai, H., Shimokawa, I., & Matsuo, T. (1992). HNK-1 expression pattern 
in normal and bis-diamine induced malformed developing rat heart: three dimensional 
reconstruction analysis using computer graphics. Anat Embryol (Berl), 186(4), 327-334.  
177 
 
Jackson, M., Connell, M. G., Smith, A., Drury, J., & Anderson, R. H. (1995). Common arterial trunk and 
pulmonary atresia: close developmental cousins? results from a teratogen induced animal model. 
Cardiovasc Res, 30(6), 992-1000.  
Jiang, Xiaobing, Choudhary, Bibha, Merki, Esther, Chien, Kenneth R., Maxson, Robert E., & Sucov, 
Henry M. (2002). Normal fate and altered function of the cardiac neural crest cell lineage in 
retinoic acid receptor mutant embryos. Mechanisms of Development, 117(1–2), 115-122. doi: 
http://dx.doi.org/10.1016/S0925-4773(02)00206-X 
Kam, R. K., Chen, Y., Chan, S. O., Chan, W. Y., Dawid, I. B., & Zhao, H. (2010). Developmental 
expression of Xenopus short-chain dehydrogenase/reductase 3. Int J Dev Biol, 54(8-9), 1355-
1360. doi: 10.1387/ijdb.092984rk 
Kam, R. K., Shi, W., Chan, S. O., Chen, Y., Xu, G., Lau, C. B., . . . Zhao, H. (2013). Dhrs3 protein 
attenuates retinoic acid signaling and is required for early embryonic patterning. J Biol Chem, 
288(44), 31477-31487. doi: 10.1074/jbc.M113.514984 
Kam, Richard Kin Ting, Shi, Weili, Chan, Sun On, Chen, Yonglong, Xu, Gang, Lau, Clara Bik-San, . . . 
Zhao, Hui. (2013). Dhrs3 Protein Attenuates Retinoic Acid Signaling and Is Required for Early 
Embryonic Patterning. The Journal of Biological Chemistry, 288(44), 31477-31487. doi: 
10.1074/jbc.M113.514984 
Kambe, T., Tada-Kambe, J., Kuge, Y., Yamaguchi-Iwai, Y., Nagao, M., & Sasaki, R. (2000). Retinoic 
acid stimulates erythropoietin gene transcription in embryonal carcinoma cells through the direct 
repeat of a steroid/thyroid hormone receptor response element half-site in the hypoxia-response 
enhancer. Blood, 96(9), 3265-3271.  
Kane, M. A., Chen, N., Sparks, S., & Napoli, J. L. (2005). Quantification of endogenous retinoic acid in 
limited biological samples by LC/MS/MS. Biochem J, 388(Pt 1), 363-369. doi: 
10.1042/BJ20041867 
Kane, M. A., & Napoli, J. L. (2010). Quantification of endogenous retinoids. Methods Mol Biol, 652, 1-
54. doi: 10.1007/978-1-60327-325-1_1 
178 
 
Kang, Jione, Gu, Ying, Li, Peng, Johnson, Betsy L, Sucov, Henry M, & Thomas, Penny S. (2008). 
PDGF‐A as an epicardial mitogen during heart development. Developmental Dynamics, 237(3), 
692-701.  
Kardami, E., & Fandrich, R. R. (1989). Basic fibroblast growth factor in atria and ventricles of the 
vertebrate heart. J Cell Biol, 109(4 Pt 1), 1865-1875.  
Kastner, P., Messaddeq, N., Mark, M., Wendling, O., Grondona, J. M., Ward, S., . . . Chambon, P. 
(1997). Vitamin A deficiency and mutations of RXRalpha, RXRbeta and RARalpha lead to early 
differentiation of embryonic ventricular cardiomyocytes. Development, 124(23), 4749-4758.  
Katz, T. C., Singh, M. K., Degenhardt, K., Rivera-Feliciano, J., Johnson, R. L., Epstein, J. A., & Tabin, 
C. J. (2012). Distinct compartments of the proepicardial organ give rise to coronary vascular 
endothelial cells. Dev Cell, 22(3), 639-650. doi: 10.1016/j.devcel.2012.01.012 
Kedishvili, N. Y. (2013). Enzymology of retinoic acid biosynthesis and degradation. J Lipid Res, 54(7), 
1744-1760. doi: 10.1194/jlr.R037028 
Keegan, Brian R., Feldman, Jessica L., Begemann, Gerrit, Ingham, Philip W., & Yelon, Deborah. (2005). 
Retinoic Acid Signaling Restricts the Cardiac Progenitor Pool. Science, 307(5707), 247-249. doi: 
10.1126/science.1101573 
Kelly, M., Widjaja-Adhi, M. A., Palczewski, G., & von Lintig, J. (2016). Transport of vitamin A across 
blood-tissue barriers is facilitated by STRA6. FASEB J, 30(8), 2985-2995. doi: 
10.1096/fj.201600446R 
Kelly, R. G. (2012). The second heart field. Curr Top Dev Biol, 100, 33-65. doi: 10.1016/b978-0-12-
387786-4.00002-6 
Kennedy-Lydon, T., & Rosenthal, N. (2015). Cardiac regeneration: epicardial mediated repair. Proc Biol 
Sci, 282(1821), 20152147. doi: 10.1098/rspb.2015.2147 
Kessel, Michael, & Gruss, Peter. (1991). Homeotic transformations of murine vertebrae and concomitant 




Kikuchi, K., Holdway, J. E., Major, R. J., Blum, N., Dahn, R. D., Begemann, G., & Poss, K. D. (2011). 
Retinoic acid production by endocardium and epicardium is an injury response essential for 
zebrafish heart regeneration. Dev Cell, 20(3), 397-404. doi: 10.1016/j.devcel.2011.01.010 
Kikuchi, Kazu, Gupta, Vikas, Wang, Jinhu, Holdway, Jennifer E., Wills, Airon A., Fang, Yi, & Poss, 
Kenneth D. (2011). tcf21 epicardial cells adopt non-myocardial fates during zebrafish heart 
development and regeneration. Development, 138(14), 2895-2902. doi: 10.1242/dev.067041 
Kilburn, K. H., Hess, R. A., Lesser, M., & Oster, G. (1982). Perinatal death and respiratory apparatus 
dysgenesis due to a bis (dichloroacetyl) diamine. Teratology, 26(2), 155-162. doi: 
10.1002/tera.1420260207 
Kim, J., Wu, Q., Zhang, Y., Wiens, K. M., Huang, Y., Rubin, N., . . . Lien, C. L. (2010). PDGF signaling 
is required for epicardial function and blood vessel formation in regenerating zebrafish hearts. 
Proc Natl Acad Sci U S A, 107(40), 17206-17210. doi: 10.1073/pnas.0915016107 
Kise, K., Nakagawa, M., Okamoto, N., Hanato, T., Watanabe, N., Nishijima, S., . . . Shiraishi, I. (2005). 
Teratogenic effects of bis-diamine on the developing cardiac conduction system. Birth Defects 
Res A Clin Mol Teratol, 73(8), 547-554. doi: 10.1002/bdra.20163 
Kliewer, S. A., Umesono, K., Mangelsdorf, D. J., & Evans, R. M. (1992). Retinoid X receptor interacts 
with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature, 
355(6359), 446-449. doi: 10.1038/355446a0 
Kochhar, D. M. (1973). Limb development in mouse embryos. I. Analysis of teratogenic effects of 
retinoic acid. Teratology, 7(3), 289-298. doi: 10.1002/tera.1420070310 
Kolodzinska, A., Heleniak, A., & Ratajska, A. (2013). Retinoic acid-induced ventricular non-compacted 
cardiomyopathy in mice. Kardiol Pol, 71(5), 447-452. doi: 10.5603/KP.2013.0090 
Koop, Demian, Holland, Nicholas D., Sémon, Marie, Alvarez, Susana, de Lera, Angel Rodriguez, Laudet, 
Vincent, . . . Schubert, Michael. (2010). Retinoic acid signaling targets Hox genes during the 
amphioxus gastrula stage: Insights into early anterior–posterior patterning of the chordate body 
plan. Developmental Biology, 338(1), 98-106. doi: http://dx.doi.org/10.1016/j.ydbio.2009.11.016 
180 
 
Kostetskii, I., Jiang, Y., Kostetskaia, E., Yuan, S., Evans, T., & Zile, M. (1999). Retinoid signaling 
required for normal heart development regulates GATA-4 in a pathway distinct from 
cardiomyocyte differentiation. Dev Biol, 206(2), 206-218. doi: 10.1006/dbio.1998.9139 
Kostetskii, I., Yuan, S. Y., Kostetskaia, E., Linask, K. K., Blanchet, S., Seleiro, E., . . . Zile, M. (1998). 
Initial retinoid requirement for early avian development coincides with retinoid receptor 
coexpression in the precardiac fields and induction of normal cardiovascular development. Dev 
Dyn, 213(2), 188-198. doi: 10.1002/(SICI)1097-0177(199810)213:2<188::AID-AJA4>3.0.CO;2-
C 
Krust, A., Kastner, P., Petkovich, M., Zelent, A., & Chambon, P. (1989). A third human retinoic acid 
receptor, hRAR-gamma. Proc Natl Acad Sci U S A, 86(14), 5310-5314.  
Kumar, S., & Duester, G. (2014). Retinoic acid controls body axis extension by directly repressing Fgf8 
transcription. Development, 141(15), 2972-2977. doi: 10.1242/dev.112367 
Kumar, S., Sandell, L. L., Trainor, P. A., Koentgen, F., & Duester, G. (2012). Alcohol and aldehyde 
dehydrogenases: retinoid metabolic effects in mouse knockout models. Biochim Biophys Acta, 
1821(1), 198-205. doi: 10.1016/j.bbalip.2011.04.004 
Kuribayashi, T., & Roberts, W. C. (1993). Tetralogy of Fallot, truncus arteriosus, abnormal myocardial 
architecture and anomalies of the aortic arch system induced by bis-diamine in rat fetuses. J Am 
Coll Cardiol, 21(3), 768-776.  
Lai, L., Bohnsack, B. L., Niederreither, K., & Hirschi, K. K. (2003). Retinoic acid regulates endothelial 
cell proliferation during vasculogenesis. Development, 130(26), 6465-6474. doi: 
10.1242/dev.00887 
Lamalice, Laurent, Le Boeuf, Fabrice, & Huot, Jacques. (2007). Endothelial Cell Migration During 




Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke, P. J., Braun, J. T., . . . et al. (1985). 
Retinoic acid embryopathy. N Engl J Med, 313(14), 837-841. doi: 
10.1056/NEJM198510033131401 
Lavine, K. J., Yu, K., White, A. C., Zhang, X., Smith, C., Partanen, J., & Ornitz, D. M. (2005). 
Endocardial and epicardial derived FGF signals regulate myocardial proliferation and 
differentiation in vivo. Dev Cell, 8(1), 85-95. doi: 10.1016/j.devcel.2004.12.002 
Lavine, Kory J., Yu, Kai, White, Andrew C., Zhang, Xiuqin, Smith, Craig, Partanen, Juha, & Ornitz, 
David M. (2005). Endocardial and Epicardial Derived FGF Signals Regulate Myocardial 
Proliferation and Differentiation In Vivo. Developmental Cell, 8(1), 85-95. doi: 
http://dx.doi.org/10.1016/j.devcel.2004.12.002 
Lee, L. M., Leung, C. Y., Tang, W. W., Choi, H. L., Leung, Y. C., McCaffery, P. J., . . . Shum, A. S. 
(2012). A paradoxical teratogenic mechanism for retinoic acid. Proc Natl Acad Sci U S A, 
109(34), 13668-13673. doi: 10.1073/pnas.1200872109 
Lepilina, A., Coon, A. N., Kikuchi, K., Holdway, J. E., Roberts, R. W., Burns, C. G., & Poss, K. D. 
(2006). A dynamic epicardial injury response supports progenitor cell activity during zebrafish 
heart regeneration. Cell, 127(3), 607-619. doi: 10.1016/j.cell.2006.08.052 
Li, E., Sucov, H. M., Lee, K. F., Evans, R. M., & Jaenisch, R. (1993). Normal development and growth of 
mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. Proceedings of the 
National Academy of Sciences of the United States of America, 90(4), 1590-1594.  
Li, P., Cavallero, S., Gu, Y., Chen, T. H., Hughes, J., Hassan, A. B., . . . Sucov, H. M. (2011). IGF 
signaling directs ventricular cardiomyocyte proliferation during embryonic heart development. 
Development, 138(9), 1795-1805. doi: 10.1242/dev.054338 
Li, P., Pashmforoush, M., & Sucov, H. M. (2010). Retinoic acid regulates differentiation of the secondary 




Li, Peng, Cavallero, Susana, Gu, Ying, Chen, Tim H. P., Hughes, Jennifer, Hassan, A. Bassim, . . . Sucov, 
Henry M. (2011). IGF signaling directs ventricular cardiomyocyte proliferation during embryonic 
heart development. Development, 138(9), 1795-1805. doi: 10.1242/dev.054338 
Liberatore, C. M., Searcy-Schrick, R. D., & Yutzey, K. E. (2000). Ventricular expression of tbx5 inhibits 
normal heart chamber development. Dev Biol, 223(1), 169-180. doi: 10.1006/dbio.2000.9748 
Lie-Venema, H., Eralp, I., Markwald, R. R., van den Akker, N. M., Wijffels, M. C., Kolditz, D. P., . . . 
Gittenberger-de Groot, A. C. (2008). Periostin expression by epicardium-derived cells is involved 
in the development of the atrioventricular valves and fibrous heart skeleton. Differentiation, 
76(7), 809-819. doi: 10.1111/j.1432-0436.2007.00262.x 
Lie-Venema, H., van den Akker, N. M., Bax, N. A., Winter, E. M., Maas, S., Kekarainen, T., . . . 
Gittenberger-de Groot, A. C. (2007). Origin, fate, and function of epicardium-derived cells 
(EPDCs) in normal and abnormal cardiac development. ScientificWorldJournal, 7, 1777-1798. 
doi: 10.1100/tsw.2007.294 
Lin, S. C., Dolle, P., Ryckebusch, L., Noseda, M., Zaffran, S., Schneider, M. D., & Niederreither, K. 
(2010). Endogenous retinoic acid regulates cardiac progenitor differentiation. Proc Natl Acad Sci 
U S A, 107(20), 9234-9239. doi: 10.1073/pnas.0910430107 
Lin, Song-Chang, Dollé, Pascal, Ryckebüsch, Lucile, Noseda, Michela, Zaffran, Stéphane, Schneider, 
Michael D., & Niederreither, Karen. (2010). Endogenous retinoic acid regulates cardiac 
progenitor differentiation. Proceedings of the National Academy of Sciences of the United States 
of America, 107(20), 9234-9239. doi: 10.1073/pnas.0910430107 
Liu, Q., Yan, H., Dawes, N. J., Mottino, G. A., Frank, J. S., & Zhu, H. (1996). Insulin-like growth factor 
II induces DNA synthesis in fetal ventricular myocytes in vitro. Circ Res, 79(4), 716-726.  
Lobo, G. P., Hessel, S., Eichinger, A., Noy, N., Moise, A. R., Wyss, A., . . . von Lintig, J. (2010). ISX is a 
retinoic acid-sensitive gatekeeper that controls intestinal beta,beta-carotene absorption and 
vitamin A production. FASEB J, 24(6), 1656-1666. doi: 10.1096/fj.09-150995 
183 
 
Lockhart, Marie M., Phelps, Aimee L., van den Hoff, Maurice J. B., & Wessels, Andy. (2014). The 
Epicardium and the Development of the Atrioventricular Junction in the Murine Heart. Journal of 
developmental biology, 2(1), 1-17. doi: 10.3390/jdb2010001 
Lohnes, D., Mark, M., Mendelsohn, C., Dolle, P., Dierich, A., Gorry, P., . . . Chambon, P. (1994). 
Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal 
abnormalities in RAR double mutants. Development, 120(10), 2723-2748.  
Lu, J., Landerholm, T. E., Wei, J. S., Dong, X. R., Wu, S. P., Liu, X., . . . Majesky, M. W. (2001). 
Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin 
reorganization and p160 rho-kinase activity. Dev Biol, 240(2), 404-418. doi: 
10.1006/dbio.2001.0403 
Maclean, G., Dolle, P., & Petkovich, M. (2009). Genetic disruption of CYP26B1 severely affects 
development of neural crest derived head structures, but does not compromise hindbrain 
patterning. Dev Dyn, 238(3), 732-745. doi: 10.1002/dvdy.21878 
Maclean, Glenn, Dollé, Pascal, & Petkovich, Martin. (2009). Genetic disruption of CYP26B1 severely 
affects development of neural crest derived head structures, but does not compromise hindbrain 
patterning. Developmental Dynamics, 238(3), 732-745. doi: 10.1002/dvdy.21878 
Maden, Malcolm, Gale, Emily, Kostetskii, Igor, & Zile, Maija. (1996). Vitamin A-deficient quail 
embryos have half a hindbrain and other neural defects. Current Biology, 6(4), 417-426. doi: 
10.1016/s0960-9822(02)00509-2 
Maekawa, M., Ishizaki, T., Boku, S., Watanabe, N., Fujita, A., Iwamatsu, A., . . . Narumiya, S. (1999). 
Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. 
Science, 285(5429), 895-898.  
Manabe, I., & Owens, G. K. (2001). Recruitment of serum response factor and hyperacetylation of 
histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-
derived in vitro smooth muscle differentiation system. Circ Res, 88(11), 1127-1134.  
184 
 
Marin-Juez, R., Marass, M., Gauvrit, S., Rossi, A., Lai, S. L., Materna, S. C., . . . Stainier, D. Y. (2016). 
Fast revascularization of the injured area is essential to support zebrafish heart regeneration. Proc 
Natl Acad Sci U S A, 113(40), 11237-11242. doi: 10.1073/pnas.1605431113 
Marques, S. R., Lee, Y., Poss, K. D., & Yelon, D. (2008). Reiterative roles for FGF signaling in the 
establishment of size and proportion of the zebrafish heart. Dev Biol, 321(2), 397-406. doi: 
10.1016/j.ydbio.2008.06.033 
Martínez-Estrada, Ofelia M, Lettice, Laura A, Essafi, Abdelkader, Guadix, Juan Antonio, Slight, Joan, 
Velecela, Víctor, . . . Hohenstein, Peter. (2010). Wt1 is required for cardiovascular progenitor cell 
formation through transcriptional control of Snail and E-cadherin. Nature genetics, 42(1), 89-93.  
Mason, Karl E. (1935). Foetal death, prolonged gestation, and difficult parturition in the rat as a result of 
vitamin A‐deficiency. American Journal of Anatomy, 57(2), 303-349.  
Masters, Megan, & Riley, Paul R. (2014). The epicardium signals the way towards heart regeneration. 
Stem Cell Research, 13(3), 683-692. doi: 10.1016/j.scr.2014.04.007 
Matt, N., Schmidt, C. K., Dupe, V., Dennefeld, C., Nau, H., Chambon, P., . . . Ghyselinck, N. B. (2005). 
Contribution of cellular retinol-binding protein type 1 to retinol metabolism during mouse 
development. Dev Dyn, 233(1), 167-176. doi: 10.1002/dvdy.20313 
McCollum, Elmer Verner, & Davis, Marguerite. (1913). The necessity of certain lipids in the diet during 
growth.  
Mellgren, A. M., Smith, C. L., Olsen, G. S., Eskiocak, B., Zhou, B., Kazi, M. N., . . . Tallquist, M. D. 
(2008). Platelet-derived growth factor receptor beta signaling is required for efficient epicardial 
cell migration and development of two distinct coronary vascular smooth muscle cell 
populations. Circ Res, 103(12), 1393-1401. doi: 10.1161/CIRCRESAHA.108.176768 
Mellgren, Amy M., Smith, Christopher L., Olsen, Gregory S., Eskiocak, Banu, Zhou, Bin, Kazi, Michelle 
N., . . . Tallquist, Michelle D. (2008). PDGFRβ signaling is required for efficient epicardial cell 
migration and development of two distinct coronary vascular smooth muscle cell populations. 
Circulation research, 103(12), 1393-1401. doi: 10.1161/CIRCRESAHA.108.176768 
185 
 
Mendez, M. G., Kojima, S., & Goldman, R. D. (2010). Vimentin induces changes in cell shape, motility, 
and adhesion during the epithelial to mesenchymal transition. Faseb j, 24(6), 1838-1851. doi: 
10.1096/fj.09-151639 
Mercader, N., Fischer, S., & Neumann, C. J. (2006). Prdm1 acts downstream of a sequential RA, Wnt and 
Fgf signaling cascade during zebrafish forelimb induction. Development, 133(15), 2805-2815. 
doi: 10.1242/dev.02455 
Merki, E., Zamora, M., Raya, A., Kawakami, Y., Wang, J., Zhang, X., . . . Ruiz-Lozano, P. (2005). 
Epicardial retinoid X receptor alpha is required for myocardial growth and coronary artery 
formation. Proc Natl Acad Sci U S A, 102(51), 18455-18460. doi: 10.1073/pnas.0504343102 
Metzler, M. A., & Sandell, L. L. (2016). Enzymatic Metabolism of Vitamin A in Developing Vertebrate 
Embryos. Nutrients, 8(12). doi: 10.3390/nu8120812 
Mic, F. A., Molotkov, A., Fan, X., Cuenca, A. E., & Duester, G. (2000). RALDH3, a retinaldehyde 
dehydrogenase that generates retinoic acid, is expressed in the ventral retina, otic vesicle and 
olfactory pit during mouse development. Mech Dev, 97(1-2), 227-230.  
Mic, Felix A., Haselbeck, Robert J., Cuenca, Arnold E., & Duester, Gregg. (2002). Novel retinoic acid 
generating activities in the neural tube and heart identified by conditional rescue of 
&lt;em&gt;Raldh2&lt;/em&gt; null mutant mice. Development, 129(9), 2271.  
Michielon, G., Di Carlo, D., Brancaccio, G., Guccione, P., Mazzera, E., Toscano, A., & Di Donato, R. M. 
(2003). Anomalous coronary artery origin from the pulmonary artery: correlation between 
surgical timing and left ventricular function recovery. Ann Thorac Surg, 76(2), 581-588; 
discussion 588.  
Mikawa, T, & Fischman, D A. (1992). Retroviral analysis of cardiac morphogenesis: discontinuous 
formation of coronary vessels. Proceedings of the National Academy of Sciences, 89(20), 9504-
9508. doi: 10.1073/pnas.89.20.9504 
Minicucci, M. F., Azevedo, P. S., Oliveira, S. A., Jr., Martinez, P. F., Chiuso-Minicucci, F., Polegato, B. 
F., . . . Zornoff, L. A. (2010). Tissue vitamin A insufficiency results in adverse ventricular 
186 
 
remodeling after experimental myocardial infarction. Cell Physiol Biochem, 26(4-5), 523-530. 
doi: 10.1159/000322320 
Minoux, M., & Rijli, F. M. (2010). Molecular mechanisms of cranial neural crest cell migration and 
patterning in craniofacial development. Development, 137(16), 2605-2621. doi: 
10.1242/dev.040048 
Mizutani, Makiko, Wu, Joseph C., & Nusse, Roeland. (2016). Fibrosis of the Neonatal Mouse Heart After 
Cryoinjury Is Accompanied by Wnt Signaling Activation and Epicardial‐to‐Mesenchymal 
Transition. Journal of the American Heart Association, 5(3). doi: 10.1161/jaha.115.002457 
Moasser, Mark M., & Dmitrovsky, Ethan. The retinoids: Biology, chemistry, and medicine, second 
edition. Trends in Endocrinology & Metabolism, 6(5), 185-186. doi: 10.1016/1043-
2760(95)90051-9 
Mollard, Richard, Viville, Stéphane, Ward, Simon J., Décimo, Didier, Chambon, Pierre, & Dollé, Pascal. 
(2000). Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse 
embryo. Mechanisms of Development, 94(1–2), 223-232. doi: http://dx.doi.org/10.1016/S0925-
4773(00)00303-8 
Morriss-Kay, G. (1993). Retinoic acid and craniofacial development: molecules and morphogenesis. 
Bioessays, 15(1), 9-15. doi: 10.1002/bies.950150103 
Moss, J. B., Xavier-Neto, J., Shapiro, M. D., Nayeem, S. M., McCaffery, P., Drager, U. C., & Rosenthal, 
N. (1998). Dynamic patterns of retinoic acid synthesis and response in the developing 
mammalian heart. Dev Biol, 199(1), 55-71. doi: 10.1006/dbio.1998.8911 
Moss, Jennifer B, Xavier-Neto, José, Shapiro, Michael D, Nayeem, Sara M, McCaffery, Peter, Dräger, 
Ursula C, & Rosenthal, Nadia. (1998). Dynamic patterns of retinoic acid synthesis and response 
in the developing mammalian heart. Developmental biology, 199(1), 55-71.  
Moutier, E., Ye, T., Choukrallah, M. A., Urban, S., Osz, J., Chatagnon, A., . . . Davidson, I. (2012). 
Retinoic acid receptors recognize the mouse genome through binding elements with diverse 
spacing and topology. J Biol Chem, 287(31), 26328-26341. doi: 10.1074/jbc.M112.361790 
187 
 
Moutier, Emmanuel, Ye, Tao, Choukrallah, Mohamed-Amin, Urban, Sylvia, Osz, Judit, Chatagnon, 
Amandine, . . . Moras, Dino. (2012). Retinoic acid receptors recognize the mouse genome 
through binding elements with diverse spacing and topology. Journal of Biological Chemistry, 
287(31), 26328-26341.  
Nanka, O., Valasek, P., Dvorakova, M., & Grim, M. (2006). Experimental hypoxia and embryonic 
angiogenesis. Dev Dyn, 235(3), 723-733. doi: 10.1002/dvdy.20689 
Narematsu, Mayu, Kamimura, Tatsuya, Yamagishi, Toshiyuki, Fukui, Mitsuru, & Nakajima, Yuji. 
(2015). Impaired Development of Left Anterior Heart Field by Ectopic Retinoic Acid Causes 
Transposition of the Great Arteries. Journal of the American Heart Association, 4(5). doi: 
10.1161/jaha.115.001889 
Niederreither, K., Abu-Abed, S., Schuhbaur, B., Petkovich, M., Chambon, P., & Dolle, P. (2002). Genetic 
evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during 
mouse development. Nat Genet, 31(1), 84-88. doi: 10.1038/ng876 
Niederreither, K., Fraulob, V., Garnier, J. M., Chambon, P., & Dolle, P. (2002). Differential expression of 
retinoic acid-synthesizing (RALDH) enzymes during fetal development and organ differentiation 
in the mouse. Mech Dev, 110(1-2), 165-171.  
Niederreither, K., McCaffery, P., Drager, U. C., Chambon, P., & Dolle, P. (1997). Restricted expression 
and retinoic acid-induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH-2) 
gene during mouse development. Mech Dev, 62(1), 67-78.  
Niederreither, K., Subbarayan, V., Dolle, P., & Chambon, P. (1999). Embryonic retinoic acid synthesis is 
essential for early mouse post-implantation development. Nat Genet, 21(4), 444-448. doi: 
10.1038/7788 
Niederreither, K., Vermot, J., Fraulob, V., Chambon, P., & Dolle, P. (2002). Retinaldehyde 
dehydrogenase 2 (RALDH2)- independent patterns of retinoic acid synthesis in the mouse 
embryo. Proc Natl Acad Sci U S A, 99(25), 16111-16116. doi: 10.1073/pnas.252626599 
188 
 
Niederreither, K., Vermot, J., Messaddeq, N., Schuhbaur, B., Chambon, P., & Dolle, P. (2001). 
Embryonic retinoic acid synthesis is essential for heart morphogenesis in the mouse. 
Development, 128(7), 1019-1031.  
Niederreither, Karen, Subbarayan, Vemparala, Dollé, Pascal, & Chambon, Pierre. (1999). Embryonic 
retinoic acid synthesis is essential for early mouse post-implantation development. Nature 
genetics, 21(4), 444-448.  
Niederreither, Karen, Vermot, Julien, Roux, Isabelle Le, Schuhbaur, Brigitte, Chambon, Pierre, & Dollé, 
Pascal. (2003). The regional pattern of retinoic acid synthesis by RALDH2 is essential for the 
development of posterior pharyngeal arches and the enteric nervous system. Development, 
130(11), 2525.  
Nishijima, S., Nakagawa, M., Fujino, H., Hanato, T., Okamoto, N., & Shimada, M. (2000). Teratogenic 
effects of bis-diamine on early embryonic rat heart: an in vitro study. Teratology, 62(2), 115-122. 
doi: 10.1002/1096-9926(200008)62:2<115::AID-TERA8>3.0.CO;2-# 
Okamoto, N., Nakagawa, M., Fujino, H., Nishijima, S., Hanato, T., Narita, T., . . . Imanaka-Yoshida, K. 
(2004). Teratogenic effects of bis-diamine on the developing myocardium. Birth Defects Res A 
Clin Mol Teratol, 70(3), 132-141. doi: 10.1002/bdra.20001 
Okishima, T., Takamura, K., Matsuoka, Y., Ohdo, S., & Hayakawa, K. (1992). Cardiovascular anomalies 
in chick embryos produced by bis-diamine in dimethylsulfoxide. Teratology, 45(2), 155-162. doi: 
10.1002/tera.1420450209 
Olivey, H. E., & Svensson, E. C. (2010). Epicardial-myocardial signaling directing coronary 
vasculogenesis. Circ Res, 106(5), 818-832. doi: 10.1161/CIRCRESAHA.109.209197 
Osmond, M. K., Butler, A. J., Voon, F. C., & Bellairs, R. (1991). The effects of retinoic acid on heart 
formation in the early chick embryo. Development, 113(4), 1405-1417.  
Oster, G., Salgo, M. P., & Taleporos, P. (1974). Embryocidal action of a bis(dichloroacetyl)-diamine: an 
oral abortifacient for rats. Am J Obstet Gynecol, 119(5), 583-588.  
189 
 
Osumi, N., Hirota, A., Ohuchi, H., Nakafuku, M., Iimura, T., Kuratani, S., . . . Eto, K. (1997). Pax-6 is 
involved in the specification of hindbrain motor neuron subtype. Development, 124(15), 2961.  
Paik, J., Haenisch, M., Muller, C. H., Goldstein, A. S., Arnold, S., Isoherranen, N., . . . Amory, J. K. 
(2014). Inhibition of retinoic acid biosynthesis by the bisdichloroacetyldiamine WIN 18,446 
markedly suppresses spermatogenesis and alters retinoid metabolism in mice. J Biol Chem, 
289(21), 15104-15117. doi: 10.1074/jbc.M113.540211 
Paiva, S. A., Matsubara, L. S., Matsubara, B. B., Minicucci, M. F., Azevedo, P. S., Campana, A. O., & 
Zornoff, L. A. (2005). Retinoic acid supplementation attenuates ventricular remodeling after 
myocardial infarction in rats. J Nutr, 135(10), 2326-2328.  
Papaioannou, Virginia E, & Behringer, Richard R. (2005). Mouse phenotypes: a handbook of mutation 
analysis: Cold Spring Harbor Laboratory Press. 
Park, Eon Joo, Ogden, Lisa A., Talbot, Amy, Evans, Sylvia, Cai, Chen-Leng, Black, Brian L., . . . Moon, 
Anne M. (2006). Required, tissue-specific roles for Fgf8 in outflow tract formation and 
remodeling. Development, 133(12), 2419-2433.  
Parlakian, Ara, Tuil, David, Hamard, Ghislaine, Tavernier, Geneviève, Hentzen, Daniele, Concordet, 
Jean-Paul, . . . Daegelen, Dominique. (2004). Targeted Inactivation of Serum Response Factor in 
the Developing Heart Results in Myocardial Defects and Embryonic Lethality. Molecular and 
Cellular Biology, 24(12), 5281-5289. doi: 10.1128/MCB.24.12.5281-5289.2004 
Paschaki, M., Schneider, C., Rhinn, M., Thibault-Carpentier, C., Dembele, D., Niederreither, K., & Dolle, 
P. (2013). Transcriptomic analysis of murine embryos lacking endogenous retinoic acid 
signaling. PLoS One, 8(4), e62274. doi: 10.1371/journal.pone.0062274 
Patterson, A. J., & Zhang, L. (2010). Hypoxia and fetal heart development. Curr Mol Med, 10(7), 653-
666.  
Pennimpede, T., Cameron, D. A., MacLean, G. A., Li, H., Abu-Abed, S., & Petkovich, M. (2010). The 
role of CYP26 enzymes in defining appropriate retinoic acid exposure during embryogenesis. 
Birth Defects Res A Clin Mol Teratol, 88(10), 883-894. doi: 10.1002/bdra.20709 
190 
 
Pennisi, D. J., & Mikawa, T. (2005). Normal patterning of the coronary capillary plexus is dependent on 
the correct transmural gradient of FGF expression in the myocardium. Dev Biol, 279(2), 378-390. 
doi: 10.1016/j.ydbio.2004.12.028 
Pennisi, David J., Ballard, Victoria L. T., & Mikawa, Takashi. (2003). Epicardium is required for the full 
rate of myocyte proliferation and levels of expression of myocyte mitogenic factors FGF2 and its 
receptor, FGFR-1, but not for transmural myocardial patterning in the embryonic chick heart. 
Developmental Dynamics, 228(2), 161-172. doi: 10.1002/dvdy.10360 
Perez-Pomares, J. M., & de la Pompa, J. L. (2011). Signaling during epicardium and coronary vessel 
development. Circ Res, 109(12), 1429-1442. doi: 10.1161/CIRCRESAHA.111.245589 
Perez-Pomares, J. M., Phelps, A., Sedmerova, M., Carmona, R., Gonzalez-Iriarte, M., Munoz-Chapuli, 
R., & Wessels, A. (2002). Experimental studies on the spatiotemporal expression of WT1 and 
RALDH2 in the embryonic avian heart: a model for the regulation of myocardial and 
valvuloseptal development by epicardially derived cells (EPDCs). Dev Biol, 247(2), 307-326.  
Pérez-Pomares, J. M., Phelps, A., Sedmerova, M., Carmona, R., González-Iriarte, M., Muñoz-Chápuli, 
R., & Wessels, A. (2002). Experimental Studies on the Spatiotemporal Expression of WT1 and 
RALDH2 in the Embryonic Avian Heart: A Model for the Regulation of Myocardial and 
Valvuloseptal Development by Epicardially Derived Cells (EPDCs). Developmental Biology, 
247(2), 307-326. doi: http://dx.doi.org/10.1006/dbio.2002.0706 
Perez-Pomares, Jose-Maria, Carmona, Rita, Gonzalez-Iriarte, Mauricio, Atencia, Gerardo, Wessels, 
Andy, & Munoz-Chapuli, Ramon. (2002). Origin of coronary endothelial cells from epicardial 
mesothelium in avian embryos. International Journal of Developmental Biology, 46(8), 1005-
1013.  
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987). A human retinoic acid receptor which 
belongs to the family of nuclear receptors. Nature, 330(6147), 444-450. doi: 10.1038/330444a0 
191 
 
Porrello, Enzo R., Mahmoud, Ahmed I., Simpson, Emma, Hill, Joseph A., Richardson, James A., Olson, 
Eric N., & Sadek, Hesham A. (2011). Transient Regenerative Potential of the Neonatal Mouse 
Heart. Science, 331(6020), 1078-1080. doi: 10.1126/science.1200708 
Porté, Sergio, Ruiz, F Xavier, Giménez, Joan, Molist, Iago, Alvarez, Susana, Domínguez, Marta, . . . 
Farrés, Jaume. (2013). Aldo–keto reductases in retinoid metabolism: Search for substrate 
specificity and inhibitor selectivity. Chemico-biological interactions, 202(1), 186-194.  
Poss, K. D., Wilson, L. G., & Keating, M. T. (2002). Heart regeneration in zebrafish. Science, 298(5601), 
2188-2190. doi: 10.1126/science.1077857 
Pratt, R. M., Goulding, E. H., & Abbott, B. D. (1987). Retinoic acid inhibits migration of cranial neural 
crest cells in the cultured mouse embryo. J Craniofac Genet Dev Biol, 7(3), 205-217.  
Qian, Li, Huang, Yu, Spencer, C. Ian, Foley, Amy, Vedantham, Vasanth, Liu, Lei, . . . Srivastava, 
Deepak. (2012). In vivo reprogramming of murine cardiac fibroblasts into induced 
cardiomyocytes. Nature, 485(7400), 593-598. doi: 
http://www.nature.com/nature/journal/v485/n7400/abs/nature11044.html#supplementary-
information 
Quadro, L., Hamberger, L., Gottesman, M. E., Colantuoni, V., Ramakrishnan, R., & Blaner, W. S. 
(2004). Transplacental delivery of retinoid: the role of retinol-binding protein and lipoprotein 
retinyl ester. Am J Physiol Endocrinol Metab, 286(5), E844-851. doi: 
10.1152/ajpendo.00556.2003 
Quadro, L., Hamberger, L., Gottesman, M. E., Wang, F., Colantuoni, V., Blaner, W. S., & Mendelsohn, 
C. L. (2005). Pathways of vitamin A delivery to the embryo: insights from a new tunable model 
of embryonic vitamin A deficiency. Endocrinology, 146(10), 4479-4490. doi: 10.1210/en.2005-
0158 
Quaggin, S. E., Vanden Heuvel, G. B., & Igarashi, P. (1998). Pod-1, a mesoderm-specific basic-helix-
loop-helix protein expressed in mesenchymal and glomerular epithelial cells in the developing 
kidney. Mech Dev, 71(1-2), 37-48.  
192 
 
Raya, A., Koth, C. M., Buscher, D., Kawakami, Y., Itoh, T., Raya, R. M., . . . Izpisua-Belmonte, J. C. 
(2003). Activation of Notch signaling pathway precedes heart regeneration in zebrafish. Proc 
Natl Acad Sci U S A, 100 Suppl 1, 11889-11895. doi: 10.1073/pnas.1834204100 
Ream, Margie, Ray, Alisa M., Chandra, Rashmi, & Chikaraishi, Dona M. (2008). Early fetal hypoxia 
leads to growth restriction and myocardial thinning (Vol. 295). 
Reese, D. E., Mikawa, T., & Bader, D. M. (2002). Development of the coronary vessel system. Circ Res, 
91(9), 761-768.  
Reeves, P. G. (1997). Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr, 
127(5 Suppl), 838S-841S.  
Reifers, F., Walsh, E. C., Leger, S., Stainier, D. Y., & Brand, M. (2000). Induction and differentiation of 
the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar). Development, 127(2), 
225-235.  
Rhinn, M., Schuhbaur, B., Niederreither, K., & Dolle, P. (2011). Involvement of retinol dehydrogenase 
10 in embryonic patterning and rescue of its loss of function by maternal retinaldehyde treatment. 
Proc Natl Acad Sci U S A, 108(40), 16687-16692. doi: 10.1073/pnas.1103877108 
Rhinn, Muriel, & Dollé, Pascal. (2012). Retinoic acid signalling during development. Development, 
139(5), 843-858. doi: 10.1242/dev.065938 
Ribes, V., Fraulob, V., Petkovich, M., & Dolle, P. (2007). The oxidizing enzyme CYP26a1 tightly 
regulates the availability of retinoic acid in the gastrulating mouse embryo to ensure proper head 
development and vasculogenesis. Dev Dyn, 236(3), 644-653. doi: 10.1002/dvdy.21057 
Riento, K., Villalonga, P., Garg, R., & Ridley, A. (2005). Function and regulation of RhoE. Biochem Soc 
Trans, 33(Pt 4), 649-651. doi: 10.1042/BST0330649 
Romand, Raymond, Kondo, Takako, Fraulob, Valérie, Petkovich, Martin, Dollé, Pascal, & Hashino, Eri. 
(2006). Dynamic expression of retinoic acid‐synthesizing and‐metabolizing enzymes in the 
developing mouse inner ear. Journal of Comparative Neurology, 496(5), 643-654.  
193 
 
Romeih, M., Cui, J., Michaille, J. J., Jiang, W., & Zile, M. H. (2003). Function of RARgamma and 
RARalpha2 at the initiation of retinoid signaling is essential for avian embryo survival and for 
distinct events in cardiac morphogenesis. Dev Dyn, 228(4), 697-708. doi: 10.1002/dvdy.10419 
Rosenkranz, Stephan. (2004). TGF-β1 and angiotensin networking in cardiac remodeling. Cardiovascular 
Research, 63(3), 423-432. doi: 10.1016/j.cardiores.2004.04.030 
Rossant, J., Zirngibl, R., Cado, D., Shago, M., & Giguere, V. (1991). Expression of a retinoic acid 
response element-hsplacZ transgene defines specific domains of transcriptional activity during 
mouse embryogenesis. Genes Dev, 5(8), 1333-1344.  
Rothman, K. J., Moore, L. L., Singer, M. R., Nguyen, U. S., Mannino, S., & Milunsky, A. (1995). 
Teratogenicity of high vitamin A intake. N Engl J Med, 333(21), 1369-1373. doi: 
10.1056/NEJM199511233332101 
Rubin, L. P., Ross, A. C., Stephensen, C. B., Bohn, T., & Tanumihardjo, S. A. (2017). Metabolic Effects 
of Inflammation on Vitamin A and Carotenoids in Humans and Animal Models. Adv Nutr, 8(2), 
197-212. doi: 10.3945/an.116.014167 
Rudat, C., Norden, J., Taketo, M. M., & Kispert, A. (2013). Epicardial function of canonical Wnt-, 
Hedgehog-, Fgfr1/2-, and Pdgfra-signalling. Cardiovasc Res, 100(3), 411-421. doi: 
10.1093/cvr/cvt210 
Rudat, Carsten, & Kispert, Andreas. (2012). Wt1 and Epicardial Fate Mapping. Circulation Research, 
111(2), 165-169. doi: 10.1161/circresaha.112.273946 
Ruiz-Villalba, A., & Perez-Pomares, J. M. (2012). The expanding role of the epicardium and epicardial-
derived cells in cardiac development and disease. Curr Opin Pediatr, 24(5), 569-576. doi: 
10.1097/MOP.0b013e328357a532 
Ruiz, F. X., Gallego, O., Ardevol, A., Moro, A., Dominguez, M., Alvarez, S., . . . Farres, J. (2009). Aldo-
keto reductases from the AKR1B subfamily: retinoid specificity and control of cellular retinoic 
acid levels. Chem Biol Interact, 178(1-3), 171-177. doi: 10.1016/j.cbi.2008.10.027 
194 
 
Ruiz, F. X., Porte, S., Gallego, O., Moro, A., Ardevol, A., Del Rio-Espinola, A., . . . Pares, X. (2011). 
Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. Biochem J, 
440(3), 335-344. doi: 10.1042/BJ20111286 
Ryckebusch, L., Wang, Z., Bertrand, N., Lin, S. C., Chi, X., Schwartz, R., . . . Niederreither, K. (2008). 
Retinoic acid deficiency alters second heart field formation. Proc Natl Acad Sci U S A, 105(8), 
2913-2918. doi: 10.1073/pnas.0712344105 
Ryckebusch, Lucile, Wang, Zengxin, Bertrand, Nicolas, Lin, Song-Chang, Chi, Xuan, Schwartz, Robert, . 
. . Niederreither, Karen. (2008). Retinoic acid deficiency alters second heart field formation. 
Proceedings of the National Academy of Sciences, 105(8), 2913-2918. doi: 
10.1073/pnas.0712344105 
Rydeen, A. B., & Waxman, J. S. (2014). Cyp26 enzymes are required to balance the cardiac and vascular 
lineages within the anterior lateral plate mesoderm. Development, 141(8), 1638-1648. doi: 
10.1242/dev.105874 
Rydeen, A., Voisin, N., D'Aniello, E., Ravisankar, P., Devignes, C. S., & Waxman, J. S. (2015). 
Excessive feedback of Cyp26a1 promotes cell non-autonomous loss of retinoic acid signaling. 
Dev Biol, 405(1), 47-55. doi: 10.1016/j.ydbio.2015.06.008 
Sakabe, M., Kokubo, H., Nakajima, Y., & Saga, Y. (2012). Ectopic retinoic acid signaling affects outflow 
tract cushion development through suppression of the myocardial Tbx2-Tgfbeta2 pathway. 
Development, 139(2), 385-395. doi: 10.1242/dev.067058 
Sakai, Y., Meno, C., Fujii, H., Nishino, J., Shiratori, H., Saijoh, Y., . . . Hamada, H. (2001). The retinoic 
acid-inactivating enzyme CYP26 is essential for establishing an uneven distribution of retinoic 
acid along the anterio-posterior axis within the mouse embryo. Genes Dev, 15(2), 213-225.  
Sandell, L. L., Sanderson, B. W., Moiseyev, G., Johnson, T., Mushegian, A., Young, K., . . . Trainor, P. 
A. (2007). RDH10 is essential for synthesis of embryonic retinoic acid and is required for limb, 
craniofacial, and organ development. Genes Dev, 21(9), 1113-1124. doi: 10.1101/gad.1533407 
195 
 
Sandell, Lisa L., Lynn, Megan L., Inman, Kimberly E., McDowell, William, & Trainor, Paul A. (2012). 
RDH10 Oxidation of Vitamin A Is a Critical Control Step in Synthesis of Retinoic Acid during 
Mouse Embryogenesis. PLoS ONE, 7(2), e30698. doi: 10.1371/journal.pone.0030698 
Sapin, Vincent, Bègue, René-Jean, Dastugue, Bernard, Chambon, Pierre, & Dollé, Pascal. (1998). 
Trophoblast Research. The maternal-fetal interfaceRetinoids and mouse placentation. Placenta, 
19, 57-76. doi: http://dx.doi.org/10.1016/S0143-4004(98)80033-7 
Satre, M. A., & Kochhar, D. M. (1989). Elevations in the endogenous levels of the putative morphogen 
retinoic acid in embryonic mouse limb-buds associated with limb dysmorphogenesis. 
Developmental Biology, 133(2), 529-536. doi: https://doi.org/10.1016/0012-1606(89)90055-9 
Schmidt, Annette, Brixius, Klara, & Bloch, Wilhelm. (2007). Endothelial Precursor Cell Migration 
During Vasculogenesis. Circulation Research, 101(2), 125-136. doi: 
10.1161/circresaha.107.148932 
Shannon, S. R., Moise, A. R., & Trainor, P. A. (2017). New insights and changing paradigms in the 
regulation of vitamin A metabolism in development. Wiley Interdiscip Rev Dev Biol, 6(3). doi: 
10.1002/wdev.264 
Sharma, B., Chang, A., & Red-Horse, K. (2017). Coronary Artery Development: Progenitor Cells and 
Differentiation Pathways. Annu Rev Physiol, 79, 1-19. doi: 10.1146/annurev-physiol-022516-
033953 
Shen, H., Cavallero, S., Estrada, K. D., Sandovici, I., Kumar, S. R., Makita, T., . . . Sucov, H. M. (2015). 
Extracardiac control of embryonic cardiomyocyte proliferation and ventricular wall expansion. 
Cardiovasc Res, 105(3), 271-278. doi: 10.1093/cvr/cvu269 
Shenefelt, RE. (1972). Gross congenital malformations. Animal model: treatment of various species with 
a large dose of vitamin A at known stages in pregnancy. The American journal of pathology, 
66(3), 589.  
Shirakami, Y., Lee, S. A., Clugston, R. D., & Blaner, W. S. (2012). Hepatic metabolism of retinoids and 
disease associations. Biochim Biophys Acta, 1821(1), 124-136. doi: 10.1016/j.bbalip.2011.06.023 
196 
 
Singh, A., Ramesh, S., Cibi, D. M., Yun, L. S., Li, J., Li, L., . . . Singh, M. K. (2016). Hippo Signaling 
Mediators Yap and Taz Are Required in the Epicardium for Coronary Vasculature Development. 
Cell Rep, 15(7), 1384-1393. doi: 10.1016/j.celrep.2016.04.027 
Sirbu, Ioan Ovidiu, Zhao, Xianling, & Duester, Gregg. (2008). Retinoic Acid Controls Heart 
Anteroposterior Patterning by Downregulating Isl1 through the Fgf8 Pathway. Developmental 
dynamics : an official publication of the American Association of Anatomists, 237(6), 1627-1635. 
doi: 10.1002/dvdy.21570 
Smart, N., Bollini, S., Dube, K. N., Vieira, J. M., Zhou, B., Riegler, J., . . . Riley, P. R. (2012). 
Myocardial regeneration: expanding the repertoire of thymosin beta4 in the ischemic heart. Ann N 
Y Acad Sci, 1269, 92-101. doi: 10.1111/j.1749-6632.2012.06708.x 
Smart, Nicola, Bollini, Sveva, Dubé, Karina N, Vieira, Joaquim M, Zhou, Bin, Davidson, Sean, . . . 
Lythgoe, Mark F. (2011). De novo cardiomyocytes from within the activated adult heart after 
injury. Nature, 474(7353), 640-644.  
Smith, C. L., Baek, S. T., Sung, C. Y., & Tallquist, M. D. (2011). Epicardial-derived cell epithelial-to-
mesenchymal transition and fate specification require PDGF receptor signaling. Circ Res, 
108(12), e15-26. doi: 10.1161/CIRCRESAHA.110.235531 
Smith, Susan M., Dickman, Eileen D., Power, Susan C., & Lancman, Joseph. (1998). Retinoids and Their 
Receptors in Vertebrate Embryogenesis. The Journal of Nutrition, 128(2), 467S-470S.  
Smith, Susan M., Dickman, Eileen D., Thompson, Robert P., Sinning, Allan R., Wunsch, Ann M., & 
Markwald, Roger R. (1997). Retinoic Acid Directs Cardiac Laterality and the Expression of Early 
Markers of Precardiac Asymmetry. Developmental Biology, 182(1), 162-171. doi: 
http://dx.doi.org/10.1006/dbio.1996.8474 
Sorrell, M. R., & Waxman, J. S. (2011). Restraint of Fgf8 signaling by retinoic acid signaling is required 




Soshnikova, Natalia, Dewaele, Romain, Janvier, Philippe, Krumlauf, Robb, & Duboule, Denis. (2013). 
Duplications of hox gene clusters and the emergence of vertebrates. Developmental Biology, 
378(2), 194-199. doi: http://dx.doi.org/10.1016/j.ydbio.2013.03.004 
Stefanovic, S., & Zaffran, S. (2017). Mechanisms of retinoic acid signaling during cardiogenesis. Mech 
Dev, 143, 9-19. doi: 10.1016/j.mod.2016.12.002 
Stuckmann, I., Evans, S., & Lassar, A. B. (2003). Erythropoietin and retinoic acid, secreted from the 
epicardium, are required for cardiac myocyte proliferation. Dev Biol, 255(2), 334-349. doi: 
http://dx.doi.org/10.1016/S0012-1606(02)00078-7 
Stuckmann, Ingo, Evans, Samuel, & Lassar, Andrew B. (2003). Erythropoietin and retinoic acid, secreted 
from the epicardium, are required for cardiac myocyte proliferation. Developmental Biology, 
255(2), 334-349. doi: http://dx.doi.org/10.1016/S0012-1606(02)00078-7 
Subbarayan, V., Kastner, P., Mark, M., Dierich, A., Gorry, P., & Chambon, P. (1997). Limited specificity 
and large overlap of the functions of the mouse RAR gamma 1 and RAR gamma 2 isoforms. 
Mech Dev, 66(1-2), 131-142.  
Sun, Xin, Meyers, Erik N., Lewandoski, Mark, & Martin, Gail R. (1999). Targeted disruption of Fgf8 
causes failure of cell migration in the gastrulating mouse embryo. Genes & Development, 13(14), 
1834-1846.  
Swindell, E. C., Thaller, C., Sockanathan, S., Petkovich, M., Jessell, T. M., & Eichele, G. (1999). 
Complementary domains of retinoic acid production and degradation in the early chick embryo. 
Dev Biol, 216(1), 282-296. doi: 10.1006/dbio.1999.9487 
Tallquist, M. D., & Molkentin, J. D. (2017). Redefining the identity of cardiac fibroblasts. Nat Rev 
Cardiol, 14(8), 484-491. doi: 10.1038/nrcardio.2017.57 
Tasaka, H., Takenaka, H., Okamoto, N., Onitsuka, T., Koga, Y., & Hamada, M. (1991). Abnormal 
development of cardiovascular systems in rat embryos treated with bisdiamine. Teratology, 43(3), 
191-200. doi: 10.1002/tera.1420430303 
198 
 
Tevosian, S. G., Deconinck, A. E., Tanaka, M., Schinke, M., Litovsky, S. H., Izumo, S., . . . Orkin, S. H. 
(2000). FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis 
and development of coronary vessels from epicardium. Cell, 101(7), 729-739.  
Tian, X., Hu, T., Zhang, H., He, L., Huang, X., Liu, Q., . . . Zhou, B. (2013). Subepicardial endothelial 
cells invade the embryonic ventricle wall to form coronary arteries. Cell Res, 23(9), 1075-1090. 
doi: 10.1038/cr.2013.83 
Tickle, C., Lee, J., & Eichele, G. (1985). A quantitative analysis of the effect of all-trans-retinoic acid on 
the pattern of chick wing development. Developmental Biology, 109(1), 82-95. doi: 
http://dx.doi.org/10.1016/0012-1606(85)90348-3 
Tomanek, R. J., Lund, D. D., & Yue, X. (2003). Hypoxic induction of myocardial vascularization during 
development. Adv Exp Med Biol, 543, 139-149.  
Tomanek, R. J., Ratajska, A., Kitten, G. T., Yue, X., & Sandra, A. (1999). Vascular endothelial growth 
factor expression coincides with coronary vasculogenesis and angiogenesis. Dev Dyn, 215(1), 54-
61. doi: 10.1002/(SICI)1097-0177(199905)215:1<54::AID-DVDY6>3.0.CO;2-0 
Trembley, M. A., Velasquez, L. S., de Mesy Bentley, K. L., & Small, E. M. (2015). Myocardin-related 
transcription factors control the motility of epicardium-derived cells and the maturation of 
coronary vessels. Development, 142(1), 21-30. doi: 10.1242/dev.116418 
Twal, W., Roze, L., & Zile, M. H. (1995). Anti-retinoic acid monoclonal antibody localizes all-trans-
retinoic acid in target cells and blocks normal development in early quail embryo. Dev Biol, 
168(2), 225-234. doi: 10.1006/dbio.1995.1075 
Uehara, M., Yashiro, K., Mamiya, S., Nishino, J., Chambon, P., Dolle, P., & Sakai, Y. (2007). CYP26A1 
and CYP26C1 cooperatively regulate anterior-posterior patterning of the developing brain and 




Uehara, Masayuki, Yashiro, Kenta, Takaoka, Katsuyoshi, Yamamoto, Masamichi, & Hamada, Hiroshi. 
(2009). Removal of maternal retinoic acid by embryonic CYP26 is required for correct Nodal 
expression during early embryonic patterning. Genes & development, 23(14), 1689-1698.  
van Wijk, Bram, Gunst, Quinn D., Moorman, Antoon F. M., & van den Hoff, Maurice J. B. (2012). 
Cardiac Regeneration from Activated Epicardium. PLoS ONE, 7(9), e44692. doi: 
10.1371/journal.pone.0044692 
Vega-Hernandez, M., Kovacs, A., De Langhe, S., & Ornitz, D. M. (2011). FGF10/FGFR2b signaling is 
essential for cardiac fibroblast development and growth of the myocardium. Development, 
138(15), 3331-3340. doi: 10.1242/dev.064410 
Vieux-Rochas, M., Coen, L., Sato, T., Kurihara, Y., Gitton, Y., Barbieri, O., . . . Levi, G. (2007). 
Molecular dynamics of retinoic acid-induced craniofacial malformations: implications for the 
origin of gnathostome jaws. PLoS One, 2(6), e510. doi: 10.1371/journal.pone.0000510 
Vieux-Rochas, Maxence, Coen, Laurent, Sato, Takahiro, Kurihara, Yukiko, Gitton, Yorick, Barbieri, 
Ottavia, . . . Levi, Giovanni. (2007). Molecular Dynamics of Retinoic Acid-Induced Craniofacial 
Malformations: Implications for the Origin of Gnathostome Jaws. PLoS ONE, 2(6), e510. doi: 
10.1371/journal.pone.0000510 
Vincent, S. D., & Buckingham, M. E. (2010). How to make a heart: the origin and regulation of cardiac 
progenitor cells. Curr Top Dev Biol, 90, 1-41. doi: 10.1016/s0070-2153(10)90001-x 
Volz, K. S., Jacobs, A. H., Chen, H. I., Poduri, A., McKay, A. S., Riordan, D. P., . . . Red-Horse, K. 
(2015). Pericytes are progenitors for coronary artery smooth muscle. Elife, 4. doi: 
10.7554/eLife.10036 
von Gise, A., & Pu, W. T. (2012). Endocardial and epicardial epithelial to mesenchymal transitions in 




von Gise, A., Zhou, B., Honor, L. B., Ma, Q., Petryk, A., & Pu, W. T. (2011). WT1 regulates epicardial 
epithelial to mesenchymal transition through beta-catenin and retinoic acid signaling pathways. 
Dev Biol, 356(2), 421-431. doi: 10.1016/j.ydbio.2011.05.668 
von Lintig, J., & Vogt, K. (2000). Filling the gap in vitamin A research. Molecular identification of an 
enzyme cleaving beta-carotene to retinal. J Biol Chem, 275(16), 11915-11920.  
Vrancken Peeters, M. P., Gittenberger-de Groot, A. C., Mentink, M. M., Hungerford, J. E., Little, C. D., 
& Poelmann, R. E. (1997). The development of the coronary vessels and their differentiation into 
arteries and veins in the embryonic quail heart. Dev Dyn, 208(3), 338-348. doi: 
10.1002/(SICI)1097-0177(199703)208:3<338::AID-AJA5>3.0.CO;2-J 
Wakino, Shu, Kintscher, Ulrich, Kim, Sarah, Jackson, Simon, Yin, Fen, Nagpal, Sunil, . . . Law, Ronald 
E. (2001). Retinoids Inhibit Proliferation of Human Coronary Smooth Muscle Cells by 
Modulating Cell Cycle Regulators. Arteriosclerosis, Thrombosis, and Vascular Biology, 21(5), 
746-751. doi: 10.1161/01.atv.21.5.746 
Wang, Hao-Jie, Zhu, Yi-Chun, & Yao, Tai. (2002). Effects of all-trans retinoic acid on angiotensin II-
induced myocyte hypertrophy. Journal of Applied Physiology, 92(5), 2162-2168. doi: 
10.1152/japplphysiol.01192.2001 
Ward, C., Stadt, H., Hutson, M., & Kirby, M. L. (2005). Ablation of the secondary heart field leads to 
tetralogy of Fallot and pulmonary atresia. Dev Biol, 284(1), 72-83. doi: 
10.1016/j.ydbio.2005.05.003 
Waxman, J. S., Keegan, B. R., Roberts, R. W., Poss, K. D., & Yelon, D. (2008). Hoxb5b acts downstream 
of retinoic acid signaling in the forelimb field to restrict heart field potential in zebrafish. Dev 
Cell, 15(6), 923-934. doi: 10.1016/j.devcel.2008.09.009 
Waxman, J. S., & Yelon, D. (2009). Increased Hox activity mimics the teratogenic effects of excess 
retinoic acid signaling. Dev Dyn, 238(5), 1207-1213. doi: 10.1002/dvdy.21951 
Waxman, Joshua S., Keegan, Brian R., Roberts, Richard W., Poss, Kenneth D., & Yelon, Deborah. 
(2008). Hoxb5b acts downstream of retinoic acid signaling in the forelimb field to restrict heart 
201 
 
field potential in zebrafish. Developmental cell, 15(6), 923-934. doi: 
10.1016/j.devcel.2008.09.009 
Wei, K., Serpooshan, V., Hurtado, C., Diez-Cunado, M., Zhao, M., Maruyama, S., . . . Ruiz-Lozano, P. 
(2015). Epicardial FSTL1 reconstitution regenerates the adult mammalian heart. Nature, 
525(7570), 479-485. doi: 10.1038/nature15372 
Wendler, Christopher C., Schmoldt, Angela, Flentke, George R., Case, Lauren C., Quadro, Loredana, 
Blaner, William S., . . . Smith, Susan M. (2003). Increased Fibronectin Deposition in Embryonic 
Hearts of Retinol-Binding Protein–Null Mice. Circulation Research, 92(8), 920-928. doi: 
10.1161/01.res.0000069030.30886.8f 
White, J. C., Shankar, V. N., Highland, M., Epstein, M. L., DeLuca, H. F., & Clagett-Dame, M. (1998). 
Defects in embryonic hindbrain development and fetal resorption resulting from vitamin A 
deficiency in the rat are prevented by feeding pharmacological levels of all-trans-retinoic acid. 
Proc Natl Acad Sci U S A, 95(23), 13459-13464.  
White, Jeffrey C., Highland, Margaret, Kaiser, Mary, & Clagett-Dame, Margaret. (2000). Vitamin A 
Deficiency Results in the Dose-Dependent Acquisition of Anterior Character and Shortening of 
the Caudal Hindbrain of the Rat Embryo. Developmental Biology, 220(2), 263-284. doi: 
https://doi.org/10.1006/dbio.2000.9635 
Wikenheiser, J., Doughman, Y. Q., Fisher, S. A., & Watanabe, M. (2006). Differential levels of tissue 
hypoxia in the developing chicken heart. Dev Dyn, 235(1), 115-123. doi: 10.1002/dvdy.20499 
Wilson, James G, Roth, Carolyn B, & Warkany, Josef. (1953a). An analysis of the syndrome of 
malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at 
various times during gestation. American Journal of Anatomy, 92(2), 189-217.  
Wilson, James G, Roth, Carolyn B, & Warkany, Josef. (1953b). An analysis of the syndrome of 
malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at 
various times during gestation. Developmental Dynamics, 92(2), 189-217.  
202 
 
Wilson, James G, & Warkany, Josef. (1948). Malformations in the genito‐urinary tract induced by 
maternal vitamin a deficiency in the rat. Developmental Dynamics, 83(3), 357-407.  
Wu, H., Lee, S. H., Gao, J., Liu, X., & Iruela-Arispe, M. L. (1999). Inactivation of erythropoietin leads to 
defects in cardiac morphogenesis. Development, 126(16), 3597-3605.  
Wu, S. P., Dong, X. R., Regan, J. N., Su, C., & Majesky, M. W. (2013). Tbx18 regulates development of 
the epicardium and coronary vessels. Dev Biol, 383(2), 307-320. doi: 
10.1016/j.ydbio.2013.08.019 
Wyss, A., Wirtz, G., Woggon, W., Brugger, R., Wyss, M., Friedlein, A., . . . Hunziker, W. (2000). 
Cloning and expression of beta,beta-carotene 15,15'-dioxygenase. Biochem Biophys Res 
Commun, 271(2), 334-336. doi: 10.1006/bbrc.2000.2619 
Xavier-Neto, J., Neville, C. M., Shapiro, M. D., Houghton, L., Wang, G. F., Nikovits, W., Jr., . . . 
Rosenthal, N. (1999). A retinoic acid-inducible transgenic marker of sino-atrial development in 
the mouse heart. Development, 126(12), 2677-2687.  
Xavier-Neto, J., Shapiro, M. D., Houghton, L., & Rosenthal, N. (2000). Sequential programs of retinoic 
acid synthesis in the myocardial and epicardial layers of the developing avian heart. Dev Biol, 
219(1), 129-141. doi: 10.1006/dbio.1999.9588 
Xavier-Neto, J., Sousa Costa, A. M., Figueira, A. C., Caiaffa, C. D., Amaral, F. N., Peres, L. M., . . . 
Castillo, H. A. (2015). Signaling through retinoic acid receptors in cardiac development: Doing 
the right things at the right times. Biochim Biophys Acta, 1849(2), 94-111. doi: 
10.1016/j.bbagrm.2014.08.003 
Xu, Huansheng, Morishima, Masae, Wylie, John N., Schwartz, Robert J., Bruneau, Benoit G., Lindsay, 
Elizabeth A., & Baldini, Antonio. (2004). Tbx1 has a dual role in the morphogenesis of the 
cardiac outflow tract. Development, 131(13), 3217-3227.  
Yang, J. T., Rayburn, H., & Hynes, R. O. (1995). Cell adhesion events mediated by alpha 4 integrins are 
essential in placental and cardiac development. Development, 121(2), 549-560.  
203 
 
Yashiro, Kenta, Zhao, Xianling, Uehara, Masayuki, Yamashita, Kimiyo, Nishijima, Misae, Nishino, 
Jinsuke, . . . Hamada, Hiroshi. (2004). Regulation of Retinoic Acid Distribution Is Required for 
Proximodistal Patterning and Outgrowth of the Developing Mouse Limb. Developmental Cell, 
6(3), 411-422. doi: 10.1016/s1534-5807(04)00062-0 
Yasui, H., Nakazawa, M., Morishima, M., Ando, M., Takao, A., & Aikawa, E. (1997). Cardiac outflow 
tract septation process in the mouse model of transposition of the great arteries. Teratology, 
55(6), 353-363. doi: 10.1002/(SICI)1096-9926(199706)55:6<353::AID-TERA1>3.0.CO;2-Z 
Yu, Shuiliang, Levi, Liraz, Siegel, Ruth, & Noy, Noa. (2012). Retinoic Acid Induces Neurogenesis by 
Activating Both Retinoic Acid Receptors (RARs) and Peroxisome Proliferator-activated Receptor 
β/δ (PPARβ/δ). The Journal of Biological Chemistry, 287(50), 42195-42205. doi: 
10.1074/jbc.M112.410381 
Yue, X., & Tomanek, R. J. (1999). Stimulation of coronary vasculogenesis/angiogenesis by hypoxia in 
cultured embryonic hearts. Dev Dyn, 216(1), 28-36. doi: 10.1002/(SICI)1097-
0177(199909)216:1<28::AID-DVDY5>3.0.CO;2-U 
Yutzey, K. E., Rhee, J. T., & Bader, D. (1994). Expression of the atrial-specific myosin heavy chain 
AMHC1 and the establishment of anteroposterior polarity in the developing chicken heart. 
Development, 120(4), 871-883.  
Zaffran, S., Kelly, R. G., Meilhac, S. M., Buckingham, M. E., & Brown, N. A. (2004). Right ventricular 
myocardium derives from the anterior heart field. Circ Res, 95(3), 261-268. doi: 
10.1161/01.RES.0000136815.73623.BE 
Zaffran, Stéphane, Robrini, Nicolas El, & Bertrand, Nicolas. (2014). Retinoids and cardiac development. 
Journal of Developmental Biology, 2(1), 50-71.  
Zhao, Dayao, McCaffery, Peter, Ivins, Kathryn J, Neve, Rachael L, Hogan, Patrick, Chin, William W, & 
Dräger, Ursula C. (1996). Molecular identification of a major retinoic‐acid‐synthesizing enzyme, 
a retinaldehyde‐specific dehydrogenase. The FEBS Journal, 240(1), 15-22.  
204 
 
Zhou, B., Honor, L. B., He, H., Ma, Q., Oh, J. H., Butterfield, C., . . . Pu, W. T. (2011). Adult mouse 
epicardium modulates myocardial injury by secreting paracrine factors. J Clin Invest, 121(5), 
1894-1904. doi: 10.1172/JCI45529 
Zhou, B., Ma, Q., Rajagopal, S., Wu, S. M., Domian, I., Rivera-Feliciano, J., . . . Pu, W. T. (2008). 
Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature, 
454(7200), 109-113. doi: 10.1038/nature07060 
Zhou, Bin, Honor, Leah B., He, Huamei, Ma, Qing, Oh, Jin-Hee, Butterfield, Catherine, . . . Pu, William 
T. (2011). Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. 
The Journal of Clinical Investigation, 121(5), 1894-1904. doi: 10.1172/JCI45529 
Zhou, Bin, & Pu, William T. (2012). Genetic Cre-loxP assessment of epicardial cell fate using Wt1-
driven Cre Alleles. Circulation research, 111(11), e276-e280. doi: 
10.1161/CIRCRESAHA.112.275784 
Zhou, Bin, von Gise, Alexander, Ma, Qing, Hu, Yong Wu, & Pu, William T. (2010). Genetic fate 
mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the 
mammalian heart. Developmental Biology, 338(2), 251-261. doi: 
https://doi.org/10.1016/j.ydbio.2009.12.007 
Zhou, M., Sutliff, R. L., Paul, R. J., Lorenz, J. N., Hoying, J. B., Haudenschild, C. C., . . . Doetschman, T. 
(1998). Fibroblast growth factor 2 control of vascular tone. Nat Med, 4(2), 201-207.  
Zile, M. H. (1999). Avian Embryo as Model for Retinoid Function in Early Development. In H. Nau & 
W. S. Blaner (Eds.), Retinoids: The Biochemical and Molecular Basis of Vitamin A and Retinoid 
Action (pp. 443-464). Berlin, Heidelberg: Springer Berlin Heidelberg. 
 
 
